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Malaria is caused by Plasmodium, an obligate intracellular eukaryotic pathogen that 
belongs to the phylum Apicomplexa. Apicomplexan parasites harbor an unusual 
plastid organelle, termed apicoplast. Several metabolic pathways, such as fatty acid 
biosynthesis type II, the non-mevalonate pathway of isoprenoid biosynthesis and 
iron-sulfur [Fe-S] cluster biosynthesis localize to the apicoplast. Because this unique 
organelle is indispensable for parasite growth it is a validated and attractive drug 
target. Using the rodent malaria parasite Plasmodium berghei, two different aspects 
of apicoplast protein functions were analyzed in this study. Firstly, a previously 
uncharacterized Plasmodium apicoplast protein, Plasmodium-specific Apicoplast 
protein important for Liver Merozoite formation (PALM), was investigated. It was 
shown that PALM localizes to the apicoplast and is expressed throughout the 
Plasmodium life cycle. Three independent palm— knockout parasite lines were 
generated by targeted gene deletion. Phenotypic analysis of these knockout lines 
revealed the importance of PALM for transition from liver- to blood-stage parasites. 
While the resulting knockout mutants developed normally for most of the life cycle, 
merozoite release into the blood stream and the ability to establish an infection was 
severely impaired. The presence of a signature blood-stage antigen, merozoite 
surface protein 1, indicated that palm— knockout parasites are arrested at a very late 
time point in liver-stage development. Experimental immunization of mice with palm— 
sporozoites elicited unprecedented potent and long-lasting protection against malaria 
re-infection. Immune profiling in old palm--immunized mice revealed persistence of 
antigen-specific IFNγ-secreting CD8+ T cells in the target organ, i.e. the liver. The 
results indicate that a tailor-made arrest in the final steps of hepatic merozoite 
formation could be an improvement over first-generation early liver-stage genetically 
arrested parasites (GAPs). 
Secondly, the six nuclear-encoded components of the apicoplast [Fe-S] cluster 
biosynthesis pathway were systematically targeted by experimental genetics. The 
genes of plastid localized sulfur utilization factors (SUFs) were refractory to gene 
deletion, suggesting that they might be essential for parasite blood-stage 
development. In contrast, it was possible to ablate the gene encoding the nitrogen 
fixation factor U (NifU)-like scaffold protein (NFUapi). The resulting parasites were 
able to complete the entire life cycle, indicating redundant or non-essential, auxiliary 
functions of NFUapi. Together, my studies show that the Plasmodium apicoplast 
harbors previously unrecognized targets for anti-malaria intervention strategies. 
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Zusammenfassung 
Malaria wird durch den einzelligen Parasiten Plasmodium verursacht. Hierbei handelt 
es sich um einen obligat intrazellulären, eukaryotischen Erreger, der zum Phylum der 
Apicomplexa gehört. Apicomplexa zeichnen sich durch das einzigartige 
Vorhandensein eines ungewöhnlichen Plastids, genannt Apicoplast, aus. Mehrere 
Stoffwechselwege wie zum Beispiel die Fettsäurebiosynthese Typ II, nicht-Mevalonat 
Biosynthese von Isoprenoiden und die [Fe-S]-Cluster Biosynthese wurden im 
Apicoplast lokalisiert. Die Exklusivität dieser Organelle und ihre metabolische 
Notwendigkeit für das Parasitenwachstum haben sie als attraktives 
pharmakologisches Ziel bestätigt. In dieser Arbeit wurden, unter Anwendung des 
Nagetier-Malariaerregers Plasmodium berghei, zwei verschiedene Aspekte von 
Apicoplast Proteinfunktionen untersucht. Zum Ersten wurde ein bislang 
unbeschriebenes Plasmodium Apicoplast Protein, Plasmodium-specific Apicoplast 
protein important for Liver Merozoite formation (PALM), charakterisiert. Es konnte 
gezeigt werden, dass PALM im Apicoplast lokalisiert ist und über den gesamten 
Lebenszyklus hinweg exprimiert wird. Drei voneinander unabhängige palm— 
Parasitenlinien, wurden durch zielgerichtete Gendeletion generiert. Die 
phänotypische Analyse dieser Knockout-Parasiten offenbarte die Bedeutung von 
PALM für den Übergang von Leber- zu Blutstadienparasiten. Die PALM Knockout-
Mutanten entwickelten sich während eines Großteils des Lebenszyklus normal, 
jedoch war die Abgabe von Merozoiten in den Blutstrom und die Fähigkeit eine 
Blutstadien-Infektion zu etablieren signifikant beeinträchtigt. Die Anwesenheit eines 
charakteristischen Blutstadienantigens, merozoite surface protein 1 (MSP1), wies 
darauf hin, dass palm— Parasiten zu einem sehr späten Zeitpunkt der 
Leberstadienentwicklung arretiert sind. Experimentelle Immunisierung von Mäusen 
mit palm— Sporozoiten bewirkte einen starken und langanhaltenden Schutz gegen 
Reinfektion mit Malaria. Immunologische Analysen in alten palm— immunisierten 
Mäusen wiesen die Persistenz von Antigen-spezifischen IFNγ-sekretierenden CD8+ 
T-Zellen im Zielorgan (der Leber) nach. Diese Ergebnisse lassen darauf schließen, 
dass Parasiten mit einem Arrest in den finalen Schritten der Bildung von 
Leberstadien-Merozoiten einen Vorteil gegenüber genetisch attenuierten Parasiten 
der ersten Generation haben, die in der frühen Leberstadienentwicklung arretiert 
sind. 
Zum Zweiten wurden die sechs Nucleus-kodierten Komponenten der [Fe-S] Cluster 
Biosynthese im Apicoplast systematisch durch experimentelle Genetik analysiert. Die 
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Gene der im Plastid lokalisierten sulfur utilization factors (SUFs) konnten nicht 
deletiert werden, was darauf hindeutet, dass sie möglicherweise eine essenzielle 
Rolle in der Blutstadientwicklung der Parasiten spielen könnten. Im Gegensatz dazu 
konnte das Gen, welches das nitrogen fixation factor U (NifU)-like scaffold Protein 
(NFUapi) kodiert, deletiert werden. Die resultierenden Parasiten konnten den 
gesamten Lebenszyklus durchlaufen, was auf eine redundante oder nicht-essenzielle 
Funktion von NFUapi hindeutet. Insgesamt zeigen meine Studien, dass bisher 
unbekannte Ziele im Plasmodium Apicoplast für Interventionsstrategien gegen 
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1.1 Plasmodium and related apicomplexan parasites 
 
Plasmodium, the etiologic agent of malaria, is an obligate intracellular eukaryotic 
pathogen that belongs to the phylum Apicomplexa. Their complex life cycle includes 
a vertebrate host and an insect vector, typically mosquitoes of the genus Anopheles. 
Five Plasmodium species are known to infect humans, namely P. falciparum, P. 
vivax, P. ovale, P. malariae, and P. knowlesi. In 2010, about 216 million cases of 
malaria were reported, most of them in sub-Saharan Africa (WHO, 2011). P. 
falciparum is the deadliest Plasmodium species to humans, often causing deaths in 
children under the age of five, pregnant women and non-immune adults (WHO, 
2011). All clinical malaria symptoms are caused by the blood-stage phase of 
infection. They include fever, anemia, coma, respiratory distress, and renal 
dysfunction (Beeson and Brown, 2002; Marsh et al., 1995). P. vivax is the most 
common species outside Africa and is difficult to control and treat because dormant 
liver stages, termed hypnozoites, can lead to relapses of malaria. Primaquine is 
currently the only available curative drug targeting this stage and preventing relapses 
(Cogswell, 1992; Wells et al., 2010).  
The impact of Plasmodium on mankind is highlighted by the fact that malaria 
parasites have imposed strong selective forces on the human genome in endemic 
regions. Balanced polymorphisms, such as sickle cell anemia and 
hemoglobinopathies, confer protection against malaria. This has led to significant co-
adaptation of human populations in malaria endemic regions with malaria parasites 
(Driss et al., 2011). 
There are dozens of Plasmodium species, however, that do not infect humans, but 
infect a variety of hosts, such as primates (P. reichenowi), rodents  (P. berghei), birds 
(P. gallinaceum), and reptiles (P. mexicanum) (Martinsen et al., 2008). 
The phylum Apicomplexa also includes various other parasites of medical and 
veterinary importance, such as Toxoplasma gondii, Theileria spp., Babesia spp., and 






Figure 1.1: Phylogenetic tree of the Apicomplexa. 
Phylogenetic tree of the phylum Apicomplexa. Selected parasites of human or 
veterinary importance are highlighted in red and green, respectively. Modified from 
(Beck et al., 2009). 
 
Infection with Toxoplasma gondii is one of the most common parasitic infections of 
humans and other warm-blooded animals. The definitive hosts of T. gondii are cats, 
where sexual recombination occurs. T. gondii infection is common in humans and 
most infections are asymptomatic. However, under certain circumstances the 
parasite can cause a devastating disease, for example in immunosuppressed 
individuals or when congenitally acquired. Toxoplasmosis is acquired by ingestion of 
oocysts or bradyzoites in the host tissue. After ingestion, the parasites penetrate 
intestinal epithelial cells, multiply in the intestine and then spread throughout the 
organism where they are able to infect virtually any nucleated cell (Hill et al., 2005). 
Protozoa of the genus Babesia infect a wide range of wild and domestic animals, 
causing fatal diseases, especially in domestic ones. Additionally, cases of human 
babesiosis have sporadically been diagnosed, mainly in North America and Europe 
(Hunfeld et al., 2008). Babesia is transmitted by ixodid ticks. During a tick bite 
sporozoites are directly injected into the bloodstream where they infect erythrocytes. 
Infection causes a host-mediated pathology and erythrocyte lysis, resulting in anemia 
and, occasionally, organ failure (Hunfeld et al., 2008).  
Theileria are intracellular protozoa, which infect wild and domestic ruminants. Like 
Babesia, they are transmitted by ticks, however, in the mammalian host, parasites 




induce a lymphoma-like phenotype in infected host leukocytes by inducing 
proliferation of the infected cells (Bishop et al., 2004). 
Cryptosporidiosis most commonly affects neonatal calves. However, infections can 
also occur in many other mammals and birds. Some Cryptosporidium species, e.g. 
C. hominis and C. parvum, are infectious to humans. Cryptosporidiosis is one of the 
most common causes of infectious diarrhea. In immunodeficient or 
immunosuppressed individuals it can cause a chronic, life-threatening diarrhea. 
Transmission occurs through the ingestion of infectious oocysts with contaminated 
water or food (Chako et al., 2010). 
 
 
1.2 The Plasmodium life cycle   
 
Plasmodium is transmitted to the vertebrate hosts during the bites of infectious 
female Anopheles mosquitoes (Fig. 1.2).  
 
  
Figure 1.2: Plasmodium life cycle.  
Schematic overview of the Plasmodium life cycle in the human host (a) and the 
mosquito vector (b). For details see main text in section 1.2. From (Wirth, 2002). 
 
During blood feeding, sporozoites are injected into the host dermis where they rapidly 




Approximately 15 minutes after the mosquito bite, the first wave of migrating 
sporozoites has left the bite site and moved into the general circulation (Sidjanski and 
Vanderberg, 1997). Sporozoite migration is dependent on their ability to move by 
substrate-dependent locomotion, called gliding motility, that relies on the parasiteʼs 
actomyosin motor (Amino et al., 2008; Menard, 2001). 
Some sporozoites appear to transform in the skin (Gueirard et al., 2010), but recent 
studies showed that this process does not contribute to blood-stage infection (Voza 
et al., 2012). 
Interestingly, sporozoites are highly infectious to the vertebrate host only after 
migration into the mosquito salivary glands (Vanderberg, 1975). In a screen using 
suppression subtractive cDNA hybridization, genes that are upregulated in infective 
sporozoites (UIS) were identified (Matuschewski et al., 2002). Some UIS genes were 
later shown to be crucial to establish infection in the vertebrate host (Mueller et al., 
2005a; Mueller et al., 2005b; Zhang et al., 2010). 
Once in the liver, sporozoites pass the liver sinusoidal barrier by transmigration 
through Kupffer cells (Frevert et al., 2005; Frevert et al., 2006; Frevert et al., 2008b; 
Ishino et al., 2005a; Ishino et al., 2004). 
Sporozoites traverse several hepatocytes by breaching their plasmamembranes 
before finally taking residence in a suitable hepatocyte (Frevert et al., 2005; Mota et 
al., 2001). Final target cell entry coincides with the formation of a replication-
competent niche, termed the parasitophorous vacuole (PV), which originates from 
the host cell plasma membrane (Sibley, 2011). The parasitophorous vacuole 
membrane prevents fusion of the developing parasite with endosomal compartments, 
thus providing a safe environment for liver-stage development.  
Upon successful invasion of a hepatocyte, a central spherical bulb forms around the 
nucleus, and the two distal ends of the sporozoite retract (Jayabalasingham et al., 
2010). The trophozoite then grows extensively, and multiple rounds of DNA 
replication occur. During this time the parasite organelles are also replicated 
(Stanway et al., 2011). Through this process, called schizogeny, and the following 
invaginations of the parasite plasma membrane thousands of first-generation 
merozoites are formed, which are then released into the blood stream in vesicles, 
termed merosomes (Sturm et al., 2006). The parasite development in the liver takes 
5 to 7 days in Plasmodium species infecting humans, but only about two days in 
rodent malaria species. After being released in the pulmonary microvasculature 




malaria blood-stage infection. The subsequent fast rounds of asexual replication 
through schizogeny within host erythrocytes allow the parasite population to multiply 
exponentially. Infection of erythrocytes is the exclusive phase that causes all clinical 
manifestations of malaria (Haldar et al., 2007). The various erythrocytic parasite 
stages can be diagnosed microscopically in Giemsa-stained thin blood smears. Ring 
stages, trophozoites, schizonts, merozoites, and gametocytes can be distinguished. 
A fraction of blood-stage parasites develops into sexual stages in a process that is 
not yet completely understood (Kooij and Matuschewski, 2007). Parasites are 
transmitted to the insect vector by ingestion of gametocytes by a mosquito during a 
blood meal. 
Exflagellation of male microgametes in the mosquito midgut is triggered by a 
mosquito-derived molecule, xanthurenic acid, in addition to a drop of temperature 
and a change in pH (Billker et al., 1998; Billker et al., 1997). The male microgametes 
then fertilize female macrogamete forming zygotes, which are the only diploid stages 
of the otherwise haploid parasites. After zygote formation meiosis takes place and 
genetic recombination occurs (Sinden and Hartley, 1985). Zygotes develop into 
motile ookinetes, which then leave the blood bolus by penetration of the peritrophic 
matrix that encloses the blood meal and traverse the epithelial layer of the mosquito 
midgut. After egress from the basal side of the epithelium ookinetes encounter the 
midgut basal lamina where they transform into sessile extracellular oocysts (Siden-
Kiamos and Louis, 2004). The oocysts start growing, and through sporogeny, a 
process that takes 10 to 14 days, hundreds of haploid sporozoites are formed 
(Matuschewski, 2006).  
When this development is completed, sporozoites are released into the hemocoel 
and migrate to the salivary glands (Matuschewski, 2006). Once mature sporozoites 
reach the salivary glands they are infectious and can be transmitted to a new 
vertebrate host by mosquito bite. 
. 
 
1.3 Rodent malaria models 
 
Malaria research greatly relies on animal models, as studies with human Plasmodium 
species are very limited for ethical reasons. Human Plasmodium spp. are 
inaccessible for in vivo investigations because access to organs such as liver, lungs 
and spleen is not possible. Laboratory research with human Plasmodium species is 




infection of primary human hepatocytes, therefore, it is currently not possible to 
reproduce the whole parasite life cycle. This limits research on host immune 
responses, parasite adaptations and mechanisms of disease. To overcome these 
limitations and to complement studies on human malaria, several animal models are 
available, e.g. avian, primate and rodent malaria models. The murine models are the 
most widely used, as they are more closely related to the human species than the 
avian models (Martinsen et al., 2008). They are also cheaper, easier to handle, and 
arising less ethical concerns than primate models. 
The rodent Plasmodium species P. berghei, P. yoelii, P. chabaudi and P. vinckei 
were initially isolated from thicket rats in Central Africa and have been adapted to 
grow in laboratory rodents, principally mice and rats (Carlton et al., 2001). The 
different species and laboratory strains differ in various aspects, such as their 
preferences to infect reticulocytes or mature erythrocytes. In addition, lethal and non-
lethal strains can be distinguished (Wykes and Good, 2009). 
Apart from the great advantage that the whole parasite life cycle can be reproduced 
and analyzed in the laboratory, rodent malaria parasites offer the possibility of easier 
and faster genetic modifications than P. falciparum (Janse et al., 2006c). Genetic 
manipulation of mosquitoes (Blandin et al., 2009), mice (Kordes et al., 2011) and 
malaria parasites (Mueller et al., 2005a) allows the investigation of specific gene 
functions from the host and the parasite perspectives. In addition, the generation of 
fluorescent parasite lines has opened the possibility to visualize the parasites live in 
the vertebrate host (Amino et al., 2007).  
The importance of murine malaria models is highlighted by their wide applications, 
such as immunopathogenesis (Lamb et al., 2006), vaccine development (Khan et al., 
2012), drug discovery (Fidock et al., 2004), drug resistance (Carlton et al., 2001), 
host-parasite interactions (Franke-Fayard et al., 2010) and placental malaria (Hviid et 
al., 2010). 
Recently, progress was achieved in the use of humanized mouse models to study 
blood-stage and liver-stage development of P. falciparum in mice (Legrand et al., 
2009; Vaughan et al., 2012). However, to date no model allows the combined study 
of liver- and blood-stage development in one system. This would be of great value to 
study the safety of whole-organism vaccines, efficacy of drugs, and biology of 
dormant liver stages of P. vivax, for instance (Vaughan et al., 2012). 
One of the most controversially discussed topics is the relevance of murine models 




falciparum infection (Hunt et al., 2010; White et al., 2010). P. berghei ANKA in 
combination with susceptible strains of mice, such as C57BL/6, replicates many 
aspects seen during human CM and is accepted as the best available model of 
experimental cerebral malaria (ECM) (de Souza et al., 2010). Infection of susceptible 
strains of mice leads to the development of fatal cerebral pathology, with clinical 
signs including ataxia, fitting, respiratory distress and coma (de Souza and Riley, 
2002). Human CM and murine ECM share several common features such as 
cytokine production, reduced blood flow, and increased lactate production in the 
brain (Hunt et al., 2010). However, there are also marked differences such as the 
sequestration of parasitized erythrocytes in human CM, in contrast to the 
accumulation of leukocytes and platelets in the venules and capillaries of the brain in 
the murine model (White et al., 2010). 
The model system always needs to be carefully chosen according to the research 
question asked and it has to be kept in mind that results of studies with animal 
models cannot be simply extrapolated to the human pathogens. Despite the 
differences between human and rodent malaria parasites, rodent malaria models 
have proven to be invaluable for malaria research. 
 
 
1.4 Apicoplast- the plastid of Apicomplexa 
 
1.4.1 The Plasmodium apicoplast 
 
Plasmodium contains three classes of DNA, the nuclear genome, the mitochondrial 
genome, and a 35kb circular genome. The 35kb circular DNA was shown to encode 
a genome similar to that of plant plastids (Williamson et al., 1994; Wilson et al., 
1996). The plastid-like DNA was shown to localize to a membrane-bound organelle in 
T. gondii, which then was termed “apicoplast” (Kohler et al., 1997; McFadden et al., 
1996). Most parasites of the genus Apicomplexa studied so far contain an apicoplast 
with the exceptions of Cryptosporidium parvum (Zhu et al., 2000) and Gregarina 
niphandrodes (Toso and Omoto, 2007). The apicoplast of Plasmodium and 
Toxoplasma is essential for parasite growth (Fichera and Roos, 1997; He et al., 
2001; McConkey et al., 1997) and has attracted attention as a drug target. 
The apicoplast is thought to originate from a complex event of secondary 




McFadden, 2010). The primary endosymbiosis resulted from a eukaryote that 
engulfed and retained a photosynthetic cyanobacterium bounded by two membranes, 
which led to the lineages of Glaucocystphytes, red algae and Viridiplantae. The 
second endosymbiosis led to the engulfment of this eukaryote by a second 
eukaryote, which then gave rise to the Chromalveolates, including Plasmodium spp., 
Toxoplasma gondii, Cryptosporidium spp., Theileria spp. and Babesia spp. It has 
initially been debated if the apicoplast is of red (Waller et al., 2003; Williamson et al., 
1994) or green algal origin (Funes et al., 2002; Kohler et al., 1997). More recently, 
the red algal origin is favored (Janouskovec et al., 2010). For instance, the plastid 
genome phylogenies of Chromeria velia, a recently described photosynthetic 
alveolate, is closely related to apicomplexan parasites (Moore et al., 2008). 
The process of secondary endosymbiosis gave rise to the four membranes 
surrounding the apicoplast (McFadden et al., 1996). The current model suggests that 
the outermost membrane is derived from the phagotrophic digestive vacuole that 
engulfed the red alga and is connected to the ER membrane (Cavalier-Smith, 2000). 
The second outermost membrane is called periplastid membrane and is derived from 
the plasma membrane of the red alga. The two inner membranes are called inner 
and outer membrane and originate from the inner and outer membrane of the primary 
plastid, respectively (Kalanon and McFadden, 2010). 
The 35kb circular plastid genome of Plasmodium encodes an inverted tandem repeat 
encompassing large- and small- subunit rRNA genes, 17 ribosomal proteins, a 
complete set of tRNAs, three subunits of a bacterial-type RNA polymerase, 
translation elongation factor Tu (EF-Tu), a member of the Clp family of molecular 
chaperones, SufB, and a few orphan open reading frames (Wilson et al., 1996). As a 
consequence, almost all apicoplast proteins are encoded in the nucleus. As in plant 
chloroplasts (Martin et al., 1998) this probably happened through gene transfer from 
the endosymbiont to the host (Huang et al., 2004; Waller et al., 1998). This requires 
an import machinery that allows specific targeting to the apicoplast and transport 
through the four membranes into the apicoplast.  
Generally, targeting to the apicoplast occurs by a N-terminal bipartite leader 
sequence consisting of a signal peptide (SP) and a transit peptide (TP)/ apicoplast 
targeting signal (ATS) (Waller et al., 1998). The SP mediates the entry into the 
secretory pathway and, most likely, is cleaved off during the co-translational import 
(Waller et al., 2000). The TP is necessary to direct the protein to the apicoplast. It is 




Experiments testing randomly scrambled sequences as TP showed that rather than a 
consensus sequence, an appropriate amino acid composition is sufficient for correct 
targeting (Tonkin et al., 2008). Furthermore, a chaperone-binding site can be critical 
for efficient and accurate targeting (Foth et al., 2003a). A stromal processing 
peptidase (SPP) has been proposed to cleave the TP in P. falciparum (van Dooren et 
al., 2002). However, a recent screen based on mRNA abundance over the cell cycle 
and on phyletic abundance in Toxoplasma identified new apicoplast-targeted proteins 
that lack this bipartite leader sequence (Sheiner et al., 2011).  
At present, 3 bioinformatics programs are available to predict targeting to the 
apicoplast. Two of them, PATS (Zuegge et al., 2001) and PlasmoAP (Foth et al., 
2003a) are optimized for P. falciparum sequences. Recently, another program was 
published, ApicoAP (Cilingir et al., 2012a), that predicts apicoplast targeting for P. 
falciparum, P. yoelii, T. gondii and B. bovis. Using PlasmoAP in a genome-wide 
screen, 466 candidate proteins for apicoplast targeting were identified in P. 
falciparum (Foth et al., 2003a). This set of putative apicoplast proteins was of great 
importance for reconstruction of several metabolic pathways that are thought to be 
present in the apicoplast (Ralph et al., 2004) and also explained why this organelle is 
essential for parasite survival. 
At present, the molecular mechanisms of protein translocation through the four 
apicoplast membranes is poorly understood. The first membrane is probably 
overcome by the co-translation import into the ER that is mediated by the SP, as the 
outermost apicoplast membrane is connected to the ER membrane (McFadden, 
1999). The periplastid membrane probably is traversed with the help of an 
apicoplast-localized ER-associated degradation (ERAD) system (Kalanon et al., 
2009; Sommer et al., 2007; Spork et al., 2009). As the two innermost apicoplast 
membranes are derived from the cyanobacterium, engulfed during primary 
endosymbiosis, the translocation through these membranes is predicted to be 
mediated by the translocon of outer envelope of chloroplast (TOC) and the 
translocon of inner envelope of chloroplast (TIC).  So far, two TIC components 
(Kalanon et al., 2009; van Dooren et al., 2008), but no TOC components have been 
described in apicoplasts. 
In Plasmodium, each parasite contains one apicoplast that changes its size and 
shape during the life cycle (Fig. 1.3). In studies using GFP as a reporter, it was 




organelle in merozoites and ring stages to a complex branched structure in schizonts 




Figure 1.3: Apicoplast morphology during the Plasmodium life cycle.  
In the non-erythrocytic stages of the parasite, green denotes apicoplast and red 
denotes mitochondrion. In the intra-erythrocytic stages and the gametocyte, green 
denotes mitochondrion and red denotes apicoplast. Blue denotes nucleus in all 
stages. Modified from (Lim and McFadden, 2010). 
 
During gametocytogenesis, the apicoplast stays round or slightly elongated 
(Okamoto et al., 2009). The male microgametes do not contain an apicoplast or 
mitochondrion (Okamoto et al., 2009), which is consistent with the maternal 
inheritance of these organelles  (Creasey et al., 1994). In oocysts the apicoplast 
again displays a branched structure and after segregation into sporozoites can be 
seen as a round or slightly elongated structure (Fig. 1.3). Similar to asexual blood 
stages, in liver stages the apicoplast expands from a small dot in early to a complex 
reticulate structure in later stages (Stanway et al., 2009). The apicoplast and the 
mitochondrion are tightly associated throughout most life-cycle stages (Okamoto et 




the heme biosynthesis pathway, which is shared between the two organelles (Sato et 
al., 2004; van Dooren et al., 2006). 
Recently, a novel trafficking pathway in P. falciparum was proposed for the 
localization of glutathione peroxidase-like thioredoxin peroxidase, which is localized 
to the apicoplast, the mitochondrion, and the cytosol (Chaudhari et al., 2012). The 
authors suggest that a common pathway for the dual localization of a single gene 
product, such as the primitive endoplasmic reticulum- Golgi route, may have been 
retained as opposed to optimization for individual organellar import pathways. 
Like all plastids, the apicoplast cannot be created de novo. Therefore, this organelle 
and its genome have to be divided and segregated into every parasite during 
replication. To date, little is known about the molecules involved in this process in 
Plasmodium. However, it could be shown that in a tightly regulated process the 
apicoplast divides prior to the mitochondrion in asexual blood stages and liver stages 
(Stanway et al., 2011; van Dooren et al., 2005). 
 
 
1.4.2 Plasmodium apicoplast pathways and drug targets 
 
Since the apicoplast is not photosynthetically active, its essentiality must be based on 
other pathways. With the help of in silico analysis and expanding experimental work 
various pathways could be mapped to the apicoplast (Ralph et al., 2004; Seeber and 
Soldati-Favre, 2010). The bacterial origin of the apicoplast renders it a good drug 
target, because it harbors pathways that either are not present in humans and 
animals or some enzymes differ substantially. Here, a brief overview of the currently 
known Plasmodium apicoplast pathways is given. 
 
DOXP pathway of isoprenoid synthesis 
Isoprenoids are a group of highly diverse natural compounds that play key roles in a 
variety of processes in Plasmodium, including protein prenylation and carotenoid 
biosynthesis (van der Meer and Hirsch, 2012). The precursors for isoprenoids are 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Their 
products are also needed for the transfer of glycosylphosphatidyl inositol (GPI)-
anchors of membrane-bound proteins, such as merozoite surface proteins (Davidson 




In mammals, yeast, higher plants, and archaebacteria, IPP is generated through the 
mevalonate pathway, which starts with the synthesis of mevalonate from acetyl-CoA.  
In bacteria and plants an alternative pathway is used for IPP production, which does 
not use mevalonate as a precursor (Rohmer et al., 1993). This pathway was also 
shown to be located in the apicoplast (Jomaa et al., 1999). The non-mevalonate 
pathway uses pyruvate and glyceraldehydes 3-phosphate (GA3P) as substrates to 
generate 1-deoxy-D-xylulose 5-phosphate (DOXP), which then is converted to 2-C-
methyl-erythritol 4-phosphate (MEP). IPP is then generated from MEP after several 
consecutive enzyme reactions. For this reason the non-mevalonate pathway of 
isoprenoid biosynthesis is also called DOXP pathway. Attempts to delete DOXP 
reductoisomerase (Dxr) in P. falciparum were unsuccessful, strongly suggesting that 
this pathway is essential for blood-stage parasites (Odom and Van Voorhis, 2010). 
Fosmidomycin is an inhibitor of the DOXP reductoisomerase (DXR) (Jomaa et al., 
1999). Recently, it was shown that fosmidomycin might also act on a second enzyme 
of the DOXP pathway, methylerythritol phosphate cytidyltransferase (IspD), 
downstream of DXR (Zhang et al., 2011). Fosmidomycin is successfully used to treat 
malaria blood-stage infection (Borrmann et al., 2004). However, it does not act on T. 
gondii, although the DOXP pathway including DXR is present there. This difference 
has been attributed to the poor uptake of the drug (Nair et al., 2011). It is still a matter 
of debate if fosmidomycin acts on P. berghei liver stages, as contradictory results 
have been published recently (Baumeister et al., 2011; Nair et al., 2011). 
In a recent paper the DOXP pathway of isoprenoid biosynthesis was suggested to be 
the sole reason for the essentiality of this pathway in P. falciparum blood stages (Yeh 
and DeRisi, 2011). The authors treated P. falciparum blood-stage cultures with 
azithromycin, a drug that acts on the apicoplast and eventually leads to parasite 
death. They were able to rescue parasite death by supplementation with IPP, the 
precursor for isoprenoid biosynthesis. However, it remains unclear what happens to 
other nuclear-encoded apicoplast proteins and if some of them might still be able to 
fulfill (part of) their functions if they are not targeted to the apicoplast. If this were the 
case, there might be other essential pathways in Plasmodium blood stages that are 
simply not affected by azithromycin treatment.  
 
Type II fatty acid synthesis 
Plasmodium has a high demand for lipids and phospholipids as it harbors various 




rhoptries (Palacpac et al., 2004). It also requires membranes during schizogeny for 
thousands of daughter parasites. 
The eukaryotic fatty acid synthase type I (FASI) combines all enzymatic steps in one 
large cytoplasmic multifunctional enzyme (Leibundgut et al., 2008). The bacterial 
type II pathway of fatty acid synthesis (FASII) was the first pathway assigned to the 
apicoplast (Waller et al., 1998). The fatty acid chain elongation step of FASII consists 
of the cycling of the growing fatty acyl moiety through four key enzymes: β-ketoacyl-
acyl carrier protein (ACP) synthase I/II (FabB/F), β-ketoacyl ACP reductase (FabG), 
β-hydroxyacyl-ACP dehydratase (FabZ), enoyl-ACP reductase (FabI) (Ralph et al., 
2004; Waller et al., 1998). Acyl carrier protein (ACP) serves to shuttle the growing 
fatty acids between the enzymes and successive cycles through the elongation 
pathway typically lead to the formation of fatty acyl ACPs of about 12 carbons 
(Upadhyay et al., 2009). 
For a long time the FASII pathway was thought to be essential for Plasmodium blood 
stages, because triclosan, a drug inhibiting bacterial FabI (Stewart et al., 1999), 
inhibited growth of asexual blood stages (Surolia and Surolia, 2001). However, it 
could be shown that triclosan does not target the Plasmodium FabI, and its efficacy 
on blood stages is probably an off-target effect (Yu et al., 2008). Additional proof was 
generated by targeted gene deletions of the enzymes involved in this pathway 
(Vaughan et al., 2009; Yu et al., 2008). Theses studies showed that in Plasmodium 
FASII is only essential for liver stages. Ablation of these enzymes resulted in late 
liver-stage arrested parasites, whereas development of blood and mosquito stages 
remained unaffected. It is unclear if this is due to the requirement of unique fatty 
acids during liver-stage schizogeny that only the parasite can synthesize or simply 
the quantity of lipids required for membrane biogenesis to form tens of thousands of 
infectious merozoites (Tarun et al., 2009). Several studies have now identified 
inhibitors of the FAS II pathway validating this pathway as a drug target for causative 
treatment (Goodman and McFadden, 2007). 
 
Lipoic acid biosynthesis 
Lipoic acid is an essential cofactor of multienzyme-complexes in the apicoplast and 
mitochondrion of Plasmodium, such as the apicoplast pyruvate dehydrogenase 
(PDH). In Plasmodium, the mitochondrion can salvage lipoic acid. De novo lipoic acid 
biosynthesis is confined to the apicoplast and depends on the supply of octanoyl-acyl 




by LipB (Thomsen-Zieger et al., 2003; Wrenger and Muller, 2004). However, 
disruption of the LipB gene had no detrimental effect on parasite growth (Gunther et 
al., 2007). Despite the great decrease of lipoic acid, the apicoplast PDH still showed 
lipoylation. It was shown that LipB function can be compensated for by a lipoic acid 
protein ligase, which is dually targeted to the apicoplast and mitochondrion (Gunther 
et al., 2007). 
Efforts to generate LipA knockout mutants in Plasmodium were so far unsuccessful, 
suggesting that the protein is essential for the survival of the malaria parasites 
(Gunther et al., 2009). 
 
Heme biosynthesis 
Heme is an important prosthetic group of proteins such as cytochromes (Meunier et 
al., 2004). Although a lot of heme is released during parasite digestion of hemoglobin 
during blood stage development and even has to be polymerized into non-toxic 
hemozoin crystals (Sullivan et al., 1996), heme de novo biosynthesis appears to be 
essential for Plasmodium (Ramya et al., 2007; Surolia and Padmanaban, 1992). 
The biosynthesis of heme in Plasmodium is split between the apicoplast and the 
mitochondrion (Ralph et al., 2004; Sato et al., 2004; van Dooren et al., 2006). This 
stands in contrast to animals and plants, where the heme biosynthesis takes place 
exclusively either in the mitochondrion or mainly in the plastid, respectively 
(Heinemann et al., 2008; Tanaka and Tanaka, 2007). Heme biosynthesis in 
Plasmodium starts in the mitochondrion from glycine and succinyl-CoA and the 
pathway later continues in the mitochondrion (Sato et al., 2004; Varadharajan et al., 
2002). 
 
[Fe-S] cluster biogenesis  
The apicoplast of Plasmodium also harbors the SUF (sulfur utilization factor) system 
for [Fe-S] cluster biogenesis, which will be described in more detail below (chapter 
1.7.2).  
 
Thanks to the bacterial origin of the apicoplast, many housekeeping functions also 
differ from the host and therefore present good drug targets. The application of 
antimalarials, targeting these pathways, benefits enormously from the extensive 
research on these processes in bacteria. Antibiotics targeting DNA replication (e.g. 




azithromycin, clindamycin) have been shown to effectively act on Plasmodium and 
other Apicomplexa (Ralph et al., 2001; Seeber, 2003). Interestingly, drugs targeting 
the apicoplast housekeeping functions cause the so-called “delayed-death” 
phenotype. This phenotype was observed for the first time in T. gondii after treatment 
with clindamycin and describes the phenomenon that treatment with some antibiotics 
does not kill the treated parasites directly, but causes them to produce progeny that 
are unable to complete a replicative life cycle (Fichera et al., 1995; Pfefferkorn et al., 
1992). This is probably due to the distribution of nonfunctional apicoplasts into the 
progeny (Fichera and Roos, 1997). 
 
 
1.5 Liver-stage genetically arrested parasites (GAPs) in Plasmodium 
 
The first successful malaria vaccine strategy, using radiation-attenuated sporozoites 
(RAS), was developed 45 years ago and has since remained the benchmark for 
malaria vaccine development (Nussenzweig et al., 1967). RAS are capable of 
establishing a normal hepatocyte infection including parasite vacuole formation. 
However, they then fail to grow and replicate. Immunization with at least three doses 
of RAS induces protracted, often sterile, protection in murine malaria models 
(Nussenzweig et al., 1967), non-human primates (Gwadz et al., 1979), and humans 
(Clyde, 1975; Hoffman et al., 2002). 
Several decades later a new benchmark was set in the form of genetically attenuated 
parasites (GAPs) (Mueller et al., 2005b). Since then, a wide range of GAPs have 
been generated that arrest at different points of liver stage development (Fig. 1.4). 
GAPs can assist malaria research in at least three ways: (1) phenotypic analysis of 
mutants can hint at possible function(s) of the missing protein, unraveling previously 
unknown mechanisms of parasite development. (2) attenuated parasites inform anti-
malaria vaccine strategies, as they can be used to analyze the immunological 
mechanisms involved in protection against parasites. (3) GAPs might be used as 
whole-organism vaccines. To achieve the latter, however, extensive research and 
optimization is still needed to ensure safety and efficacy. This includes generation of 
parasites with a complete arrest without breakthrough infections, which might be 
achieved by simultaneous deletion of various genes. Production processes, storage 
and routes of administration of Plasmodium whole-organism vaccines are currently 







Figure 1.4: Developmental arrest in liver stages of rodent genetically 
attenuated parasites (GAPs).  
WT sporozoites invade hepatocytes by formation of a parasitophorous vacuole (PV) 
(red). Subsequently sporozoites round up into early liver stages and nuclei (blue) 
start to divide. The parasite grows and nuclear division progresses in late liver 
stages. Liver-stage development is finalized by merozoite formation and release of 
merozoites in merosomes. GAPs are arrested at different time points of this 
development. Modified from (Vaughan et al., 2010). 
 
The parasites with the earliest arrest in liver-stage development are Pbp36— and 
Pbp52— (= Pbp36p—) mutants (Ishino et al., 2005b; van Dijk et al., 2005). Ishino and 
colleagues generated these mutants and described them as having an extremely 
elevated cell traversal rate and a very low infection rate in hepatoma cells. In the few 
cases, where early liver stages were formed, they were much smaller than WT liver 
stages (Ishino et al., 2005b). However, Dijk and colleagues showed that Pbp52— (= 
Pbp36p—) parasites are able to traverse and infect hepatocytes as well as WT 
parasites. Pbp52— parasites arrest early in liver stage development, fail to maintain a 
parasitophorous vacuole (PV) and most of them can no longer be detected at 24 




breakthrough blood-stage infections were observed both with Pbp36— and Pbp52— 
parasites (Ishino et al., 2005b; van Dijk et al., 2005). 
Double knockout mutants of p52 and p36 have been generated in P. yoelii (Labaied 
et al., 2007), P. berghei (Annoura et al., 2012) and P. falciparum (VanBuskirk et al., 
2009). In P. yoelii p52—/p36— mutants are completely attenuated. In P. berghei and 
P. falciparum, however, it was shown that occasionally parasites are able to develop 
fully and, in the case of P. berghei, establish blood-stage infection in mice (Annoura 
et al., 2012). 
By deletion of sporozoite and liver stage asparagine-rich protein (SLARP), a key 
regulator of sporozoite gene expression and liver-stage development, another early 
arrested parasite was generated. Pbslarp— sporozoites productively invade 
hepatocytes by forming a parasitophorous vacuole (PV), but subsequent remodeling 
of the parasitophorous vacuole membrane (PVM) is impaired as a consequence of 
drastic down-regulation of genes encoding PVM-resident proteins (Silvie et al., 
2008). This results in the inability of the parasites to establish a blood-stage infection. 
Immunization with these mutants only confers limited protective immunity in mice 
(Silvie et al., 2008). However, in the Balb/c model Pyslarp— (=Pysap1—) parasites 
confer sterile protection (Aly et al., 2008). 
The first GAPs were generated by knocking out two parasitophorous vacuole 
membrane (PVM) proteins, upregulated in infective sporozoites gene 3 (UIS3) 
(Mueller et al., 2005b) and upregulated in infective sporozoites gene 4 (UIS4) 
(Mueller et al., 2005a). Pbuis3— mutants are arrested early in liver-stage 
development and are impaired to develop to liver-stage trophozoites (Mueller et al., 
2005b). In the C57BL/6 model these parasites are completely attenuated and confer 
sterile protection against re-infection after three immunizations. Similarly, Pbuis4— 
parasites are also arrested early in development and confer sterile protection against 
re-infection after 3 immunizations. However, occasional breakthrough infections of 
blood-stage parasites were observed with this mutant. Pbuis3—/uis4— double-
knockout mutants were also generated and showed a similar phenotype and 
protective efficacy as the single- knockouts (Jobe et al., 2007). 
Several late liver-stage arrested GAPs were subsequently generated by deletion of 
genes involved in the type II fatty acid biosynthesis. FABB/F was deleted in P. yoelii 
and P. berghei, FABZ in P. yoelii and FABI in P. berghei and P. falciparum. 
Pyfabb/f— parasites are smaller than WT parasites at 44 hours after invasion of 




expression of the merozoite signature protein merozoite surface protein 1 (MSP1) 
and are tightly arrested in the Balb/c model (Vaughan et al., 2009). In sharp contrast, 
Pbfabb/f— mutants were able to establish blood-stage infections in all sporozoite-
injected C57BL/6 mice (Annoura et al., 2012). Pyfabz— show the same complete 
arrest in late liver-stage development as Pyfabb/f— in vivo (Vaughan et al., 2009). 
PbfabI— parasites show impaired nuclear division in late liver stages and most 
parasites lack expression of MSP1 at 60 hours after sporozoite invasion in vitro (Yu 
et al., 2008). However, in vivo breakthrough blood-stage infections were regularly 
observed in C57BL/6 mice (Yu et al., 2008). Taken together, deletion of genes 
involved in the type II fatty acid biosynthesis cause defects in late liver-stage 
development with varying degrees of attenuation in different models.  
In P. yoelii, knockouts of the apicoplast pyruvate dehydrogenase (PDH) subunits 
E1α and E3 were generated. These mutants can infect hepatocytes, but fail to form 
mature schizonts and initiate blood-stage infections (Pei et al., 2010). 
Parasites missing liver-specific protein 1 (LISP1) develop liver stage merozoites, but 
do not rupture the parasitophorous vacuole membrane (PVM) efficiently. 
Nevertheless, Pblisp1— parasites are able to establish a blood stage infection in 
Wistar rats and therefore do not display an attenuation phenotype in the stricter 
sense (Ishino et al., 2009). 
A different kind of GAP was generated by conditional knockout of P. berghei cGMP-
dependent protein kinase (PbPKG) in sporozoites. Here, the targeted gene is not 
only essential for liver-stage development, but also in blood stages. Through 
conditionally knocking out the gene only in sporozoites, this limitation was 
circumvented. These mutant parasites are arrested late in liver-stage development, 
only rarely form merosomes in vitro and do not establish blood-stage infections in 
vivo, except for breakthroughs of WT parasites where PKG was not excised. 
Most GAPs have been generated in the rodent malaria parasites P. berghei and P. 
yoelii, as transgenic parasites are generated faster and mutant parasites can be 
analyzed throughout the whole parasite life cycle. However, for some GAPs there are 
discrepancies between the two models in terms of attenuation phenotype, as for 
p52—/p36— parasites (Annoura et al., 2012; Labaied et al., 2007), and protective 
potency, as for slarp— parasites (Aly et al., 2011; Silvie et al., 2008). In the past years 
the first P. falciparum GAPs were generated (Mikolajczak et al., 2011; van Schaijk et 
al., 2008; VanBuskirk et al., 2009). 




revealed that protection is mainly mediated by IFNγ-producing CD8+ T lymphocytes 
(Jobe et al., 2007; Mueller et al., 2007). In the P. berghei/ C57BL/6 model, 
persistence of uis3— parasites is crucial for protective efficacy, as primaquine 
treatment completely abolished protection (Mueller et al., 2007). 
As different parasite species, mouse strains and immunization protocols were used 
for studies using GAPs as whole-organism vaccines, comparison of protective 
efficacy in these studies is not easily achieved. Generally, sterile protection is more 
easily achieved in the P. yoelii/ Balb/c model than the P. berghei/ C57BL/6 model 
(Doolan and Hoffman, 2000; Ngonseu et al., 1998). A recent study using the P. yoelii/ 
Balb/c model showed that late arrested fabb/f— parasites mount superior antimalarial 
immunity compared to early arrested sap1— parasites, suggesting enhanced 
protection of late liver-stage arrested GAPs due to a broader set of presented 
antigens (Butler et al., 2011). The longevity of protection with whole-organism 
vaccines against Plasmodium re-challenge was assessed for up to 1 year 
(Douradinha et al., 2011; Douradinha et al., 2007; Jobe et al., 2007; Nganou-
Makamdop et al., 2012). Again a variety of different parasite species, mouse strains 
and immunization protocols were used. 
 
 
1.6 Loss-of-function studies of Plasmodium  apicoplast genes  
 
To date, various apicoplast genes have been deleted in Plasmodium (Fig. 1.5). They 
include genes involved in the type II fatty acid biosynthesis (Vaughan et al., 2009; Yu 
et al., 2008) and two subunits of the pyruvate dehydrogenase complex (Pei et al., 
2010), highlighting the importance of fatty acid biosynthesis for late liver-stage 
development.  
The lipoic acid synthesis pathway has been targeted by disruption of the PfLipB 
gene. Loss of LipB did not negatively affect parasite growth despite a drastic loss of 
lipoic acid (Gunther et al., 2007). It was shown that LipB function can be 
compensated for by a lipoic acid protein ligase, which is dually targeted to apicoplast 





Figure 1.5: Overview of Plasmodium apicoplast knockout mutants. 
Shown is an overview of apicoplast localized biosynthesis pathways that have been 
targeted for gene deletions in Plasmodium. Apicoplast enzymes successfully 
targeted by transfection plasmids are depicted in green. For references see section 
1.5 and 1.6. (PPT= phospho-enolpyruvate transporter, PEP= phospho-enolpyruvate, 
PDH= pyruvate dehydrogenase, CoA= coenzyme A, FabD= malonyl-CoA:ACP 
transacylase, ACP= acyl carrier protein, FabH= b-ketoacyl-ACP synthase III, FabG= 
β-ketoacyl-ACP reductase, FabZ= β-hydroxyacyl-ACP dehydratase, FabI= trans-2-
enoyl-ACP reductase, FabB/F= β-ketoacyl-acyl-carrier-protein synthase, LipB= 
lipoate protein ligase, LipA= lipoate synthase, TPT= triose phosphate transporter, 
TrioseP= triose-phosphate, IspG= GcpE; 4-hydroxy-3-methyl-but-2-enyl-diphosphate 
(HMBPP)-synthase, IspH= LytB; HMBPP-reductase, DMAPP= dimethylallyl 
pyrophosphate, IPP= isopentenyl pyrophosphate, MiaB=  (Dimethylallyl)adenosine-
tRNA-methylthiotransferase), DOXP= 1-deoxy-D-xylulose-5-phosphate). 
 
In a recent study, two apicoplast sugar phosphate transporters, triose phosphate 
transporter (TPT) and phospho-enolpyruvate transporter (PPT), were targeted by 
gene deletion (Banerjee et al., 2012). PbTPT — parasites only survived a few cycles 
of blood-stage replication. In contrast, PbPPT— parasites developed similar to the 
WT in the blood stages. However, the absence of PPT led to defects in mosquito and 
liver-stage development (Banerjee et al., 2012).  
At large, the generation of apicoplast gene knockout mutants helps to reveal the 
importance of the various apicoplast pathways for different life cycle stages of 
Plasmodium. This is of enormous value to understand the apicoplast physiology and 




proteins that are likely targeted to the apicoplast have been functionally assigned. 
Therefore, it is highly likely that additional pathways and molecules with important 
functions will be identified. 
 
 
1.7 [Fe-S]  cluster biogenesis 
 
1.7.1 Overview on biogenesis of [Fe-S]  clusters  
 
Iron-sulfur [Fe-S] clusters are inorganic cofactors that constitute one of the most 
ancient and ubiquitous prosthetic groups. Proteins containing [Fe-S] clusters are 
involved in numerous biological processes, such as mitochondrial oxidative 
phosphorylation (Bych et al., 2008), photosynthesis (Sakurai and San Pietro, 1985), 
DNA replication (Klinge et al., 2007), DNA repair (Porello et al., 1998), ribosome 
biogenesis (Kispal et al., 2005) and regulation of gene expression (Haile et al., 1992). 
Accordingly, the list of [Fe-S] cluster-containing proteins is continuously expanding. 
Although early in vitro studies suggested a spontaneous assembly of [Fe-S] clusters 
(Malkin and Rabinowitz, 1966), in vivo [Fe-S] clusters are not formed spontaneously, 
but need a rather complex machinery involving numerous proteins for their assembly.  
Bacteria harbor the ISC (iron-sulfur cluster) and the SUF (sulfur utilization factor) 
systems for assembly of [Fe-S] clusters. In E. coli the ISC system is thought to 
mediate housekeeping functions, whereas the SUF system was shown to be 
especially important under stress conditions such as iron starvation (Lill, 2009; 
Outten et al., 2004). Deletion of either of the operons alone is not lethal (Takahashi 
and Tokumoto, 2002; Tokumoto and Takahashi, 2001).  
The NIF (nitrogen fixation) system is only present in nitrogen-fixing bacteria such as 
Azotobacter vinelandii and is generally exclusively for the maturation of nitrogenase 
(Johnson et al., 2005b; Zheng et al., 1993). However, Nif-like components are also 
found in many species that do not fix nitrogen (Ali et al., 2004; Angelini et al., 2008; 
Leon et al., 2003; Touraine et al., 2004). 
In eukaryotes, [Fe-S] biogenesis machineries are thought to have evolved from their 
bacterial counterparts that had been acquired by endosymbiosis (Muhlenhoff and Lill, 
2000). Different systems of [Fe-S] cluster assembly are required for biogenesis in 




mitochondrion and the SUF (sulfur utilization factor) system in plastids (Fig. 1.6). The 
mitochondrial ISC proteins were found to supply [Fe-S] clusters not only to the 
mitochondrial [Fe-S] proteins, but also to [Fe-S] proteins in the cytosol (Kispal et al., 
1999), where the CIA (cytosolic iron-sulfur protein assembly) machinery is 




Figure 1.6: Eukaryotic machineries for the biogenesis of [Fe-S] cluster 
proteins and their putative evolutionary origin.  
The ISC (iron-sulfur cluster) assembly machinery of mitochondria was likely inherited 
from α-proteobacteria. The SUF (sulfur utilization factor) machinery of plastids in 
plant cells was probably aquired by endosymbiosis of a photosynthetic bacterium. 
Maturation of cytosolic and nuclear [Fe-S] proteins requires the mitochondrial ISC 
assembly machinery, a mitochondrial ISC export system, and the cytosolic iron-sulfur 
protein assembly (CIA) machinery. The bacterial NIF (nitrogen fixation) system is 
specialized for the assembly of nitrogenase in nitrogen-fixing bacteria. Small red and 
yellow circles depict [Fe-S] clusters. From (Lill and Muhlenhoff, 2006). 
 
In spite of the differences between bacteria and eukaryotes, the basic principles of  
[Fe-S] clusters biogenesis seem to be conserved (Fig.1.7). In a first step the [Fe-S] 
cluster is assembled de novo onto a scaffold protein. For this step sulfur is mobilized 
from cysteine by a cysteine desulfurase (IscS, SufS, NifS) (Hidese et al., 2011). The 
iron source is mostly unknown. In a second step the [Fe-S] cluster is transferred from 
the scaffold protein to a target apoprotein and assembled into the polypeptide chain. 
The most common [Fe-S] clusters are rhombic [2Fe-2S] or cubic [4Fe-4S], however 
more complex structures have been described that can also include other heavy 





Figure 1.7: Principles of [Fe-S] cluster biogenesis.  
Numbers in the figures correspond to the following steps: (1) a desulfurase acquires 
sulfur for the [Fe-S] cluster from cysteine, converting the cysteine to alanine. (2) An 
iron donor delivers iron to the scaffold protein. (3) Electrons are needed for the 
reduction of S0 (present in cysteine) to sulphide (S2-, present in [Fe-S] clusters). (4) 
The [Fe-S] cluster is assembled on scaffold proteins and then (5) transfer proteins 
load the [Fe-S] cluster from the scaffold proteins to apoproteins converting them to 
holoproteins. From (Lill, 2009). 
 
Because most studies on the SUF system were conducted in bacteria the functions 
of SUF proteins will be briefly exemplified for E. coli. The SUF system in E.coli 
consists of 6 genes organized in the sufABCDSE operon (Takahashi and Tokumoto, 
2002). SufS acts as cysteine desulfurase that provides the sulfur for the [Fe-S] 
cluster and SufE has been shown to interact with SufS to enhance its activity up to 
50-fold (Loiseau et al., 2003; Outten et al., 2003). SufBCD forms a functional 
complex serving as a [Fe-S] scaffold (Chahal et al., 2009; Wollers et al., 2010) and 
also enhancing SufS function (Outten et al., 2003). SufC was shown to contain 
ATPase activity in Erwinia chrysanthemi (Nachin et al., 2003) and the crystal 
structure of E. coli SufC confirmed it to be an ABC-type ATPase (Kitaoka et al., 
2006). SufA interacts with SufBCD to accept Fe-S clusters formed de novo on the 
SufBCD complex (Chahal et al., 2009). 
As mentioned earlier, proteins showing similarity with the NifU protein of Azotobacter 
vinelandii can be found in many other species in the mitochondria as well as plastids 
(Leon et al., 2003). NifU-like proteins seem to act as scaffolds for [Fe-S] cluster 
biosynthesis (Tong et al., 2003; Touraine et al., 2004). However, their specific roles 
may vary in different organisms and localizations. For instance in humans, mutations 




proteins, which causes a fatal disease (Navarro-Sastre et al., 2011). In contrast, 
Saccharomyces cerevisiae mitochondrial NFU1 is involved in [Fe-S] cluster 
biogenesis, but is not an essential protein (Schilke et al., 1999). 
 
 
1.7.2 [Fe-S]  cluster biogenesis in the apicoplast of Apicomplexa 
 
Compared to bacteria, yeast and plants, relatively little is known about [Fe-S] cluster 
biosynthesis in Apicomplexa. In Plasmodium components of the SUF, ISC and CIA 
system have been identified by bioinformatics analysis (Ellis et al., 2001; Seeber, 
2002; Seeber and Soldati-Favre, 2010). As it is the case for other eukaryotes, the 
ISC system localizes to the mitochondrion and the SUF system to the apicoplast 
(Seeber, 2002) (Fig. 1.8). In Plasmodium, all components of the Suf system are 
nuclear-encoded, except for SufB, which is encoded in the apicoplast genome 
(Wilson et al., 1996). 
 
 
Figure 1.8: Overview of Plasmodium apicoplast-resident proteins containing a 
[Fe-S] cluster or involved in the biosynthesis of  [Fe-S] clusters.  
Shown is an overview of the principal apicoplast localized biosynthesis pathways: 
fatty acid synthesis (FASII pathway), non-mevalonate isoprenoid synthesis (DOXP 
pathway), lipoic acid synthesis and [Fe-S] cluster synthesis (highlighted in brown), 
with their respective precursors and products. Apicoplast proteins that contain a [Fe-




A recent biochemical study has focused on the P. falciparum plastid SUF system and 
provided evidence that SufC is localized to the apicoplast (Kumar et al., 2011). In 
bacteria and plants, SufC interacts with SufB (Nachin et al., 2003; Rangachari et al., 
2002; Xu et al., 2005), which could be confirmed in P. falciparum (Kumar et al., 
2011). Furthermore, ATPase activity of recombinant PfSUFB and PfSUFC proteins 
provided compelling evidence for the evolutionary conservation of the plastid SUF 
system between plants and apicomplexan parasites (Kumar et al., 2011). In 
Arabidopsis thaliana, SUFB and SUFC display ATPase activity (Xu et al., 2005), 
whereas the bacterial SufB seems to lack this activity. 
In Plasmodium [Fe-S] cluster-containing proteins in the apicoplast are involved in 
pathways such as mevalonate-independent isoprenoid biosynthesis, lipoic acid 
metabolism and biogenesis of [Fe-S] clusters itself (Fig. 1.8). Because some proteins 
are involved in pathways that are essential for parasite growth, such as the DOXP 
pathway of isoprenoid biosynthesis (Yeh and DeRisi, 2011), [Fe-S] cluster assembly 
is likely to be essential for parasite survival.  
 
 
1.8 Aims of this thesis 
 
After transmission by infectious Anopheles mosquito bites, malaria parasites undergo 
an intra-hepatic expansion phase in the vertebrate host that leads to the formation of 
thousands of infectious merozoites. The pre-erythrocytic phase is clinically silent and 
provides an excellent target for antimalarial vaccines. Hence, a better understanding 
of liver-stage biology is highly desirable, but remains challenging as liver stages have 
the most limited experimental accessibility in the Plasmodium life cycle. 
The aim of this thesis was to characterize genes that are important for liver-stage 
development and to demonstrate their significance by applying targeted gene 
deletions in the rodent malaria parasite Plasmodium berghei. If possible, a late liver-
stage arrested parasite line should be generated. This should allow to test if a later 
developmental arrest would lead to a broader range of presented antigens and could 
mount superior protective immune responses compared to early arrested parasites.  
Most Apicomplexa harbor a plastid organelle termed apicoplast. The apicoplast 
harbors various pathways that are not present in humans, such as the DOXP 
pathway of isoprenoid biosynthesis and the SUF system of [Fe-S] cluster biogenesis. 




essential for parasite development. However, no experimental data are available yet. 
As part of this thesis, systematic targeted gene deletions should be attempted to 
unravel the role of the various genes involved [Fe-S] cluster biogenesis in the 
apicoplast and also to estimate which of them might be considered as potential drug 
targets. 
In general, these experiments will help to further characterize the importance of the 
apicoplast for parasite development and survival and identify new key players in 
Plasmodium liver-stage development. 
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2.1.1 Organisms and cell lines 
female NMRI and C57BL/6 mice Charles River Laboratories, 
Germany 
Anopheles stephensi       Nijmegen, Netherlands 
Plasmodium berghei ANKA-GFP-507cl    referred to as WT ANKA-GFP
         (Janse et al., 2006b) 
Plasmodium berghei ANKA Bergreen   (Kooij et al., 2012) 
Plasmodium berghei ANKA  referred to as WT ANKA  
Prof. Dr. Chris Janse, LUMC 
Leiden, Netherlands 
Huh7 human hepatoma cells Prof. Dr. Ralf Bartenschlager, 
Universitätsklinikum Heidelberg, 
Germany 
E. coli XL-1blue        Stratagene, Germany 
 
2.1.2 Laboratory equipment  
Centrifuges: 
Bench centrifuge, 5424      Eppendorf, Germany 
Megafuge1.OR        Heraeus, Germany 
Cooled bench centrifuge 5415R     Eppendorf, Hamburg 
 
Incubators: 
Incubator, for cells, Thermo scientific    Heraeus, Germany 
Incubator, for P. berghei transfection    Mytrom, Germany 
Incubator for bacteria, Thermo scientific    Heraeus, Germany 
Incubator, Shaker for bacteria, Innova40   Eppendorf, Germany 
Incubator for Mosquitoes      Mytrom, Germany 
 
Microscopes: 
Binoculars, M80, MZ10F      Leica, Germany 
Leica DM2500        Leica, Germany 
Confocal laser scanning microscope, TSP-SP1 Leica, Germany 
 
 
Agarose gel casting apparatus, Horizon11.14   Biometra, Germany 
Amaxa Electroporator       Amaxa, Germany 
Axiovert, 200M, with XL-3 incubator    Zeiss, Germany 
Electrophoresis power supply  Amersham Pharmacia Biotech/ 
GE Healthcare, Germany 
FACS Diva        BD Biosciences, Germany 
Flow cytometers LSRII and Fortessa   BD Biosciences, Germany 
Gel documentation system, Gel Doc 2000   BIORAD, Germany 
Heating block, Thermo Scientific     Eppendorf, Germany 
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Micropipette (Gilson)       Abimed, Germany 
Mosquito cages        BioQuip Products Inc, USA 
Nanodrop ND 1000       peQLab, Germany 
Neubauer counting chamber     Marienfeld, Germany 
PCR Thermocycler, MJ-mini      BIORAD, Germany 
PCR Thermocycler, StepOnePlus    Applied Biosystems, USA 
pH-meter         Mettler Toledo, Germany 
Photometer, GeneQuant pro     Amersham, Germany 
Sterile hood, Herasafe KS12     Heraeus, Germany 
Vortex-Genie2        Scientific Industries, USA 
 
2.1.3 Consumables  
6-well and 24-well plates      Greiner bio-one, Germany 
8-well chamber slides, LabTek     Nunc, Fischer, Germany 
CellTrics filters        Partec, Germany 
Cover slips        Roth, Germany 
Cryo-freezing tubes       Greiner bio-One, Germany 
Electroporation cuvettes      Amaxa, Germany 
Eppendorf tubes, 1.5 ml      Eppendorf, Germany 
Falcon blue cap (50 mL and 15 mL)    Greiner Bio-One, Germany 
Filter paper        Schleier and Schuel, Germany 
Forceps         Neolab, Germany 
Glass slides, clear       Menzel, Germany 
Microscope oil        Zeiss, Germany 
Needles, sterile        Braun, Germany 
Neubauer counting chamber     Roth, Germany 
Nitrocellulose membrane, Hybond     Amersham, Germany 
Pasteur pipettes        Roth, Germany 
PCR tubes        Greiner Bio-One, Germany 
Petri-dishes        Sarstedt, Germany 
Poly-L-Lysins Coated Cover slips     BD, BioCoad, Belgium 
Pipettes tips        Brand GMBH, Germany 
Serological pipettes (10 and 25 ml)    Greiner Bio-One, Germany 
Sterile filter (0.2 and 0.4 mm)     Millipore, Ireland 
Sterile filtration units (500 ml)     Nalgene®, USA 
Syringes, 1ml        Roth, Germany 
Syringes, insuline       Braun, Germany 
Tissue culture flasks (50 and 250 ml)    Greiner Bio-One, Germany 




Standard reagents were obtained from Merck, Sigma and Roth, unless otherwise 
indicated. 
 
Agarose         Invitrogen, Germany 
dNTP-mix         Fermentas, Germany 
DRAQ5 Axxora/Enzo Life Sciences, 




Evans Blue       Sigma-Aldrich, Germany 
Fibrous Cellulose Powder      Whatman, United Kingdom 
Fluoromount-G        Southern Biotech, USA 
Gentamycin        Invitrogen, Germany 
Giemsa stain        VWR, Germany 
Heparin         Ratiopharm, Germany 
Hepes         Merck/Calbiochem, Germany 
Hoechst 33342        Invitrogen, Germany 
human T-cell Nucleofector™ solution    Amaxa, Lonza, Germany 
Isofluran         Baxter, Germany 
Ketamin (10%) (=Ketavet)     Pfizer, Germany 
LB-agar powder (Lennox L Agar)     Invitrogen, Germany 
Nycodenz         Axis Shield, Norway 
Para-formaldehyde       Serva, Germany 
PCR-buffer set        Roche, Germany 
Percoll        GE Healthcare, Germany 
Power SYBR®Green PCR Master Mix    Applied Biosystems, Germany 
SYBR Safe DNA Gel stain      Invitrogen, Germany 
SYBR Green PCR Mastermix    Applied Biosystems, Germany 
Xylazin (= Rompun 2%)     Bayer, Germany 
 
antibiotics: 
ampicillin         Roth, Germany 
azithromycin        Pfizer, Germany 
fosmidomycin        Sigma-Aldrich, Germany 
penicillin/streptomycin, liquid     Invitrogen, Germany 
2.1.5 Commercial Kits  
DNAse Turbo        Ambion, Germany 
HiSpeed Plasmid Midi Kit     Qiagen, Germany 
Human T Cell Nucleofactor Kit     Lonza, Germany 
QIAamp DNA-Blood Mini Kit     Qiagen, Germany 
QIAquick PCR Purification Kit    Qiagen, Germany 
QIAprep Spin Miniprep Kit     Qiagen, Germany 
Rapid DNA Dephos & Ligation Kit    Roche, Germany 
RETROscript        Ambion,Germany 
RNeasy Mini Kit       Qiagen, Germany 
 
Southern blot kits and reagents from Roche, Germany: 
PCR DIG Probe synthesis kit; Cat. No. 11 636 090 910 
DIG Wash and block buffer set; Cat. No. 11 585 762 001 
DIG Easy Hyb; Cat. No. 11 603 558 001 
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2.1.6 Enzymes  
Restriction endonucleases      New England Biolabs, Germany 
T4-DNA-ligase        Fermentas, Germany 
Taq DNA polymerase       Fermentas, Germany 
Phosphatase        Roche, Germany 
Platinum Taq DNA polymerase (HF)    Invitrogen, Germany 
ProteinaseK        Invitrogen, Germany 
 
2.1.7 Media, solutions, buffers, markers 
6x loading dye        Fermentas, Germany 
1kb DNA-Ladder       Fermentas, Germany 
Antibiotic-Antimycotic (Anti-anti)    Gibco Invitrogen, Germany 
DMEM 41966        Gibco Invitrogen, Germany 
FCS (Fetal Calf Serum), certified (USA)    Gibco Invitrogen, Germany 
FCS          Gibco Invitrogen, Germany 
HBSS, w/o Ca and Mg      Gibco Invitrogen, Germany 
Lysing buffer (BD Pharm Lyse™)    BD Biosciences, Germany 
PBS, sterile solution       Gibco Invitrogen, Germany 
PBS, tablets        Gibco Invitrogen, Germany 
Perm/Wash™ buffer      BD Biosciences, Germany 
RPMI Medium 1640 w/HEPES     Gibco Invitrogen, Germany 
SOC          Invitrogen, Germany 




Ampicillin stock solution     100mg/ml ampicillin in ddH2O 
LB-Agar         LB-medium, 15g/l Bacto-agar 
Luria Broth- (LB-) medium  10g/l Bacto- tryptone, 5g/l 
Bacto-yeast extract, 5g/l NaCl, 
add to ddH2O pH 7.5; 
autoclaved 
giemsa staining solution   10% Giemsa solution in H2O 
hepatocyte cell culture medium    450ml DMEM, 50ml FCS SA, 
5ml penicillin/streptomycin or 
anti-anti 
mosquito breeding water     1 ‰ sea salt in ddH2O 
mosquito dissecting medium 3% Bovine albumin serum in 
RPMI 
mosquito feeding solution 10g sucrose, 20μg pABA; ad 
100ml ddH2O    
3 M NaAc solution  24,06 g ad 100 ml ddH2O; pH        
4,8 
Nycodenz-stock solution 5μM Tris pH 7.5 (1M stock), 
3mM KCL (250mM stock), 
0.3mM EDTA (0.5 M stock) and 
110.4g Nycodenz (27.6 g/100 
ml), dissolved in 400ml dH2O, 
autoclaved  
P. berghei freezing solution      Glycerin, Alseverʼs Solution (1:9) 
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P. berghei culture medium (transfection)  160ml RPMI-medium 1640, 
25mM HEPES, L-Glutamin 
(Gibco); 40ml FCS USA (heat 
inactivated 30min at 56°C), 
50μl gentamycin (50mg/ml), 
sterile filtered 
100 x Pyrimethamin- stock solution    7mg Pyrimethamin /ml in DMSO 
50 x TAE-Puffer  2M Tris, 250mM sodium 
acetate, 0,5mM EDTA; pH 7,8  
TBST 20mM Tris pH 7,6; 137mM 
NaCl; 0,1% Tween 
Tris / HCl, pH 6,8       0,5M Tris / HCl, pH 6,8 
Tris / HCl, pH 8,8       1,5M Tris / HCl, pH 8,8 
 
 
2.1.8 Antibodies  
 
α-ACP (rabbit)     (Friesen et al., 2010) 
α-HSP70 (mouse)   (Tsuji et al., 1994) 
α-PyMSP1 (mouse) Prof. Dr. Anthony Holder, NIMR London, UK 
α-c-Myc (clone 9E10) (mouse) Santa Cruz Biotechnology, Germany  
α-UIS4 (rabbit)   Dr. Georgina Montagna, MPIIB Berlin, Germany 
 
 
α-CD8 (clone 53.6-7), α-CD4 (clone GK1.5), α-CD11a (clone M17/4), α-CD3 (145-
2C11), α-CD28 (37.51), α-IL-2 (JES6-5H4), α-TNF (MP6-XT22) and α-IFNγ 
(XMG1.2) were purchased from eBiosciences. 
 
 
Donkey α-mouse IgG Alexa Fluor 488/ 546, donkey α-rabbit IgG Alexa Fluor 488/ 
546, goat α-mouse IgG Alexa Fluor 488/ 546 and goat α-rabbit IgG Alexa Fluor 
488g/ 546 were purchased from Invitrogen. 
 
2.1.9 Peptides 
P1 (KIYNRNIVNRLLGDA)     (Boscardin et al., 2006)  
S and T peptides correspond to immunodominant Plasmodium CD8+ T cell epitopes 
(Hafalla et al., unpublished data). 
 
 
2.1.10 Plasmodium targeting vectors 
b3D.DT^H.^D  Prof. Dr. Andy Waters, University of Glasgow, 
Scotland 
pBART-SIL6     (Kooij et al., 2012) 
pBAT (intermediate construct) (Kooij et al., 2012) 
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2.1.11 Oligonucleotides  
All oligonucleotides were ordered from Eurofins MWG Operon.  
 
Table 2.1: Primer list. 
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Table 2.1 continued 
 
 
a  Restriction endonuclease (REase) sites in primer sequence. 
b TV and GT indicate primers designed for the generation of transfection vectors and 
genotyping, respectively. RT-PCR and qPCR indicate primers used for reverse 
transcription PCR and quantitative real-time PCR, respectively. 
c Forward (F) and reverse (R) sense primers. 
 
 
2.1.12 Software and databases 
 
Primer design was performed with Primer3 (http://frodo.wi.mit.edu/) and OligoCalc 
(Kibbe, 2007). SerialCloner 2.1 (Serial Basics) and EnzymeX (Nucleobytes Inc.) were 
used for DNA sequence analysis and plasmid design. DNA and amino acid sequence 
alignments were done with ClustalW2 (Larkin et al., 2007) and MUSCLE (Edgar, 
2004). 
PlasmoDB (Aurrecoechea et al., 2009), EupathDB (Aurrecoechea et al., 2007), 
OrthoMCL (Chen et al., 2006) and BLAST (Altschul et al., 1990) were used for DNA 
and amino acid sequence retrieval and search for gene orthologs. 
In silico prediction of cellular localization of proteins was done with PlasmoAP (Foth 
et al., 2003a), ApicoAP (Cilingir et al., 2012a), MitoProt (Claros and Vincens, 1996) 
and  PlasMit (Bender et al., 2003a). 
Flow cytometry analysis was performed with FlowJo software . Statistical analysis 
was done with GraphPad Prism version 5.0c (GraphPad Software, Inc.). Image and 
data processing was done with Adobe Illustrator, Adobe Photoshop, ImageJ (US 
National Institute of Health, Bethesda), GraphPad Prism version 5.0c (GraphPad 
Software, Inc.), Microsoft Excel and Microsoft Powerpoint. The bibliography was 
managed with EndNote (Thomson Reuters). 





2.2.1 Microbiological methods 
 
2.2.1.1 Culture of E. coli on agar plates 
To obtain clonal colonies of E. coli, liquid cultures were spread with glass beads on 
agar plates containing ampicillin. These were incubated over night at 37°C and kept 
at 4°C for long-term storage. 
 
2.2.1.2 Culture of E. coli in liquid medium 
For liquid culture of E. coli, 3ml (for mini-preps) or 50ml (for midi-preps) of LB-
medium containing 1:1000 ampicillin stock solution were inoculated with cells from 
one colony on a agar plate or from glycerol-stock. Cultures were incubated over night 
at 37°C and 230rpm. 
 
2.2.1.3 Long-term storage of E. coli 
800μl of overnight liquid bacteria culture was mixed with 300μl 80% glycerol in cryo-
tubes and stored at  -80°C. 
 
2.2.1.4 Transformation of E. coli 
Competent E.coli XL1 blue cells were thawed for 10min on ice. Per transformation 
reaction 0.68µl β-Mercaptoethanol was added to 35µl of cells and incubated for 
10min on ice. 5µl ligation reaction was added to the cells and kept on ice for 30min. 
Heatshock was performed at 42°C for 45s. Cells were kept on ice for 2min and then 
100µl pre-warmed SOC medium was added and bacteria were spread with glass 
beads on pre-warmed LB agar plates containing ampicillin. Plates were incubated 
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2.2.2 Molecular biological methods 
 
2.2.2.1 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed to separate DNA molecules, according to 
their charge, size and conformation. Gels were typically prepared with 1% agarose in 
1x TAE buffer. The solution was boiled in a microwave to dissolve the agarose and 
after cooling down, 12µl SYBR Safe green (10μg/ 100ml) was added. The DNA 
samples were loaded in 1x loading dye. 3 to 5µl of 1kb ladder was loaded and DNA 
fragments were separated at about 100V for 40-60 min. Ultraviolet light was used to 
visualize the separated DNA molecules in a gel documentation system. 
 
2.2.2.2 Isolation of recombinant plasmids 
Plasmids were isolated from E. coli over night liquid cultures using the QIAprep Spin 
Miniprep Kit (Qiagen) or, for large scale-preparation of transfection plasmids, the 
HiSpeed Plasmid Midi Kit (Roche) according to the manufacturerʼs protocol. 
 
2.2.2.3 DNA purification by ethanol precipitation 
Plasmids for transfection of parasites were purified by precipitation using 0.1x 
volumes of sodium acetate (pH 4.8) and 2.5 x volumes of 100% ethanol. After a 5min 
incubation at -80ºC, the precipitated DNA was collected by centrifugation for 10min at 
maximum speed (13,000 rpm) at 4ºC. The DNA pellet was washed two times with 
ice-cold 70% ethanol and centrifuged for 5min at 4ºC. The air-dried DNA pellet was 
then dissolved in an appropriate volume of ddH2O. 
 
2.2.2.4 DNA purification using the PCR purification kit 
For purification of PCR fragments and digestion preparations, the PCR purification kit 
(Qiagen) was used according to the manufacturerʼ protocol. PCR fragments were 
analyzed by agarose gel electrophoresis. 
 
2.2.2.5 Amplification of DNA sequences by polymerase chain reaction (PCR) 
PCR was used to amplify specific DNA sequences for molecular cloning and parasite 
genotyping. Platinum Taq-Polymerase was employed for amplification of fragments 
used for expression cloning and Taq-Polymerase was used for analytical PCR. Due 
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to the high AT content of Plasmodium DNA, the annealing temperature was typically 
55°C and the extension temperature was 60ºC. PCR composition and conditions 
were further set according to the primers, polymerase and amplification targets. PCR 
products were purified with the QIAquick PCR Purification Kit (Qiagen) following the 
manufacturerʼs protocol if used for molecular cloning. 
 
Standard PCR program: 
Step 1: Denaturation    94ºC, 5min 
Step 2: Denaturation     94ºC, 30s 
Step 3: Annealing    55ºC, 30s 
Step 4: Elongation     60ºC, 2-5min 
Cycling between steps 2-4    35 cycles 
Step 5: Elongation     60ºC, 10min 
Step 7: store      4ºC, ∞ 
 
 
2.2.2.6 Restriction endonuclease reactions 
DNA was digested with restriction endonucleases purchased from New England 
Biolabs. For test-digests of recombinant plasmids, typically, 1µl of DNA from a Mini 
or Midi plasmid preparation was digested for 1h at 37°C and analyzed by agarose gel 
electrophoresis. 
 
2.2.2.7 Ligation of DNA fragments 
DNA ligations were performed using the Rapid Ligation Kit (Roche) according to the 
manufacturerʼs protocol. 
 
2.2.2.8 Construction of Plasmodium targeting vectors 
For generation of PALM-mCherry-myc parasites fragments of the C-terminal coding 
region and 3ʼ untranslated region (UTR) of PALM were amplified from gDNA using 
gene-specific primers: PbPALM-F5-EcoRI and PbPALM-R5-Blunt (C-terminal 
fragment, 422bp), and PbPALM-F7-HindIII and PbPALM-R6-KpnI (3ʼ fragment, 
545bp). Fragments were cloned into a vector (pBAT intermediate construct) (Kooij et 
al., 2012), which contains the mCherry coding region fused to a quadruple c-myc tag 
sequence and the pyrimethamine-resistant Toxoplasma gondii dihydrofolate 
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reductase/thymidylate synthetase cassette. The resulting plasmid, pPbPALM-
mCherry-myc, was linearized with EcoRI and Acc65I and to minimize transfection 
with partially digested plasmid ampicillin resistance cassette was cut with ScaI.  
In order to generate palm— parasites, fragments of the 5ʼUTR and part of the N-
terminal coding region and of the 3ʼUTR were amplified from gDNA using the 
following primer combinations: PbPALM-F2-BamHI and PbPALM-R1-EcoRI (5ʼ 
fragment, 587bp), and PbPALM-F7-HindIII and PbPALM-R6-KpnI (3ʼ fragment, 
545bp). PCR fragments were cloned into the B3D vector. The resulting plasmid, 
pPbPALM-KO, was linearized with BamHI and Acc65I. In addition, the plasmid 
backbone was cut with SapI to minimize transfection with partially digested plasmid. 
This plasmid was used to transfect P. berghei ANKA parasites and a clone, termed 
ANKA-GFP, which expresses GFP under the control of the constitutive PbEF1a 
promoter (Janse et al., 2006b). 
For a third palm— parasite line, termed palm—-NT-tag, fragments of the 5ʼUTR 
including part of the N-terminal coding region corresponding to the apicoplast 
targeting signal and of the 3ʼUTR were amplified from gDNA using the following 
primer combinations: PbPALM-F3-NotI and PbPALM-R3-PshAI (5ʼ fragment, 700bp), 
and PbPALM-F7-HindIII and PbPALM-R6-KpnI (3ʼ fragment, 545bp). PCR fragments 
were cloned into a targeting vector (pBAT intermediate construct) (Kooij et al., 2012), 
which contains the mCherry coding region fused to a quadruple c-myc tag sequence 
and the pyrimethamine-resistant Toxoplasma gondii dihydrofolate 
reductase/thymidylate synthetase cassette. The resulting plasmid, pPbPALM-KO2, 
was linearized with NotI and ScaI., and cut with SapI to minimize transfection with 
partially digested plasmid.  
For targeted gene deletion of the P. berghei SUF and NFUapi genes, fragments of 
the 5ʼUTR and of the 3ʼUTR were amplified using gene-specific primers (see chapter 
2.1.10) from gDNA. PCR fragments were cloned into the berghei adaptable 
recyclable transfection vector (pBART-SIL6) (Kooij et al., 2012), which contains drug-
selectable and high-expressing GFP cassettes. First, the 3ʼUTR homologous 
sequences were cloned following restriction digestion of vector and insert with HindIII 
and KpnI. Then, the 5ʼUTR homologous sequences digested with SacII and EcoRV 
were cloned into SacII and PvuII linearized vector, thus removing the mCherry-3xMyc 
tag from the original vector. The resulting plasmids were linearized with SalI and ScaI 
and used to transfect P. berghei ANKA parasites. 
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2.2.2.9 Determination of DNA concentration 
DNA concentration was determined using the Nanodrop ND 1000. 
 
2.2.2.10 DNA sequencing 
When coding gene regions were amplified for generation of gene-tagging vectors, 
correct PCR amplification was verified by DNA sequencing (MWG), in order to avoid 
unwanted mutations or frame-shifts and to ensure subsequent functionality. 
  
2.2.2.11 Isolation of mRNA  
Isolation of parasite mRNA was performed with the RNeasy Mini Kit (Qiagen). 
Collected parasite cells were kept in 350μl RTL buffer with 3.5μl β-mercaptoethanol, 
in RNAse free tubes and stored at –80°C. After mRNA isolation, samples were eluted 
in H2O and subsequently processed to cDNA or stored at –80°C. An additional 
DNAse treatment was applied with Turbo DNAse to avoid gDNA contamination of 
samples. For mRNA isolation filter tips were used to avoid RNase contamination of 
the sample. 
 
2.2.2.12 Complementary DNA (cDNA) synthesis and reverse transcription PCR 
(RT-PCR) 
RT-PCR was used to confirm inactivation of PALM. Total RNA was isolated from 
livers excised from infected mice at 44h after infection using the RNeasy Mini kit 
(Qiagen) following the manufacturerʼs protocol. To remove contaminating genomic 
DNA, RNA samples were treated with Turbo-DNA-free (Ambion). After clearance of 
gDNA contamination was confirmed by PCR, cDNA was synthesized by a two-step 
PCR reaction using oligo dT primers (Ambion). For the detection of PALM transcripts, 
cDNA samples were tested using gene specific primers PbPALM-F6 and PbPALM-
R5 (260bp). Primers specific for heat shock protein 70 (HSP70, PbHSP70-F and 
PbHSP70-R, 164bp) were used to control cDNA load. 
 
2.2.2.13 Southern blot analysis 
Genotyping of knockout parasite lines was confirmed by Southern blot analysis using 
the PCR DIG Probe Synthesis kit and the DIG Luminescent Detection kit (Roche), 
according to the manufacturer's protocol. 
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In short, gDNA of blood-stage parasites was isolated and 1-5µg of gDNA were 
precipitated and dissolved in 10-50µL of water. Digestion of gDNA was performed 
over night at 37°C in a reaction volume of 25-40µl. Digested gDNA was run on a 
0.8% agarose gel o/n at 15-20V. The gel was stained with SYBR safe and a picture 
of the gel was taken with a ruler next to it. The DNA in the agarose gel was 
depurinated in 0.5M HCl for 10min and then denatured in 0.5M NaOH/ 1.5M NaCl for 
30min. The DNA was blotted on a Hybond-N membrane for a few hours or over 
night. Hybridization and probe detection was performed using DIG Easy Hyb and DIG 
Luminescent Detection kit (Roche) according to the manufacturerʼs protocol. 
Probe synthesis was done with the PCR DIG Probe synthesis kit (Roche). 
For genotyping of WT ANKA-GFP and palm— ANKA-GFP primers PbPALM-F2-
BamHI and PbPALM-R1-EcoRI, and PbPALM-F7-HindIII and PbPALM-R6-KpnI were 
used for amplification of the 5ʼ and 3ʼ probes, respectively. The 5ʼ probe was 
annealed to EcoRI-digested gDNA resulting in bands of 8.2kb (ANKA GFP) and 
3.6kb (palm— ANKA-GFP). The 3ʼ probe was annealed to KpnI-digested gDNA 
resulting in bands of 1.5kb (WT ANKA-GFP) and 5.3kb (palm— ANKA-GFP). 
For analysis of the clonal nfu— parasite line primers TV-3ʼNFU-F and TV-3ʼNFU-R 
were used for amplification of the hybridization probe. The hybridization probe 




2.2.3 Plasmodium berghei methods 
 
2.2.3.1 Rearing of Anopheles stephensi mosquitoes 
Mosquitoes were raised in a 14h light /10h dark cycle, at 75 % humidity and kept at 
28°C or 20°C for uninfected and infected mosquitoes, respectively. Adult mosquitoes 
were fed with sucrose solution and mosquito breading solution. 
 
2.2.3.2 Mosquito infection with P. berghei 
Mosquitoes were infected 2 to 6 days after hatching. Mosquitoes were starved for 
several hours prior to blood meal feeding. A drop of tail-blood was analyzed for male 
gametocyte exflagellation and mice were only used for blood-meal, if at least three 
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exflagellation centers (each corresponding to one male gametocyte) could be 
observed per microscopic field. The mice were anesthetized with 80-100μl ketamin/ 
xylazinhydrochlorid. Infected mice were placed on top of mosquito cages and 
mosquitoes were allowed to feed for about 30min. After blood meal, the mosquitoes 
were kept in incubators at 20°C to ensure optimal parasite development. 
 
2.2.3.3 Exflagellation assay of male gametocytes 
In order to characterize the functionality of mutant parasites or to obtain optimal 
mosquito infection rates, exflagellation of male gametocytes can be tested ex 
vivo. A drop of tail-blood is placed onto a cover slip and examined with the 40x 
objective using a bright-field microscope. The drop in temperature induces the 
exflagellation process after about 10min (Billker et al., 1997). Exflagellation 
centers per microscopic field were then counted. 
 
2.2.3.4 Analysis of Plasmodium mosquito-stage development 
Blood-feeding and mosquito dissection were performed as described previously 
(Vanderberg, 1975). In order to determine infectivity, and quantify midgut and 
salivary gland associated sporozoites, infected mosquitoes were dissected at days 
10, 14 and 17-21 after feeding, respectively. Oocysts of GFP-expressing parasites 
and non-fluorescent parasites were counted in isolated midguts using a fluorescent 
microscope or a bright-field microscope, respectively. Midguts and salivary glands 
were grinded with plastic pestles to liberate sporozoites. After two washing steps, 
sporozoites were counted in a Neubauer chamber using a bright-field microscope. 
 
2.2.3.5 Giemsa-stained blood smears and determination of parasitemia 
Giemsa staining of Plasmodium blood stages allows the monitoring of red blood cell 
infection, differentiation between developmental stages and determination of the 
parasitemia, the percentage of erythrocytes infected with Plasmodium.  
One drop of tail-blood from an infected mouse was smeared on a glass slide. The 
slide was fixed in methanol for a few seconds and then stained in Giemsa solution for 
5 to 20min. The slides were rinsed in water and air-dried. Microscopical analysis was 
performed using a 100x objective of a bright-field microscope. The number of 
erythrocytes in one field was determined and the number of parasites was counted in 
15 to 50 fields with comparable erythrocyte density. The parasitemia was calculated 
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as follows: # of parasites / (# of erythrocytes per field x # of counted fields). 
 
2.2.3.6 Infection of mice with salivary gland sporozoites 
For all infections with P. berghei sporozoites female C57BL/6 mice were used. 
Sporozoites were liberated from mosquito salivary glands and injected in a maximum 
volume of 100µl RPMI medium into the tail-vein.  
 
2.2.3.7 Overnight P. berghei culture and purification of schizonts for 
transfection 
Transfection of P. berghei mature schizonts purified from parasite overnight cultures 
and selection of recombinant parasites was performed as described previously 
(Janse et al., 2006a; Waters et al., 1997). 
To obtain parasites for the overnight culture, NRMI mice were infected by 
intraperitoneal injection of either Plasmodium berghei ANKA (WT ANKA) or 
Plasmodium berghei ANKA-GFP-507cl (WT ANKA-GFP) parasites. Animals with 2 to 
3% parasitemia and low gametocyte density were used for the schizonts culture. The 
blood was harvested by heart puncture from isofluran-anesthetized animals with 
heparin-treated syringes. The blood was washed once in 10ml of pre-warmed 
transfection medium, containing 250μl heparin/PBS (200U/ml), by centrifugation at 
1,000rpm for 8min at room temperature. The blood pellet was mixed with 50ml of 
pre-warmed transfection medium and pipetted under the final 100ml transfection 
culture in the Erlenmeyer vessel. The culture was incubated for 16 to 18h at gentle 
shaking by 77 to 80 rpm at 37°C in a mixed gas incubator at 10% O2, 5% CO2 and 
85% N2. The culture was monitored for schizont development by Giemsa-stained thin 
blood smears. When enough schizonts were detected, the culture was transferred 
into four 50ml tubes (35ml per tube). A 55% Nycodenz/PBS solution (27.5ml 
Nycodenz stock solution + 22.5ml sterile PBS) was prepared and 10ml of the 
Nycodenz-solution were gently pipetted under the culture suspension in each tube. 
The tubes were tared and centrifuged for 25min at 1,500rpm, RT, without brake. The 
brown interphase (30-40ml) was carefully collected with a Pasteur pipette. 20ml of 
culture medium from top of gradients were added to wash the schizonts by 
centrifugation at 1,500rpm for 8min. The supernatant was discarded and the pellet 
was used for electroporation. 
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2.2.3.8 Electroporation of P. berghei schizonts 
The schizont pellet was resuspended in culture medium and transferred to x 
eppendorf tubes  (1.17-3.107 parasites in 1ml for one transfection). The cells were 
pelleted by centrifugation for 5s at maximum speed. The supernatant was discarded, 
and the parasite pellet resuspended in 100µl Human T-cell Nucleofactor solution 
buffer, which contained 5-10µl DNA (1µg/µl final concentration. This solution was 
transferred to a cuvette and was transfected with the Amaxa gene pulser using 
protocol U33. Immediately after transfection, 50µl culture medium was added and 
transfected parasites were injected intravenously into the tail-vein of a naive NMRI 
mouse. 
 
2.2.3.9 Positive selection of recombinant parasites 
One day after transfection, the selection pressure was applied by adding the 
antifolate drug pyrimethamine (70 ng/ml; pH 3.6- 5.0) to the drinking water of NMRI 
mice. Parasitemia was monitored starting at day 8 after transfection. When 
parasitemia reached <1%, blood was collected by heart-puncture. Parasites were 
stored as blood stabilates and parasite gDNA was isolated for genotyping. 
 
2.2.3.10 Cryostabilates for long-term storage of blood-stage parasites 
100µl of blood from an infected mouse was mixed with 200µl freezing solution and 
stored in cryo-tubes in liquid nitrogen or at -80°C. 
 
2.2.3.11 Isolation of parasites from infected blood 
Blood of P. berghei -infected mice was obtained by heart-puncture. Erythrocytes 
were separated from leukocytes and thrombocytes by running the blood through a 
column filled with cotton, cellulose and glass beads (from bottom to top). The 
erythrocytes were eluted from the column with 1xPBS and collected in a 15ml falcon 
tube. Erythrocytes were pelleted by centrifugation at 1,500 rpm for 8min at room 
temperature. Subsequently, parasites were isolated by erythrocyte lysis, through 
resuspension of the erythrocyte pellet in 14ml 0.2% Saponin/ 1xPBS. The parasites 
were pelleted by centrifugation for 8min at 3,000 rpm, room temperature. Parasites 
were transferred to a 1.5ml eppendorf tube and washed once in 1xPBS by 
centrifugation at 7,000rpm for 3min at room temperature. The parasite pellet was 
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resuspended in 200μl 1xPBS and stored at –20 °C or directly used to isolate parasite 
gDNA. 
 
2.2.3.12 Isolation of parasite genomic DNA  
The genomic DNA was isolated from blood stage parasites for gene amplification or 
genotyping of transgenic parasite lines. Blood of infected mice was obtained by 
heart-puncture and parasites were isolated as described. The gDNA was then 
isolated with the QIAamp DNA-Blood Mini Kit (Qiagen) according to the 
manufacturerʼs protocol and stored at –20°C. 
 
2.2.3.13 Genotyping of parasite populations 
For genotyping of parasite populations after transfection experiments, parasite gDNA 
was isolated and tested by WT- and integration-specific PCR. 
Integration-specific PCR amplification of the PALM locus to confirm the predicted 
deletion of PALM in palm— ANKA and palm— ANKA-GFP parasites was done using 
the following primers: PbPALM-F1 and TgForw (5ʼ integration, 1261bp), TgRevPro 
and PbPALM-R7 (3ʼ integration, 988bp), PbPALM-F1 and PbPALM-R2 (5ʼ ANKA-
GFP control, 799bp), and PbPALM-F6 and PbPALM-R7 (3ʼ ANKA-GFP control, 
906bp). For 5ʼ ANKA-GFP control of palm—-NT-tag parasites the primers PbPALM-
F1 and PbPALM-R4 (904bp) were used. 
Correct integration in PALM-mCherry-myc parasites was confirmed using the 
following specific primer combinations: PbPALM-F4 and mCherryRev (5ʼ integration, 
979bp), TgRevPro and PbPALM-R7 (3ʼ integration, 988bp), PbPALM-F4 and 
PbPALM-R6-KpnI (5ʼ ANKA-GFP control, 1,450bp), and PbPALM-F6 and PbPALM-
R7 (3ʼ ANKA-GFP control, 906bp).  
Integration-specific PCR amplification of the NFUapi locus to confirm the predicted 
deletion of NFUapi was done using the following primers: 5ʼHSP70rev and GT-
5ʼNFU-F (5ʼ integration, 958bp), and GT-3ʼNFU-R and 5ʼDHFRrev (3ʼ integration, 
1,210bp). Absence of WT-specific PCR products using primers GT-5ʼNFU-F and GT-
5ʼNFU-R (5ʼ WT ANKA control, 960bp), and GT-3ʼNFU-F and GT-3ʼNFU-R (3ʼ WT 
ANKA control, 702bp) were used to confirm the purity of the clonal nfu– parasite line. 
Integration-specific PCR amplification of the SUF loci was performed as for the 
NFUapi locus with the according locus specific primers. 
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All primer sequences, including primers for WT-specific PCRs, are listed in section 
2.1.10. 
 
2.2.3.14 Parasite cloning by limiting parasite dilutions 
Clonal parasite populations were obtained in vivo by intravenous injection of limiting 
dilutions of one parasite per recipient NMRI mice, and calculated as follows: 
7 x 106 x parasitemia x 10-2 parasites = number of parasitized erythrocytes per μl 
blood. 
Blood was collected by heart-puncture from mice with < 1 % parasitemia and series 
of 6 1:10 dilutions were prepared in RPMI medium on ice. After intravenous injection 
of single parasites in a volume of 100µl into NMRI mice, animals were kept under 
pyrimethamine treatment. When the parasitemia reached >1% mice were bled by 
heart-puncture. Stabilates for long-term storage were prepared and gDNA was 
isolated. The clonality of the parasite population was confirmed by PCR with 
integration specific primers. 
 
2.2.3.15 Parasite cloning by flow cytometry 
Parasite cloning by flow cytometry was performed as recently described 
(Kenthirapalan et al., 2012). 
When parasitemia of the parental population was still <1%, one drop of tail blood was 
collected and resuspended in 1ml of Alseverʼs solution in order to minimize 
agglutination of the blood. The samples were passed through 30µm CellTrics filters 
to remove cell aggregates. All sorting experiments were performed on a BD 
Biosciences FACSDiva using a purity sort-mask at a sorting speed of 30,000 events 
per second. Excitation of GFP was done at a wavelength of 488 nm, while 
fluorescence was detected using a band pass filter of 530/30 nm with the 
photomultiplier tube voltage set to its maximum sensitivity. Forward and sideward 
scatter gating was used to exclude small particles (such as blood platelets and 
debris) as well as overly large cells (predominantly leukocytes). The remaining 
population mainly consisted of erythrocytes and was gated for high-expressing GFP 
(GFPhi) but low-expressing phycoerythrin (PElo) cells, thus excluding autofluorescent 
cells with equal GFP and PE levels, 500 of which were collected in 200µl of 20% 
FCS/RPMI. After sorting, the collection tube was washed with 800µl of 20% 
FCS/RPMI. Naive recipient NMRI mice were injected intravenously with 100µl cell 
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suspension containing approximately 50 parasite-infected erythrocytes. At a 
parasitemia of >1%, mice were bled, parasite stabilates were frozen, and parasite 
gDNA was isolated. FACS sorting was done in collaboration with the Flow Cytometry 
Core Facility at the Deutsches Rheuma-Forschungszentrum (Berlin). 
 
2.2.3.16 Phenotypical analysis of mixed blood-stage parasites growth in vivo 
NMRI mice were injected intravenously with 1,000 blood-stage parasites and 
monitored for blood stage development by daily examination of Giemsa-stained 
thin blood smears. 
 
2.2.3.17 Blood-stage transfer experiment 
In order to test the presence of parasites in the blood below Giemsa-stained thin 
blood smear detection threshold, blood-transfers were performed. C57BL/6 mice 
were infected by bites of mosquitoes infected with WT ANKA-GFP or palm— ANKA-
GFP parasites. At day 3, 4 and 5 after infection (when parasitemia was undetectable 
by thin blood smears), about 30µl of tail-blood were transferred by intravenous 
injection into naive recipient mice. Development of blood-stage infection was 
monitored in the recipient mice by daily thin Giemsa-stained blood smears. 
 
2.2.3.18 Evans Blue staining for assessment of blood-brain barrier breaching 
During all experiments, mice were monitored for the development of behavioral and 
functional abnormalities (Lackner et al., 2006), as indicators of ECM development. 
Mice were classified as suffering from ECM when they were diagnosed with at least 
three behavioral and functional abnormalities (e.g. positional passivity, body position, 
limb grasping, toe pinch, etc.). Mice were immediately sacrificed upon showing 
sudden onset of signature symptoms of ECM, such as ataxia, paralysis, convulsions 
or coma. To test the integrity of the blood–brain barrier as a further indication for the 
susceptibility to ECM, 100µl of 2% Evans Blue were injected in saline intravenously 
into naive C57BL/6 mice, or mice infected with 10,000 or 100,000 palm-, or 10,000 
WT ANKA-GFP sporozoites at day 4 after patency. After one hour, mice were 
sacrificed, brains prepared, and digital images taken using standardized lighting, 
exposure and white balance settings. This experiment was done in collaboration with 
Dr. Taco Kooij and Carolin Nahar. 
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2.2.3.19 Liver-stage development assay 
P. berghei in vitro liver stages were cultured in DMEM complete medium and 
analyzed using standard techniques (Silvie et al., 2008). 30,000 hepatoma (HuH7) 
cells per well were plated in eight-well chamber slides (Nalge Nunc International). 
After 24h the cells were incubated with 10,000 sporozoites. First for 60min at room 
temperature, then at 37°C for 90–120min. Non-invaded sporozoites were washed off 
and medium was changed daily. At the time points indicated, infected hepatoma 
cultures were fixed for 10min with ice-cold methanol and blocked with PBS/10% FCS. 
For drug tests with azithromycin and fosmidomycin, antibiotics were added to the 
DMEM complete medium and were applied after washing off the sporozoites. 
Medium was changed daily and cells were kept in this medium until development 
was stopped with methanol. Controls contained DMEM complete medium with equal 
amounts of DMSO, when drugs were dissolved in DMSO. 
 
2.2.3.20 Merosome development assay 
Merosome formation was followed using two different methods, either by (1) seeding 
of 100,000 to 150,000 Huh7 hepatoma cells per well in 24-well plates and inoculation 
with 100,000 sporozoites per well 24h later, or by (2) seeding of 30,000 Huh7 
hepatoma cells per well in eight-well Labtek chamber slides and inoculation with 
10,000 sporozoites 24h later. Sporozoites were left to settle for one hour at room 
temperature. Sporozoite invasion occurred at 37°C for 1.5 to 2 hours. After invasion 
sporozoites were carefully washed off with DMEM complete medium. Culture 
medium was changed 24 and 48h after infection. Merosomes were harvested and 
counted in a Neubauer chamber 72h after infection.  
 
2.2.3.21 Infection of mice with merosomes 
Infectivity of in vitro cultured WT ANKA-GFP and palm— parasites was tested by 
intravenous injection of the complete merosome containing liver-stage culture 
supernatants in naive NMRI mice. All animals were monitored for parasitemia by 
daily Giemsa-stained thin blood smears. 
 
2.2.3.22 Quantification of relative parasite liver infection load by real-time PCR 
Plasmodium liver stages can be detected and quantified by real-time PCR (Bruna-
Romero et al., 2001). For quantification of parasite liver loads, mice were immunized 
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twice with 10,000 palm– sporozoites and received one challenge/boost by 
intravenous injection of 10,000 WT sporozoites. One year after the last boost, 
animals were challenged by intravenous injection of 10,000 WT sporozoites. Control 
animals were one year old. Mice were sacrificed 41h after challenge infection, and 
livers were removed and homogenized. Total RNA was extracted using the RNeasy 
Kit (Qiagen) and used as template for cDNA synthesis with the RETROscript Kit 
(Ambion) according to the manufacturerʼs protocol. Quantitative real-time PCR was 
performed using the Power SYBR Green PCR Master Mix (Applied Biosystems). All 
reactions were performed in triplicate.  
 
Standard qRT-PCR program:  
Step 1: 95°C, 15 min 
Step 2: 95°C, 15 sec 
Step 3: 55°C, 15 sec 
Step 4: 60°C, 45 sec 
Step 5: 40 cycles between step 2 and 3 
Step 6: 60°C, 45 sec 
 
The mean Ct value of the P. berghei 18S ribosomal subunit (gene ID: 160641), 
normalized to the Ct value of mouse GAPDH (gene ID: 281199965) was determined 
with the ΔΔCt method, as described previously (Friesen et al., 2010). 
  
2.2.3.23 Immunofluorescent assays (IFA) of P. berghei 
To quantify liver-stage parasites, monoclonal mouse anti-P. berghei heat shock 
protein 70 (HSP70) antibodies (1:300 dilution; (Tsuji et al., 1994)) were used. Bound 
antibodies were detected using donkey anti-mouse IgG Alexa Fluor 488 conjugated 
antibodies (1:3000 dilution, Invitrogen). Nuclei were visualized with DNA-dyes 
Hoechst 33342 (Invitrogen) and DRAQ5 (Axxora; both 1:1000 dilution) and coverslips 
were mounted with Fluoromount-G (Southern Biotech). Total numbers of parasites 
were counted using a Leica DM2500 epifluorescence microscope. 
Midguts of PALM-mCherry-myc infected mosquitoes were dissected at day 10 after 
infection and fixed with 4% paraformaldehyde with 0.0075% glutaraldehyde. 
Subsequently, midguts were permeabilized with 0.5% Triton X-100 and blocked with 
3% bovine serum albumin. Incubation with mouse anti-myc antibodies (1:200 dilution, 
Santa Cruz Biotechnology) was done overnight at 4°C. Bound antibodies were 
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detected using donkey anti-mouse IgG Alexa Fluor 488 conjugated antibodies 
(1:2,000 dilution, Invitrogen).  
Salivary glands of PALM-mCherry-myc infected mosquitoes were dissected and 
liberated sporozoites were settled in RPMI medium containing 3% bovine serum 
albumin and fixed with 4% paraformaldehyde. Subsequently, sporozoites were 
permeabilized with 0.1% Triton X-100 in PBS and blocked with 3% bovine serum 
albumin. Incubation with mouse anti-myc antibodies (1:100 dilution, Santa Cruz 
Biotechnology) was done overnight at 4°C. Bound antibodies were detected using 
donkey anti-mouse IgG Alexa Fluor 546 conjugated antibodies (1:1,000 dilution, 
Invitrogen).  
Liver-stage PALM-mCherry-myc parasites were fixed and incubated with mouse anti-
myc antibodies (1:1000 dilution, Santa Cruz Biotechnology). To confirm apicoplast 
targeting of PALM, liver-stage parasites were co-stained with rabbit anti-P. berghei 
ACP peptide antiserum (1:750 dilution;(Friesen et al., 2010)). Completion of liver 
merozoite formation was analyzed using rabbit anti-P. berghei upregulated in 
infectious sporozoites protein 4 (UIS4) peptide antiserum (1:2,000 dilution; kindly 
provided by Dr. G. Montagna, MPI-IB, Berlin) and a monoclonal mouse anti-P. yoelii 
merozoite surface protein 1 (MSP1) antibody against a 90 kDa N-terminal fragment 
of the protein that shares 74% identity with P. berghei MSP1 (1:2,000 dilution; kindly 
provided by Prof. Dr. A. Holder, National Institute for Medical Research, London, 
UK). Bound antibodies were detected using donkey anti-rabbit/mouse IgG Alexa 
Fluor 488/546 conjugated antibodies (1:3,000 dilution, Invitrogen).  
For confirmation of expression and determination of the subcellular localization of 
NFUapi, fixed nfu::tag liver stage parasites were incubated with mouse anti-myc 
antibodies (1:1,000 dilution, Santa Cruz Biotechnology) and rabbit anti-P. berghei 
ACP peptide antiserum (1:750 dilution). Monoclonal mouse anti-P. berghei heat 
shock protein 70 (HSP70) antibodies (1:300 dilution;(Tsuji et al., 1994)) were used to 
visualize and quantify nfu– liver stage parasites. Bound antibodies were detected 
using donkey/goat anti-rabbit/mouse IgG Alexa Fluor 488/546 conjugated antibodies 
(1:3,000 dilution, Invitrogen).  
In all experiments, with exception of sporozoite stainings, nuclei were visualized with 
DNA-dyes Hoechst 33342 (Invitrogen) and DRAQ5 (Axxora; both 1:1,000 dilution) 
and coverslips were mounted with Fluoromount-G (Southern Biotech). Images were 
recorded using a Leica TCS SP-1 confocal microscope. 
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2.2.4 Immunology methods 
Lymphocyte isolations, peptide stimulations and immunological flow cytometry 
experiments were done in collaboration with Jan Burgold.  
 
2.2.4.1 Immunizations with palm– sporozoites 
For all immunization experiments age-matched female C57BL/6 mice were used. 
Mice were immunized with two doses of 1,000 or 10,000 palm– sporozoites extracted 
from salivary glands of infected mosquitoes. Sporozoites were injected intravenously 
in a volume of 100µl. For the prime/boost protocol, animals that remained malaria-
free after the first immunization were given a second dose 5–7 weeks after the first 
immunization. Only animals that remained blood-stage parasite-negative after the 
first immunization and subsequent boost were used for the challenge experiments at 
4–6 weeks after the last immunization. Mice were challenged with five WT ANKA-
GFP-infected mosquitoes, 10,000 intravenously injected WT ANKA-GFP sporozoites, 
or 10 intravenously injected WT ANKA-GFP blood-stage parasites. The number of 
ANKA-GFP salivary gland sporozoites per mosquito used for the challenge by bite 
ranged from 20,000 to 70,000. At least three age-matched naive animals were 
included to verify infectivity of sporozoites during all challenge experiments. 
Parasitemia was monitored by daily Giemsa-stained thin blood smears, starting from 
day 3 after immunization or WT ANKA-GFP challenge until at least day 17. 
To test, whether vaccine efficacy is quantifiable beyond one year, two cohorts were 
used. All mice received two doses of 10,000 palm– sporozoites given at a 51 day 
interval. Mice in group 1 received a challenge/boost by intravenous injection of 
10,000 WT ANKA-GFP sporozoites four weeks later. Animals in group 2 were first 
exposed to bites of five WT-infected Anopheles mosquitoes one month later, followed 
by an additional challenge/boost by intravenous injection of 10,000 WT ANKA-GFP 
sporozoites another two weeks later. All mice from groups 1 and 2 remained malaria-
free until the final challenge. Challenge infections were done 14 and 15 months after 
the final boosts for animals in groups 1 and 2, respectively, by intravenous injection 
of 20,000 WT ANKA-GFP sporozoites. As controls for the challenge infections, five 
aged (15 months old) and three young (two months old) C57BL/6 mice were used. All 
animals were monitored for presence of blood stage parasites by daily microscopic 
examination of Giemsa-stained thin blood smears until day 17 after challenge. 
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2.2.4.2 Isolation of liver lymphocytes 
For flow cytometric analysis, mice were immunized twice with 10,000 palm– 
sporozoites and received one challenge/boost by intravenous injection of 10,000 WT 
sporozoites. One year after the last boost, animals were challenged by intravenous 
injection of 10,000 WT sporozoites. Control animals were one year old. Animals were 
anesthetized and livers were removed 41 hours after infection. 
The livers were perfused via the portal vein with 20ml PBS/ 2% FCS (pH7.0) and 
gently passed through a 200-gauge stainless steel mesh. Cells were resuspended in 
RPMI 1640 medium containing 10%FCS/ 2%penicillin/ streptomycin (RPMI complete) 
and centrifuged at 1,800 rpm for 3 min. The supernatant was removed and the pellet 
was resuspended in ~40% Percoll solution (27.1ml HBSS (Hanksʼ Balanced Salt 
Solution) or RPMI complete, 14.2ml Percoll, 1.6ml 10x PBS, 100U/ml heparin) and 
centrifuged at 2,000rpm for 20min at room temperature. The supernatant was 
discarded and the cells were washed once with RPMI complete. The pellet was 
resuspended in 1ml 1x NH4Cl lysis solution and incubated for 10min. After a washing 
step with RPMI complete the pellet was resuspended in 400µl medium. Cell numbers 
were calculated using a Neubauer chamber, and live/dead cell differentiation was 
performed using trypan blue.  
 
2.2.4.3 Isolation of spleen lymphocytes 
For flow cytometric analysis, mice were immunized twice with 10,000 palm– 
sporozoites and received one challenge/boost by intravenous injection of 10,000 WT 
sporozoites. One year after the last boost, animals were challenged by intravenous 
injection of 10,000 WT sporozoites. Control animals were one year old. Animals were 
anesthetized and spleens were removed 41 hours after infection. 
Spleens were pressed through a cell strainer with 5ml RPMI complete (10% FCS/ 2% 
penicillin/ streptomycin). The cells were then centrifuged for 3min at 1,800rpm. 
The pellet was resuspended in 1ml 1x Lysing buffer and incubated at room 
temperature for 10min. RPMI complete was added to obtain a total volume of 15ml 
and cells were centrifuged for 3min at 1,800rpm. In the end the pellet was 
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2.2.4.4 Surface staining of lymphocytes 
For phenotypic analysis of cellular activation, cells were surface stained for CD8 
(clone 53.6-7), CD4 (clone GK1.5) and CD11a (clone M17/4). Cells were 
resuspended in 50µl per well in a 1:150 dilution of the surface marker in 2%FCS/ 
PBS and incubated at 4°C for 30min. Cells were then washed twice with 2% FCS/ 
PBS and then centrifuged for 3min at 1,800rpm. 
 
2.2.4.5 Ex vivo peptide stimulations 
For the analysis of IFN-γ, IL-2, and TNF production, cells were stimulated with 
antibodies to CD3 (145-2C11) and CD28 (37.51), with the S and T peptides 
corresponding to immunodominant CD8+ T cell epitopes (Hafalla et al., unpublished 
data), or with a peptide corresponding to a conserved CD4+ T cell epitope, P1 
(KIYNRNIVNRLLGDA) of P. yoelii circumsporozoite protein (CSP) (Boscardin et al., 
2006).  
30µl of spleen or liver cell suspensions per well were pipetted into a 96-well-plate and 
centrifuged for 3min at 1,800rpm. Lymphocytes were stimulated with 200µl per well, 
with one of the peptides or CD3 and CD28 antibodies in a 1:5,000 dilution in RPMI 
and in the presence of Brefeldin A (1:5,000). All T cell stimulations were done for 5 
hours and were followed by surface staining for CD8 and CD4. After fixation and 
permeabilization, cells were stained for intracellular IFN-γ, IL-2 and TNF.  
 
2.2.4.6 Intracellular cytokine staining 
For intracellular cytokine staining after ex vivo stimulation, cells were centrifuged for 
3min at 1,800rpm and then fixed with 50µl 4%PFA per well for 30min at 4°C. 
Subsequently, cells were permeabilized 2x with 100µl 1x Perm/Wash buffer and 
centrifuged for 3min at 1,800rpm. For intracellular cytokine staining, cells were 
incubated with anti-TNF, anti-IL-2 and anti-INFγ antibodies (1:150) in 1x Perm/Wash 
buffer for 30min at 4°C. Cells were then washed twice with 100µl 1x Perm/Wash 
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2.2.4.7 Flow cytometry analysis 
Flow cytometers LSRII and Fortessa (BD Biosciences) were used for flow cytometry 
analysis of surface and intracellular cytokine stained lymphocytes and data was 






3.1 Plasmodium apicoplast protein important for liver merozoite 
formation (PALM) 
 
3.1.1 Identification of the candidate Plasmodium liver stage specific 
gene PALM 
 
To identify Plasmodium genes with a specific critical function in liver merozoite 
formation, available data sets (Aurrecoechea et al., 2009; Tarun et al., 2008) were 
systematically searched for potential liver stage-specific genes of unknown functions. 
The attention came to a small hypothetical gene (PY01863) expressed during liver-
stage development and upregulated in late liver stages (i.e. 50 hours after infection) 
(Tarun et al., 2008). The only additional expression data available were from a recent 
RNA sequencing effort of synchronous P. falciparum blood stages that revealed 
negligible PALM transcription levels with a slight upregulation in mature blood stages 
(Otto et al., 2010). 
Via BLAST analysis, orthologs were readily identified in other Plasmodium species 
such as P. berghei (PBANKA_010110), P. chabaudi (PCHAS_010180), P. falciparum 
(PF3D7_0602300), P. vivax (PVX_113280) and P. knowlesi (PKH_114760), but not 
in any other organism. The overall amino acid sequence identities of PALM orthologs 
in P. yoelii (PY01863), P. falciparum (PF3D7_0602300) and P. vivax (PVX_113280), 
compared with P. berghei PALM (PBANKA_010110) are 88%, 50%, and 50%, 
respectively (Fig. 3.1 A). Using cross-species comparisons, the Plasmodium berghei 
gene was manually re-annotated, disclosing a previously unrecognized N-terminal 
region.  Sequence analysis through PlasmoAP, a P. falciparum specialized, rules-
based algorithm that uses amino-acid frequency and distribution to identify putative 
apicoplast-targeting peptides (Foth et al., 2003a), revealed a putative apicoplast-
targeting sequence in all orthologs (Fig. 3.1 A, B). For these reasons and the loss-of-
function analysis (see sections 3.1.11 and 3.1.14), the protein was termed 







Figure 3.1: The Plasmodium-specific apicoplast protein important for liver 
merozoite formation (PALM). 
(A) Primary structure of Plasmodium PALM proteins. Shown are the overall primary 
sequence structures and amino acid sequence identities of PALM orthologs in P. 
yoelii (PY01863), P. falciparum (PF3D7_0602300) and P. vivax (PVX_113280), 
compared with P. berghei PALM (PBANKA_010110). Signal peptide (red), 
apicoplast-targeting sequence (green) as predicted with PlasmoAP (Foth et al., 
2003a), and the conserved domain (gray) with two conserved cysteine residues 
(yellow) are shown. (B) Sequence alignment of Plasmodium PALM proteins. In 
addition to proteins in (A), P. chabaudi PALM (PCHAS_010180) and P. knowlesi 
PALM (PKH_114760) are shown. Color code as in (A). * fully conserved residue, : 
conservation of strongly similar properties and . conservation of weakly similar 




A central, highly conserved domain that contains two strictly conserved cysteine 
residues is apparent in all analyzed Plasmodium species (Fig. 3.1 A, B).  Application 
of a recently developed extended similarity group method (Chitale et al., 2009) 
predicted P. falciparum PALM to display potential transferase activity of uncertain 
specificity. However, neither functional domains nor transmembrane regions could be 
readily identified in Plasmodium PALM. 
 
 
3.1.2 Generation of PALM-mCherry-myc parasites 
 
The apicoplast-targeting signal prediction tool PlasmoAP revealed a high probability 
of PALM being targeted to the apicoplast. To confirm this in silico prediction and to 
analyze PALM expression in vivo, a parasite line was generated where the C-
terminus of the endogenous PALM gene was linked in-frame to mCherry and a 




Figure 3.2: Live cell imaging of PALM in infected hepatoma cells. 
(A) Generation of PALM-mCherry-myc parasites. The PbPALM genomic locus was 
targeted with a replacement plasmid containing the C-terminal PALM fragment (gray) 
fused in-frame to the mCherry coding sequence (red), and a quadruple c-myc tag 
(blue) and followed by the 3ʼUTR of PbDHFS/FPGS. In addition, the targeting 
plasmid contains the PbDHFR/TS positive selectable marker (black box), and a 
fragment of the PALM 3ʼUTR. Upon a double cross-over event, the targeting plasmid 




tagged PALM fusion protein. Arrows and bars indicate specific primers and PCR 
fragments, respectively. (B) Genotyping of the PALM-mCherry-myc parasite line. 
Using integration-specific primer combinations (A), the successful replacement event 
was verified. Absence of the WT signal from PALM-mCherry-myc parasites 
confirmed the purity of the clonal population. (C) Hepatoma cells were infected with 
PALM-mCherry-myc sporozoites. PALM expression was visualized in late liver 
stages 2 days after infection. Note the branched structure of the mCherry signal. 
Bars, 10 µm. 
 
For this purpose the C-terminal part and the 3ʼUTR of PALM were amplified by PCR 
and cloned into a targeting vector, which contains the mCherry coding region fused 
to a quadruple c-myc tag sequence and the pyrimethamine-resistant T. gondii 
dihydrofolate reductase/thymidylate synthetase cassette for positive selection. 
Plasmodium berghei WT ANKA-GFP parasites were transfected with the linearized 
plasmid and correct integration by double homologous recombination of the 
replacement construct was confirmed by integration specific PCR using primers 
PbPALM-F4 and mCherryRev (5ʼ integration, 979 bp) and TgRevPro and PbPALM-
R7 (3ʼ integration, 988 bp) (Fig. 3.2 B). After successful integration, a clonal parasite 
line was generated by intravenous injection of limiting dilutions of parasites into mice. 
Absence of WT specific PCR products using primers PbPALM-F4 and PbPALM-R6-
KpnI (5ʼ WT ANKA-GFP control, 1450bp), and PbPALM-F6 and PbPALM-R7 (3ʼ WT 
ANKA-GFP control, 906bp) confirmed the purity of the clonal PALM-mCherry-myc 
parasite line (Fig. 3.2 B). 
 
 
3.1.3 PALM-mCherry-myc parasites exhibit normal life cycle 
progression 
 
Clonal PALM-mCherry-myc parasites were fed to mosquitoes in two independent 
feedings. The infectivity at day 10 after feeding, and midgut and salivary gland 
sporozoite numbers at day 14 and day 17 after feeding, respectively, were assessed. 
Liver stage and merosome development were analyzed in cultured Huh7 cells. 
Finally, re-infection of mice by natural bite of PALM-mCherry-myc parasites infected 
mosquitoes showed the progression of the mutant parasites through one whole life 
cycle (Tab. 3.1). In all of the analyzed life cycle stages mutant parasites were 





Table 3.1: Phenotypical analysis of PALM-mCherry-myc and three independent 
palm— clones. 
 
a Numbers of infected midguts were determined at day 10 after the blood meal. 
Shown are mean numbers (± S.D.). 
b Midgut-associated (mg) sporozoites were determined at day 14 after the blood 
meal. Shown are mean numbers (± S.D.). 
c Salivary gland (sg) sporozoites were determined at day 17 after the blood meal. 
Shown are mean numbers (± S.D.). N is the number of independent feeding 
experiments from which the number of mosquito stage parasites was determined. 
d Liver stages were immunostained with anti-PbHSP70 antibodies at the indicated 
time points after infection of hepatoma cells. Shown are mean numbers (± S.D.). N is 
the number of independent experiments. 
e Numbers of merosomes were counted in a Neubauer chamber 72 hours after 
infection of hepatoma cells. Shown are mean numbers of triplicate wells (± S.D.). See 
the methods section for the differences between the two methods used. 
f Mice immunized twice with 10,000 palm— sporozoites were challenged with 10,000 
intravenously injected WT ANKA-GFP sporozoites or in the case of PALM-mCherry-
myc by natural bite of five infectious mosquitoes. Blood stage infection following 
challenge was determined by Giemsa-stained thin blood smears at indicated time 
points. 
g Prepatency was determined by daily Giemsa-stained thin blood smears. Shown are 
mean numbers. 
h Mice were monitored for the development of signature symptoms of experimental 
cerebral malaria (ECM), such as ataxia, paralysis, convulsions, and coma. N is the 















3.1.4 PALM is expressed throughout the life cycle 
 
PALM-mCherry-myc parasites permit to follow protein expression and localization 
either live through the fluorescent mCherry protein tag or indirectly via antibody 
staining of the c-myc tag in fixed parasites. First, PALM expression was followed in 
live parasites. Structured, although weak, signals could be observed in in vitro 
cultured liver-stage parasites (Fig. 3.2 C). Absence of a detectable signal in any of 
the other life cycle stages indicated that PALM expression levels in general are low, 
with the exception of mature liver stages. Therefore, indirect immunofluorescence 
microscopy was employed using mouse anti-myc antibodies on fixed parasites, to 
take advantage of the quadruple myc epitope that was fused in-frame to the 
endogenous PALM open reading frame. In good agreement with the report of low 
levels of PALM transcripts in mature blood stages (Otto et al., 2010), a structured 
PALM signal was detected in mature asexual blood stages, but not in ring stages or 
trophozoites (Fig. 3.3 A). Moreover, a structured staining could be observed inside 
developing Plasmodium oocysts that segregated in mature oocysts (Fig. 3.3 B), as 
well as a single dot in salivary gland sporozoites (Fig. 3.3 C). During in vitro liver-
stage development the PALM signal started as a dot at 24h after infection (Fig. 3.3 
D) and developed into the typically branched structure at 48h (Fig. 3.3 E) and 65h 
after infection (Fig. 3.3 F). 
Together, these stainings are in accordance with the structures of previously 
published apicoplast proteins (Stanway et al., 2009), thus suggesting the correctness 






Figure 3.3: Expression of PALM during the Plasmodium berghei life cycle.  
PALM-mCherry-myc parasites were used to infect mice and Anopheles stephensi 
mosquitoes. Intra- and extracellular parasite stages were fixed, permeabilized and 
stained with mouse anti-myc antibody (red). In replicating stages, nuclei were stained 
with the DNA-dye DRAQ5 (blue). The GFP signal in fixed sporozoites was used to 
display the extracellular parasite. (A) Blood-stage schizont (BS schizont) from an 
infected mouse. The anti-myc signal was very weak and only detectable after 
background subtraction in comparison with WT parasite-infected erythrocytes. Bars, 
5 µm. (B) Oocyst fixed at day 10 after infection. Bars, 10 µm. (C) Salivary gland 
sporozoite fixed at day 17 after infection. Bars, 10 µm. Liver-stage parasites fixed at 




3.1.5 Subcellular localization of PALM 
 
To further corroborate the localization of PALM to the apicoplast, liver stages, where 
the PALM signal is most prominent, were used for co-localization studies. Polyclonal 
antibodies against a signature apicoplast protein, acyl carrier protein (ACP; (Friesen 
et al., 2010)), were used to co-stain fixed PALM-mCherry-myc parasite-infected 
hepatocytes with a monoclonal anti-myc antibody. The staining overlapped 
substantially, strongly suggesting that tagged PALM is indeed transported efficiently 
into the apicoplast (Fig. 3.4). 
 
 
Figure 3.4: Apicoplast localization of PALM. 
Co-staining of fixed, PALM-mCherry-myc parasite-infected hepatoma cells 48 hours 
after infection using anti-myc and anti-ACP antibodies. Note the substantial overlap 
between PALM and the signature apicoplast protein ACP. 
 
Since in apicomplexan parasites the apicoplast and the mitochondrion are in close 
association (van Dooren et al., 2005), additional proof for an exclusive localization to 
one of the two organelles was required. Previous work established that antibiotic 
treatment during liver-stage development abrogated apicoplast growth and 
segregation (Friesen et al., 2010). Therefore the immunofluorescence assay was 
repeated in the presence or absence of 1µM azithromycin. Destruction of the 
apicoplast integrity by this treatment abolished the ACP- and PALM-positive 
branched structure in in vitro liver stages 48 hours after infection and limited the 
signal to a small peripheral dot (Fig. 3.5).  
Combined, the co-localization of PALM with the apicoplast signature protein ACP and 
the disappearance of PALM-positive structures upon azithromycin treatment indicate 








Figure 3.5: Branched PALM-positive structures disappear upon treatment with 
azithromycin. 
(A) PALM-mCherry-myc parasite-infected hepatoma cells left untreated, fixed at 48 h 
after infection, and stained with antibodies specific for the myc epitope and 
upregulated in infective sporozoites protein 4 (UIS4), a signature protein of the 
parasitophorous vacuole. Note the branched PALM-positive structures. (B) 
Antibiotics treatment with 1 µM azithromycin abolishes the branched PALM-positive 
structures while parasites appear to remain healthy otherwise. (C) Antibiotics 
treatment with 1 µM azithromycin abolishes the branched PALM-positive structures 
as well as ACP-positive structures. All bars, 10 µm. 
 
 
3.1.6 Generation of palm— parasites 
 
A systematical study of the in vivo function of PALM was performed by generation 
and analysis of PALM knockout parasites. For targeted gene deletion, the P. berghei 
PALM locus was disrupted by the standard gene replacement strategy (Menard and 
Janse, 1997). Fragments of the 5ʼUTR and part of the N-terminal coding region and 




standard transfection vector, which contains the pyrimethamine-resistant 
Toxoplasma gondii dihydrofolate reductase/thymidylate synthetase cassette. The 
resulting plasmid, pPbPALM-KO, was linearized and P. berghei WT ANKA and WT 
ANKA-GFP parasites were transfected (Fig. 3.6 A).  
 
 
Figure 3.6: Generation of palm— parasites. 
(A) The PbPALM genomic locus was targeted with a replacement plasmid containing 
PALM 5ʼ and 3ʼ fragments (thick black lines) and the DHFR/TS positive selectable 
marker (black box). Upon a double cross-over event, the targeting plasmid is 
expected to replace the endogenous PALM open reading frame. Arrows and light 
gray solid lines indicate specific primers and PCR fragments respectively. Black bars 
indicate specific 5ʼ and 3ʼ probes; dark gray dashed lines represent EcoRI or KpnI 
restriction-digested fragments of WT or knockout parasite gDNA. (B) Alternative 
gene replacement vector to ablate the PALM locus. The PbPALM genomic locus was 
targeted with a replacement plasmid containing a PALM 5ʼ fragment, containing a 




(red box) and quadruple myc tag (blue box), followed by the DHFR/TS positive 
selectable marker (black box) and the 3ʼ flanking region (thick bar). Upon a double 
cross-over event, the targeting plasmid is expected to replace the endogenous PALM 
open reading frame. Arrows and bars indicate specific primers and PCR fragments 
respectively. (C) Mouse-mosquito-mouse transmission experiment starting from a 
mixed WT/ palm— infection (input) and resulting in a pure WT population after 
completion of one transmission cycle (output). Parasites were genotyped by PCR 
using wild-type (WT)- and replacement (INT)-specific primer pairs, as indicated in 
(A). (D) Parasite transcript detection in WT and palm- parasite-infected livers 
confirms the successful ablation of PALM in the knockout line. cDNA was prepared 
from liver homogenates extracted from mice at 44h after sporozoite infection. Quality 
of cDNA preparations and presence of parasites in vivo was controlled using HSP70-
specific primers. (E) Genotyping of the three clonal palm— parasite lines obtained 
from independent transfection experiments. Using integration-specific primer 
combinations (A, B) the successful replacement event (INT) was verified. Absence of 
the WT signal from palm— parasites confirmed the purity of the clonal populations. 
The clonal populations palm— ANKA (blue) and palm— ANKA-GFP (green) were 
obtained according to design (A), using WT-ANKA and WT ANKA-GFP parasites as 
recipient lines (left); the clonal population palm—-NT-tag (red) was obtained 
according to design (C), using WT ANKA-GFP parasites as recipient line (right). (F) 
Genotyping of the palm— ANKA-GFP parasite line used for the majority of 
experiments through Southern blot analysis. Probes at the 5ʼ and 3ʼ UTR of PALM 
were used to demonstrate the expected size shift of restriction-digested gDNA of WT 
and knockout parasites. 
 
For a third knockout line fragments of the 5ʼUTR including part of the N-terminal 
coding region corresponding to the apicoplast targeting signal and of the 3ʼUTR were 
amplified from gDNA. PCR fragments were cloned into a targeting vector, which 
contains the mCherry coding region fused to a quadruple c-myc tag sequence and 
the pyrimethamine-resistant Toxoplasma gondii dihydrofolate reductase/thymidylate 
synthetase cassette. The resulting plasmid, pPbPALM-KO2, was linearized and used 
to transfect P. berghei WT ANKA-GFP parasites (Fig. 3.6 B).  
 
 
3.1.7 Feeding of parental palm— population 
 
To obtain a first indication, whether palm— parasites progress through the life cycle 
normally or show any sign of arrest in their development, the parental population, 
which consists of a mixture of WT and palm— parasites, was fed to mosquitoes. 
When sporozoites had colonized the salivary glands, a naive C57BL/6 mouse was 
infected by natural bite of mosquitoes. Five days after infection, the mouse was bled 




specific primers of the parasite population before (input) and after (output) feeding 
revealed that only WT parasites were able to complete the transmission cycle (Fig. 
3.6 C). 
This finding argued for the generation of a clonal palm— population to further analyze 
PALM knockout parasites in detail. 
 
 
3.1.8 Generation of three clonal palm— parasite lines 
 
Three independent clonal palm— parasite lines were generated by intravenous 
injection of limiting dilutions of parasites into mice: palm— ANKA-GFP and palm—-NT-
tag following transfection of the GFP expressing WT ANKA-GFP line using vectors 
PbPALM-KO and PbPALM-KO2, respectively, and palm— ANKA following 
transfection of WT ANKA parasites with PbPALM-KO. 
Inactivation of PALM in the palm— ANKA-GFP line was confirmed through RT-PCR. 
Total RNA was isolated from livers isolated from infected mice at 44 hours after 
infection and used to generate cDNA by RT-PCR. For the detection of PALM 
transcripts, cDNA samples were tested using gene specific primers PbPALM-F6 and 
PbPALM-R5 (260 bp). Primers specific for heat shock protein 70 (HSP70, PbHSP70-
F and PbHSP70-R, 164 bp) were used to control the cDNA load (Fig. 3.6 D).  
Integration-specific PCR amplification of the PALM locus to confirm the predicted 
deletion of PALM in palm— ANKA and palm— ANKA-GFP parasites was done by 
diagnostic PCR (Fig. 3.6 E). 
Genotyping of WT ANKA-GFP and palm— ANKA-GFP gDNA was also performed by 
Southern blot analysis (Fig. 3.6 F). 
 
 
3.1.9 Blood stage replication of palm— parasites is unaffected 
 
PALM could be deleted in blood stages, as observed by the ability to generate the 
three knockout lines, and is therefore not essential for blood-stage parasites. 
However, this does not rule out that ablation of PALM could cause a growth defect of 
Plasmodium berghei blood stages. To study this, 1,000 mixed blood –stage parasites 




C57BL/6 mice. The parasitemia was monitored by daily Giemsa-stained thin blood 
smears from day 3 to day 8 after infection. The growth curves of WT and mutant 
parasites were indistinguishable and equally high parasitemia was detected, 




Figure 3.7: Palm— parasites display normal life cycle progression during 
blood-stage development and sporogony in the insect vector. 
(A) Normal blood-stage development of palm— parasites. C57BL/6 mice were 
injected intravenously with 1,000 blood-stage WT ANKA-GFP or palm— ANKA-GFP 
parasites (n=10 each) and monitored for blood-stage development of parasites by 
examination of Giemsa-stained blood-smears. WT ANKA-GFP and palm— ANKA-
GFP blood-stage development is indistinguishable. Shown are mean numbers (± 
SD). (B) Normal infectivity of palm— parasites. The number of mosquitoes with 
oocyst-infected midguts (infectivity) was determined at day 10 after the blood meal. 
Shown are mean numbers (± SD), for WT ANKA-GFP (feedings n=3) and for palm— 
ANKA-GFP (feedings n=9). (C) palm— parasites form normal sporozoites in the 
insect vector. Midgut and salivary gland sporozoites were determined at day 14 and 
17, respectively, after the blood meal. Shown are mean numbers per infected 
mosquito. Number of feedings: WT ANKA-GFP, n=3; palm— ANKA-GFP, n=9. 
 
 
3.1.10 PALM is dispensable for parasite transmission to the invertebrate 
host and development in the mosquito 
 
The next step in the Plasmodium life cycle after replication in erythrocytes is the 
transmission of gametocytes from the vertebrate to the invertebrate host and the 
parasite development in the mosquito. To examine the progression of palm— 
parasites through this part of the life cycle, infected NMRI mice were checked for 




palm— parasites displayed the typical exflagellation process after 10 to 12 minutes, 
similar to WT parasites (data not shown) and were fed to mosquitoes. At day 10 after 
feeding mosquito midguts were dissected and the percentage of oocyst-infected 
mosquitoes was calculated (Fig. 3.7 B). At days 14 and 17 mosquitoes were 
dissected to determine the number of midgut and salivary glands, respectively (Fig. 
3.7 C). Infectivity and sporozoite numbers of palm— ANKA-GFP, palm— ANKA and 
palm—-NT-tag parasite lines were indistinguishable from WT ANKA-GFP mosquito 
feedings (Tab. 3.1).  
 
 
3.1.11 In vitro liver stage and merosome development of palm— 
parasites is severely impaired 
 
As the abundance of PALM transcripts is highest in late liver stages, this part of the 
Plasmodium life cycle was of particular interest. In the Plasmodium berghei model 
liver-stage development can either be studied in vitro by infection of hepatoma cells 
with salivary gland sporozoites or in vivo by injection of freshly dissected salivary 
gland sporozoites or transmission through the bites of Plasmodium infected 
mosquitoes.  
First, liver-stage development of palm— parasites was studied in vitro (Fig. 3.8). To 
this end, Huh7 hepatoma cells were seeded in 8-well Labtec slides and the next day 
each well was infected with 10,000 freshly dissected sporozoites. Development of the 
parasites was stopped at various time-points and the parasites were stained with 
anti-HSP70 antibodies. This allowed the comparison of the number of parasites at 
the indicated time-points between WT and palm— infected hepatoma cells. At 24 and 
48 hours after infection WT and mutant parasite numbers were indistinguishable. 
However, at 72 hours after infection, when most WT parasites typically have been 
released into the supernatant as merosomes, palm— parasites remained inside the 
host cells as seen by the clearly higher parasite numbers (Fig. 3.8 A).  This was also 
reflected in strikingly lower merosome numbers in the supernatant of palm— infected 
cells (Fig. 3.8 B). Remarkably, when the whole merosome-containing supernatants 
were injected into mice, palm— merosomes were infectious and capable of inducing a 
blood-stage infection (Fig. 3.8 C). The delay in parasite appearance in Giemsa-
stained blood smears of palm— parasites compared to WT is most likely a 




These findings indicated that the vast majority of palm— parasites is trapped inside 
the host cells and only very few, if any, knockout parasites are able to develop fully 






Figure 3.8: Palm— parasites display 
a defect in liver-stage maturation. 
(A) Quantification of liver stages in 
cultured hepatoma cells at 24, 48 and 
72 h after infection with 10 000 P. 
berghei WT ANKA-GFP and palm— 
ANKA-GFP sporozoites. Infected cells 
were fixed and stained with mouse 
anti-PbHSP70 antibodies. Note that in 
contrast to WT ANKA-GFP parasites, 
palm— ANKA-GFP parasites remain 
inside the host cells even at 72 h after 
infection. Data are from two 
independent experiments done in 
triplicate. Shown are mean numbers 
(±SD). (B) Quantification of 
merosomes obtained from cultured 
hepatoma cells infected with WT 
ANKA-GFP and palm— ANKA-GFP 
parasites at 72 h after inoculation with 
100 000 sporozoites. (C) Complete 
merosome- containing supernatants 
harvested under (B) were injected into 
recipient C57BL/6 mice (WT ANKA-
GFP, n= 5; palm—, n= 4) and 
monitored for malaria infections by 
examination of Giemsa-stained blood-
smears. 
 
3.1.12 Palm— parasites express the merozoite signature protein 
merozoite surface protein 1 (MSP1) 
 
To further pinpoint the developmental arrest of palm— parasites, in vitro infections of 
hepatoma cells and immunofluorescence assays were repeated with anti-UIS4 
antibodies, staining the parasitophorous vacuole surrounding the parasite, and 
antibodies against MSP1, a merozoite signature protein. It was described previously 




dehydrogenase (PDH) subunit E1α (Pei et al., 2010) or the FASII enzyme FabB/F 
(Vaughan et al., 2009) do not show any MSP1 expression during liver-stage 
development. Similarly, Plasmodium berghei parasites missing the FASII enzyme 
FabI only show negligible MSP1 expression during liver-stage development (Yu et 
al., 2008). MSP1 staining offered the possibility to compare PALM knockout parasites 
to these other late liver-stage arrested parasites. 
Hepatoma cells were infected with WT ANKA-GFP and palm— ANKA-GFP 
sporozoites and development was stopped at 24, 48, 60, 72 and 94 hours after 
infection (Fig. 3.9). At 24 h and 48 h after infection WT ANKA-GFP and palm— 
ANKA-GFP parasites were indistinguishable, surrounded by the UIS4- containing 
parasitophorous vacuole membrane. Typically, at 24 h after infection parasites do not 
show any MSP1 staining and at around 48 h after infection MSP1 expression starts 
at the rim of the developing schizont, which then invaginates around parasite material 
during the cytomere stage (Sturm et al., 2009). During merozoite formation around 60 
to 72h after infection, however, striking differences were observed between WT 
ANKA-GFP and palm— ANKA-GFP parasites (Fig. 3.9 A). While WT parasites formed 
merozoites surrounded by a MSP1 containing membrane, palm— parasites seemed 
unable to form individual merozoites. At this stage, and even more pronounced at 
94h after infection, numerous palm— ANKA-GFP parasites showed unusual MSP1 
staining outside the parasitophorous vacuole, maybe indicating disintegration of 
parasites (Fig. 3.9 A). To quantify liver merozoite formation liver stages from WT 
ANKA-GFP and palm— ANKA-GFP parasites were scored at 48, 60, 72 and 94h after 
infection (WT ANKA-GFP n = 105, 94, 82, 25; palm— n = 99, 124, 107, 53) according 
to five categories, namely: no MSP1, rim staining of MSP1, intracellular schizont 
staining of MSP1, formation of MSP1-positive merozoites, and aberrant, external 
MSP1 staining. This quantification revealed a slight developmental delay of palm— 
parasites at 48h after infection as seen by the lower percentage of intracellular 
schizont staining of MSP1. At 60h after infection levels of parasites with no MSP1 or 
rim staining of MSP1 were equal in WT ANKA-GFP and palm— ANKA-GFP parasites, 
but in contrast to WT ANKA-GFP, palm— ANKA-GFP parasites seemed to be almost 
unable to form merozoites, which became even more apparent at 60h after infection.  
At 94h after infection palm— ANKA-GFP parasites had not been able to catch up on 
merozoite formation, excluding a simple developmental delay. Instead, over 40% of 







Figure 3.9: Palm— parasites cannot form liver merozoites efficiently. 
(A) Defect in liver-stage merozoite segregation in palm— parasites. In vitro cultured P. 
berghei WT ANKA-GFP and palm— ANKA-GFP liver stages, were fixed at various 
time points after sporozoite infection and visualized by immunofluorescence using 
monoclonal mouse anti-P. yoelii MSP1 and rabbit anti-P. berghei UIS4 antibodies. 
Nuclei were stained with the DNA-dye DRAQ5 (blue). Palm— ANKA-GFP parasites 
develop normally until late liver stages, but rarely form merozoites. Shown are 
representative images of WT ANKA-GFP and palm— ANKA-GFP parasites at various 
time points. Bars, 10 µm. (B) Quantification of productive liver merozoite formation. 
Liver stages from WT ANKA-GFP and palm— ANKA-GFP parasites were scored at 
48, 60, 72 and 94h after infection (WT ANKA-GFP n = 105, 94, 82, 25; palm— n = 99, 
124, 107, 53) according to the five categories indicated by the representative images 
in the inset. The categories are: no MSP1 (white), rim staining of MSP1 (light green), 
intracellular schizont staining of MSP1 (dark green), formation of MSP1-positive 
merozoites (yellow), and aberrant, external MSP1 staining (black). Note the high 
proportion of MSP1-positive schizonts in palm— parasites, which correlates with a low 





Together, these findings revealed attenuation of palm— parasites at the final steps of 
liver merozoite formation. This clearly distinguishes the time of liver-stage arrest of 
palm— parasites from early genetically arrested parasites, such as UIS3 and UIS4 
knockout parasites. MSP1 expression in palm— parasites might also suggest a later 
arrest compared to the above mentioned Pye1α.—,  Pyfabb/f-— and PbfabI— parasites, 
where the expression of this merozoite signature protein is absent. 
 
 
3.1.13 Apicoplast morphology appears to be normal in palm— parasites 
 
To test whether PALM ablation affects the structure of the apicoplast, the organelle 
harboring PALM, the palm—-NT-tag parasite line was generated. In this parasite line 
the N-terminal part of PALM containing the signal peptide and the apicoplast-
targeting signal was fused to mCherry and a quadruple c-myc tag, and the protein 
coding part of PALM was deleted by double-homologous recombination. This should 
allow visualizing the apicoplast in PALM knockout parasites by targeting mCherry to 
the apicoplast while simultaneously deleting PALM. However, no live mCherry could 
be observed, probably due to the low expression driven by the PALM promoter (data 
not shown).  
Therefore, apicoplast morphology in palm— parasites was monitored by 
immunofluorescence assay on fixed parasites (Fig. 3.10). To this end hepatoma cells 
were infected with PALM-mCherry-myc and palm—-NT-tag parasites. At 48 hours 
after sporozoite infection the cells were fixed and stained with anti-ACP antibodies to 
visualize the apicoplast. As exemplified for the palm—-NT-tag line, mutant liver stages 
showed no obvious difference in apicoplast morphology when compared with the 






Figure 3.10: Apicoplast morphology appears normal in palm— liver stages.  
Hepatoma cells infected with WT and palm— parasites were fixed at 48 or 60h after 
infection and stained for parasite cytoplasm and the apicoplast using anti-HSP70 and 
anti-ACP antibodies respectively. The merge includes an additional DRAQ5 nuclear 
stain. Bars, 10 µm. 
 
 
3.1.14 Palm— parasites are severely impaired in initiation of a blood 
stage infection in vivo 
 
The rodent malaria model offers the possibility of not only following liver-stage 
development in vitro, but also in vivo by infection of susceptible C57BL/6 mice. To 
analyze if attenuation of palm— parasites also occurs in vivo, C57BL/6 mice were 
infected by natural bite of five mosquitoes infected with either WT ANKA-GFP (n= 11) 
or palm— ANKA-GFP (n= 13) (Fig. 3.11 A). All WT ANKA-GFP infected mice became 
parasite positive in Giemsa-stained blood smears 4 days after infection, whereas 
~50% of mice exposed to palm— ANKA-GFP-infected mosquitoes remained 
completely malaria-free, while the other half showed a severe delay in patency 







Figure 3.11: Infection with palm— sporozoites leads to attenuated liver-stage 
development in vivo. 
(A) Kaplan–Meier analysis of time to malaria blood-stage infection. C57BL/6 mice 
were infected by natural bite with five mosquitoes infected with WT ANKA-GFP (grey, 
n= 11) or palm— ANKA-GFP (black, n= 13). Animals were monitored daily for 
presence of parasites in Giemsa-stained blood smears. (B) Kaplan–Meier analysis of 
time to malaria blood-stage infection. C57BL/6 mice were infected with 1,000, 
10,000, or 100,000 WT ANKA-GFP (blue, n= 3, 9, 3) or palm— ANKA-GFP (red, n= 
20, 82, 45) sporozoites by intravenous injection. Animals were monitored daily for 
presence of parasites in Giemsa-stained blood smears. Next, C57BL/6 mice were 
infected by intravenous injection of increasing doses of WT ANKA-GFP or palm— 
sporozoites (Fig. 3.11 B). All mice injected with WT ANKA-GFP sporozoites became 
patent on day 3 after infection as monitored by daily Giemsa-stained blood smears. 
In sharp contrast, patency of mice injected with sporozoites of either of the three 
palm— lines was severely delayed by at least 4 days. Most importantly, a large 
proportion (~70%) of mice remained entirely malaria-free at day 17 after infection 
independent of the dose of injected palm— sporozoites. In the rodent malaria model 
system, a delay of 1 day in patency corresponds to a 10-fold reduction in initial 
asexual blood-stage parasite load.  
 
The prolonged pre-patent period in case of palm— breakthrough infections could be 
either due to the release of less merozoites from hepatocytes or a prolonged time of 
merozoite formation of palm— parasites and hence a retardation of merozoite 
release. To test this, C57BL/6 mice were infected by natural bite of five mosquitoes 
infected with WT ANKA-GFP (n= 2) or palm— ANKA-GFP (n=5) and 30µl of blood 
were obtained from the tail 3, 4 and 5 days after per bite infection and injected into 
naive C57BL/6 mice (Fig. 3.12). The parasitemia was followed by daily Giemsa-
stained blood smears. All recipient mice that received blood transfusions of either of 










Figure 3.12: Palm— parasites are 
present in the blood of mice three 
days after per bite infection. 
C57BL/6 mice were infected by bites 
of WT ANKA-GFP (n= 2) or palm— 
ANKA-GFP (n= 5) infected 
mosquitoes. At the indicated time 
points after infection, blood was 
transfused to recipient mice and 
parasitemia was followed by 
microscopic examination of Giemsa-
stained blood smears. 
 
Recipient mice that were infected with palm— ANKA-GFP parasites also became 
positive with transfusion from day 3 on after per bite infection, although this was only 
the case for a fraction of the animals. Blood transfers at later time points led to a 
higher proportion of infected animals. This suggests that at least in some mice 
infected with palm— ANKA-GFP, parasites are already present in the blood at day 3 
after per bite infection. It is possible that this is not the case for all animals because 
some mice only become blood-stage positive later or that the amount of blood that 
was transfused was too small to harbor the few infected erythrocytes. Taken 
together, the delay in patency seen with in vivo infections with palm— ANKA-GFP 
parasites is probably primarily due to a lower number of merozoites released from 
hepatocytes and not to a general delay in development. 
The results of palm— in vivo infections are in good agreement with the phenotype 
during in vitro liver-stage development. In a large proportion of cases palm— 
parasites are not able to complete liver merozoite formation and therefore are not 
able to initiate erythrocyte infection. In the rather rare event of merozoite formation of 
palm— parasites, only very few merozoites are released into the bloodstream, hence 










3.1.15 Impaired liver stage development leads to reduced incidence of 
experimental cerebral malaria (ECM) 
 
The clinical symptoms of population ʻ+ʼ, i.e. those mice that became palm—-blood-
stage-positive were followed. Only few palm—-infected mice developed symptoms of 
experimental cerebral malaria (ECM), a fatal outcome of an acute Plasmodium 
infection (de Souza and Riley, 2002), as compared with WT ANKA-GFP-infected 
animals (Fig. 3.13 A). Signature signs of ECM are sudden onset of ataxia, paralysis, 
convulsion or coma (de Souza et al., 2010). Symptoms of ECM typically develop on 
the fourth day after patency in sporozoite-induced infections. Of note, none of the 
mice that were infected by bite of palm—-infected mosquitoes developed ECM. It is 
important to exclude any impairment in parasite virulence due to the genetic 
manipulation. Previously, normal blood-stage growth of palm— parasites was 
detected (Fig. 3.7 A). To confirm that palm— parasites are as virulent as WT 
parasites, mice were inoculated with 1,000 erythrocytes infected with either palm— 
ANKA-GFP or, as controls, WT ANKA-GFP parasites via blood transfusion, thus 
bypassing the liver merozoite phase. All animals developed the signature ECM 
symptoms (Fig. 3.13 A). Therefore, the reduced ECM incidence of palm—-infected 




Figure 3.13: Development of symptoms of ECM is reduced in palm— 
sporozoite- infected animals.  
(A) Shown is the percentage of parasite-positive C57BL/6 mice that develop 
signature symptoms of ECM (i.e. mice showing sudden onset of ataxia, paralysis, 
convulsion or coma, or a minimum of three behavioral and functional abnormalities) 
after injection of 1000 blood-stage parasites (WT ANKA-GFP, grey, n= 15; palm— 
ANKA-GFP, black, n= 15), injection of sporozoites [10,000 ANKA-GFP, grey, n= 9; 
palm— ANKA-GFP, black, 1,000 (n= 6), 10,000 (n= 20), or 100,000 (n= 13)], or 




11) or palm— ANKA-GFP (black, n= 13). (B) Integrity of the blood–brain barrier is 
preserved in most palm— sporozoite-infected mice. Mice were infected with 10 000 
WT ANKA-GFP sporozoites (n= 4), or 10 000 (n= 5) or 100 000 (n= 7) palm— ANKA-
GFP sporozoites. Evans blue was injected intravenously at day 4 after appearance of 
blood-stage parasites and brains removed for documentation. One mouse infected 
with 100 000 palm— ANKA-GFP sporozoites showed behavioral abnormalities and 
breakdown of the blood–brain barrier.  
 
Finally, the integrity of the blood-brain barrier was determined in sporozoite-injected 
animals by Evans blue stain at the peak of clinical symptoms, in WT-infected animals 
typically day 4 after patency. This experiment was done in collaboration with Dr. Taco 
Kooij and Carolin Nahar. If the integrity of the blood-brain barrier is disrupted, the 
intravenously injected dye is able to the reach the brain as seen by the blue staining 
(Fig. 3.13 B). In good agreement with the reduced number of palm—-infected mice 
with behavioral abnormalities when compared to WT controls, only one palm—-
infected mouse showed blue staining of the brain. This analysis further corroborated 









3.2 Immunizations with palm— parasites 
 
Mice were immunized with genetically arrested palm— parasites in order to analyze 
long-term protection potential and mechanisms of protection. Lymphocyte isolations, 
peptide stimulations and immunological flow cytometry experiments were done in 
collaboration with Jan Burgold, MPI-IB, Berlin.  
 
3.2.1 Immunizations with palm— parasites confer potent protection 
against re-infection 
 
Next, it was tested whether immunization with palm— parasites can confer protection 
against sporozoite challenge in population ʻ-ʼ. Previous work with either irradiated 
sporozoites or genetically arrested parasites showed that in the P. berghei-C57BL/6 
model three consecutive doses of attenuated parasites are needed to induce sterile 
immunity (Douradinha et al., 2007; Mueller et al., 2005a; Nussenzweig et al., 1967). 
In addition, two studies reported sterile protection of between 25% and 70% of mice 
up to 10 days following immunization using two immunizations (Mueller et al., 2005b; 
van Dijk et al., 2005). Anticipating comparable levels of protection using three 
immunization rounds, a two-dose immunization protocol was attempted, with 10,000 
palm— ANKA-GFP sporozoites each (Tab 3.2).  
Table 3.2: Immunization with palm— sporozoites confers potent protection 
against re-infection. 
 
a Age-matched female C57BL/6 mice were immunized with palm- sporozoites (spz) in 
the numbers indicated. The immunization protocol is described in the methods 
chapter. 
b Animals were checked for parasitemia by daily examination of Giemsa-stained 
blood smears. 
c Prepatency is the time until detection of the first parasite in the peripheral blood. 
d One additional naive mouse (not included) stayed initially malaria-free but became 
positive at day 3 after intravenous re-challenge. 
e Challenge at 110 days after the last immunization. 






When the immunizations were reduced to two doses of 1,000 sporozoites, sterilizing 
immunity and protection from development of signs of ECM were lost, but infections 
became patent with a two-day delay, indicative of a substantial degree of protective 
immune responses (Tab. 3.2).  
To study stage-specificity of protection, four mice were re-challenged with ten WT 
ANKA-GFP blood-stage parasites. These mice had previously been immunized twice 
with 10,000 palm— ANKA-GFP sporozoites and challenged by WT ANKA-GFP-
infected mosquito bites and were shown to be completely protected from sporozoite 
challenge. However, no protection or delay in prepatency with blood-stage challenge 
in comparison with naive control mice was observed, indicating that protection is 
restricted to pre-erythrocytic stages (Tab. 3.2). 
Together, these findings demonstrate that palm—parasites can elicit potent protective 




3.2.2 Long-term protection in palm— immunized mice 
 
Palm— immunized C57BL/6 mice showed potent protection, even after a period of 
more than 100 days (Tab. 3.2). To further corroborate the long-term protection 
potential of genetically arrested palm— parasites a 3 to 4 dose immunization protocol 
was applied, with a challenge of more than 13 months after the last immunization 






Figure 3.14: Vaccination with palm– sporozoites elicits protracted, partial 
protection beyond one year. 
(A) Experimental design and time scale of vaccination and challenge in two 
experimental groups. During the immunization phase, C57BL/6 mice were 
immunized twice by intravenous injection of 10,000 palm– sporozoites. Sterile 
immunity was validated by early challenge infections by exposure to five WT-infected 
Anopheles stephensi mosquitoes and/or intravenous injection of 10,000 WT 
sporozoites. Mice were left untreated for 14 or 15 months and challenged by 
intravenous injection of 20,000 WT sporozoites, followed by monitoring of Giemsa-
stained thin blood smears. (B) Kaplan-Meier analysis of vaccinated and age-matched 
control animals after final challenge as depicted in (A). (C) Parasitemia of control and 
immunized mice after final challenge was determined by daily microscopic 
examination of Giemsa-stained thin blood smears and grouped as days after 





3 of 12 palm— immunized animals showed sterile protection against challenge with 
20,000 WT ANKA-GFP sporozoites. The remaining 9 animals became blood-stage 
positive between days 4 and 9 after infection with a mean delay of 2.3 days 
compared to naive control mice (Fig. 3.14 B). A delay of 1 day in patency 
corresponds to a 10-fold reduction in initial asexual blood-stage parasite load in the 
rodent malaria model system. These results show that even in unprotected palm— 
immunized mice the initial blood stage parasite load was highly reduced. Whenever 
blood stage parasites could be detected in blood smears, the parasitemia was 
quantified (Fig. 3.14 C). A slightly reduced parasite growth was observed in palm— 
immunized animals. However, 3 days after patency similar high parasitemias were 
reached in immunized and control animals (Fig. 3.14C). 
 
 
3.2.3 Liver parasite loads one year after palm– vaccination 
 
To determine if the long-term protection against WT challenge is also reflected by a 
reduced relative liver infection load, livers of a third group of mice (n=4) were 
analyzed. These animals previously received two intravenous immunizations with 
10,000 palm– sporozoites and one intravenous challenge/boost of 10,000 WT 
sporozoites was analyzed. Immunized and non-immunized mice (n=4 each) were 
challenged with 10,000 WT ANKA-GFP sporozoites one year after the last boost. 
The livers of these animals were isolated 41 hours after infection to determine 
relative parasite liver loads by quantitative real-time RT-PCR (Bruna-Romero et al., 
2001).  Livers of immunized animals showed a significantly lower relative liver 
infection load when compared to non-immunized, challenged control animals (Fig. 
3.15). The variation of the parasite load in immunized mice was also substantial, 
ranging over 3 orders of magnitude. This variance reflects the differences in the 
initiation of blood-stage development after sporozoite challenge (Fig. 3.14 B). 
Presumably, animals with very low liver loads would be protected against WT 





Figure 3.15: Protective efficacy of palm—-sporozoite vaccination after one year 
as measured by liver parasite load. 
Relative parasite liver infection load was determined in control and palm–-immunized 
mice by quantitative real-time RT-PCR 41 hours after challenge by intravenous 
injection of 10,000 WT sporozoites one year after the last immunization. Shown are 
medians. Statistical significance was assessed using the two-tailed Mann-Whitney 
test. A P value of P < 0.05 was taken as significant (*). 
 
 
3.2.4 Antigen-experienced T cells one year after palm– vaccination 
 
To evaluate if differences in the amount of antigen-experienced CD8+ T cells (CD8αlo 
CD11ahi) and CD4+ T cells (CD4lo CD11ahi) can still be found in the liver of 
immunized and control mice, liver lymphocytes were isolated and FACS analysis was 
employed after surface staining. A small, but significant increase of antigen-
experienced CD4+ T cells as well as CD8+ T cells could be observed (Fig. 3.16 A, B). 
However, overall levels of CD8αlo CD11ahi T cells were very high, which is probably 
due to the old age of the mice. The high baseline level renders this activation marker 






Figure 3.16: Levels of antigen-experienced CD4+ T cells (CD4lo CD11ahi) T cells 
and CD8+ (CD8α lo CD11ahi) in livers of palm—-immunized mice.  
C57BL/6 mice were immunized twice by intravenous injections with 10,000 palm– 
sporozoites and received one intravenous challenge/boost of 10,000 WT sporozoites. 
Immunized and non-immunized mice (n=4 each) were challenged with 10,000 WT 
ANKA-GFP sporozoites one year after the last boost. Livers were isolated 41hour 
after challenge and single cell suspensions were generated. Cells were stained with 
anti-mouse CD4, anti-mouse CD8 and anti-mouse CD11a antibodies and analyzed 
by flow cytometry. (A) Representative FACS plots and quantitation of antigen-
experienced CD4+ T cells (CD4lo CD11ahi) in livers of control and palm—-immunized 
mice. (B) Representative FACS plots and quantitation of antigen-experienced CD8+ T 
cells (CD8lo CD11ahi) in livers of control and palm—-immunized mice.  Medians are 
shown. Statistical significance was assessed using the Mann-Whitney test for 
nonparametric samples. *, P < 0.05. 
 
 
3.2.5 Intracellular cytokine production after ex vivo stimulations 
 
INFγ is long known to play an important role in malaria immunity (Schofield et al., 
1987). A pathogen-unspecific CD3/CD28 stimulation and Plasmodium-specific ex 
vivo stimulations were employed to quantify INFγ production in T cells of palm—-
immunized mice.  
The CSP-derived peptide P1 has been described previously as a CD4+ epitope in the 
C57BL/6 model (Boscardin et al., 2006). Stimulations with the P1 peptide resulted in 
slightly, but significantly more INFγ-producing CD4+ lymphocytes in the livers of 




CD3/CD28 antibodies revealed no significant difference between control and 
immunized mice (Fig. 3.17 A). 
Two P. berghei peptides, termed S and T peptides, were recentlyshown to be 
immunodominant CD8+ epitopes (Hafalla et al., unpublished data). Pathogen-
unspecific stimulation with CD3/CD28 antibodies resulted in more INFγ-producing 
CD8+ lymphocytes in the livers, but not the spleens, of palm—-immunized mice when 
compared to control animals (Fig. 3.17 A). In contrast, stimulation with the S and T 
peptides (Fig. 3.18 B, C, respectively) resulted in more INFγ-producing CD8+ 




Figure 3.17: Slight increase of INFγ-producing CD4+ liver lymphocytes in 
palm—-immunized mice as compared to naive mice after ex vivo stimulation 
with a CD4 epitope. 
Representative FACS plots and percentage of INFγhi CD4+ lymphocytes after ex vivo 
stimulation with CD3/CD28 antibodies (A) and with the Plasmodium-specific P1 
peptide, a CD4 epitope (B). Medians are shown. Statistical significance was 






Figure 3.18: Plasmodium-specific ex vivo stimulations resulted in more CD8+ 
INFγhi lymphocytes in livers and spleens of palm—-immunized mice. 
Representative FACS plots and quantifications of INFγhi CD8+ lymphocytes after ex 
vivo stimulation with (A) CD3/CD28 antibodies, Plasmodium-specific peptides S (B) 
and T (C) are shown for livers and spleens of control and palm—-immunized mice. 
Levels of CD8+ INFγhi are significantly higher in spleens and livers of palm—-
immunized mice with all used ex vivo stimulations, except for spleen lymphocytes 
following CD3/CD28 stimulation. Statistical significance was assessed using the 
Mann-Whitney test for nonparametric samples. *, P < 0.05. 
 
No significant differences in IL-2 and TNF production in the liver CD8+ lymphocytes of 
control and palm—-immunized mice could be observed with either of the 3 different 









Figure 3.19: Proportions of TNF- and IL-2-producing CD8+ liver lymphocytes 
remain unchanged in palm—-immunized mice. 
Single-cell suspensions of livers of control and palm—-immunized mice were 
stimulated ex vivo with CD3/CD28 antibodies, or one of the CD8 epitope peptides S 
or T. Flow cytometry revealed no significant differences in the proportions of either 
TNF- (A) or IL-2-producing (B) CD8+ lymphocytes. Shown are the means ±S.D. of 
control and palm—-immunized mice (each n= 4). 
 
Together, the results of the long-term protection experiments revealed a correlation 
of higher frequencies of antigen-specific INFγ-secreting CD8+ and CD4+ T cells, 
particularly in the target organ, i.e. the liver, and partial, albeit quantifiable protection 




















3.3 In silico analysis of genes involved in the [Fe-S]  cluster biogenesis 
pathway in Apicomplexa 
 
The characterization of PALM indicated that additional proteins in the apicoplast 
might be attractive targets for experimental genetics. The expression profile of 
NFUapi, a protein involved in [Fe-S] cluster biogenesis in the apicoplast, showed a 
similar upregulation in late liver stages as PALM (Tarun et al., 2008). Therefore, the 




3.3.1 Identification of SUF genes of the [Fe-S]  cluster biogenesis 
pathway in the apicoplast 
 
Previous studies described the identification of genes involved in the [Fe-S] cluster 
biogenesis pathway in the apicoplast (Ellis et al., 2001; Kumar et al., 2011; Seeber, 
2002). However, since genome annotations of Apicomplexa are still ongoing and 
additional genes are continuously identified, an updated overview of the [Fe-S] 
cluster biogenesis pathway in the apicoplast was warranted. Various Apicomplexa 
species were compared using the OrthoMCL database (Chen et al., 2006; Li et al., 
2003) and BLAST analysis.  
The recently published ApicoAP prediction tool for apicoplast targeting sequences in 
Apicomplexa (Cilingir et al., 2012a) was also included to complement the established 
tools PlasmoAP (Foth et al., 2003a), PlasMitII  (Bender et al., 2003a) and MitoProtII 
(Claros and Vincens, 1996). This offered the unprecedented possibility for in silico 
predictions of apicoplast targeting sequences in T. gondii and B. bovis. The genomes 
of the following species were interrogated: P. falciparum, P. berghei, P. yoelii, T. 
gondii, B. bovis, T. annulata and C. parvum.  
In P. falciparum, P. berghei and P. yoelii a full set of SufA, SufB, SufC, SufD, SufE, 
SufS and NFUapi genes could be identified (Tab. 3.3). In P. yoelii the sequence of 
SufB was not yet assigned to a genomic location, but is likely to be encoded in the 
apicoplast genome, as it is in P. falciparum and P. berghei. P. yoelii SufC is not yet 
annotated, but EST blastn revealed various P. yoelii ESTs with high similarity to the 




In T. gondii SufB, SufC, SufD, SufE, SufS and NFUapi, but no orthologs of SufA were 
identified (Tab. 3.4).  
 





a Gene IDs of the P. berghei and P. falciparum orthologs (http://PlasmoDB.org). 
b Putative targeting of the P. falciparum SUF pathway proteins to the apicoplast or 
mitochondrion was predicted using four different algorithms. ApicoAP (Cilingir et al., 
2012b) predicts whether a given protein lacks the required signal peptide (“No SP”), 
contains a signal peptide but no transit peptide (“non-ATP”), or is an apicoplast 
targeted protein (“ATP”) that uses the bipartite signaling mechanism. PlasmoAP 
(Foth et al., 2003b) indicates the likelihood of the presence of the required signal 
peptide followed by the likelihood of an apicoplast localization (“-” = unlikely, “0” = 
undecided, “+” = likely, “++” = very likely). PlasMit  (Bender et al., 2003b) predicts the 
likelihood of a mitochondrial localization for P. falciparum proteins (“99% non-mito”, 
“91% mito”, and “99% mito”). MitoProtII (Claros, 1995) gives a probability score for 
the likelihood of mitochondrial localization but is not optimized for Plasmodium 
sequences. No analysis was done for SUFB as the gene is encoded on the 
apicoplast genome and hence needs no targeting sequences. 
 
B. bovis and T. annulata only possess a minimal set of Fe-S cluster biosynthesis 
genes in the apicoplast, namely SufS and SufE. In addition, T. annulata contains a 
copy of NFUapi (Tab. 3.4).  The orthologs in B. bovis and T. annulata were verified 
by reciprocal BLAST searches, i.e. blastp of amino acid sequence of P. falciparum 
against T. annulata and B. bovis and vice versa was performed. Through the search 
for Pfam domain PF02657-containing orthologs with OrthoMCL, two previously 
unrecognized SufE orthologs, namely BBOV_III005960 and TA12620, were identified 
that were also briefly mentioned in a recent review (Seeber and Soldati-Favre, 2010). 
These genes were previously grouped genes containing an unrelated tRNA 
methyltransferase domain (PF03054). It appears, that in B. bovis and T. annulata the 
tRNA methyltransferase and the SufE genes are fused to just one gene, presuming 
the annotation is correct. The B. bovis SufE/ tRNA methyltransferase gene 
BBOV_III005960 as well as the tRNA methyltransferases PF3D7_1019800 and 




apicoplast, which favors the interesting hypothesis that in B. bovis both genes could 
indeed be fused. In T. annulata apicoplast-targeting prediction is not yet possible.  
 
Table 3.4: SUF genes of the [Fe-S]  cluster biogenesis pathway in the 





C. parvum probably does not posses an apicoplast (Zhu et al., 2000) and therefore it 
is not surprising that the [Fe-S] cluster genes in the apicoplast could not be identified. 
The only exception is a publlcation where cgd2_30 was listed as SUFS gene for C. 
parvum (Fleige et al., 2010). However, this gene does not cluster with the 
Plasmodium SUFS in OrthoMCL and experimental evidence would be necessary to 
draw a final conclusion. 
As annotations of Apicomplexa species are not yet finished, absence of an ortholog 
might be either due to missing sequencing and/or annotation (as for SufC in P. yoelii) 
or actual absence in the genome. 
 
 
3.3.2 Identification of NifU und NifU-like domain-containing genes 
 
Since NFUapi stands out as a likely regulatory component without an assigned direct 
role in [Fe-S] cluster biosynthesis, an overview of all NifU und NifU-like domain-

















T. gondii  encodes a NifU-like domain-containing protein (TGME49_012930)  with 
unclear localization and a putative NFU protein (TGME49_037560), which might 
localize to the mitochondrion (PlasmoDB comment). Recently, a hypothetical protein 
with a NifU-like domain (TGME49_021920) was shown to localize to the apicoplast 
by IFA (Sheiner et al., 2011). Although its sequence is not very similar to 
Plasmodium NFUapi, it might serve a related function in the apicoplast (Tab. 3.5 and 
Fig. 3.20). 
B. bovis has two orthologs of the mitochondrial NifU-like genes, but no NFU that 
localizes to the apicoplast. In contrast, all three NifU-like genes can be found in T. 






Figure 3.20: Apicomplexan NFUapi proteins. 
(A) Primary structure of representative apicomplexan NFUapi proteins. Shown are 
the overall sequence structures and amino acid sequence identities of NFUapi 
orthologs in P. falciparum (PF3D7_0921400), P. vivax (PVX_099490), Theileria 
annulata (TA19885), and Toxoplasma gondii (TGME49_021920) compared with P. 
berghei NFUapi (PBANKA_082230). Signal peptide (red), apicoplast-targeting 
sequence (green), and the NifU-like domain (brown) are shown. (B) Sequence 
alignment of three Plasmodium NFUapi proteins. The NifU-like domain (gray 
shading) is well conserved. 
 
 
3.3.3 Identification of [Fe-S]  cluster-containing proteins  
 
The list of [Fe-S] cluster-containing proteins is constantly expanding. In order to 
clarify where these proteins are localized and in which pathways they might be 
involved, the currently identified [Fe-S] cluster-containing proteins in Plasmodium 




2009) and their localization predicted with PlasmoAP (Foth et al., 2003a), ApicoAP 
(Cilingir et al., 2012a), PlasMit  (Bender et al., 2003a) and MitoProtII (Claros and 
Vincens, 1996) (Tab. 3.6). Not all predictions for cellular localizations are conclusive 
and therefore this list only represents an estimate and might have to be revised with 
new experimental data and optimized prediction tools. Furthermore, Plasmodium 
orthologs of A. thaliana [Fe-S] cluster-containing proteins (Balk and Pilon, 2011) 
were searched and added to the list as possible candidates of [Fe-S] cluster-
containing proteins that might be considered for further analysis (Tab. 3.6). 
 





All proteins were either retrieved from PlasmoDB or based on similarity to A. thaliana 




3.4 Systematic experimental genetics of the iron-sulfur [Fe-S]  cluster 
biogenesis pathway in the apicoplast of Plasmodium berghei  
 
3.4.1 SUF genes are refractory to targeted gene deletion 
 
[Fe-S] cluster-containing proteins in the apicoplast are involved in essential 
biosynthesis pathways (Fig. 1.8). Therefore, genes involved in the formation and 
assembly of [Fe-S] clusters in the apicoplast are likely to be vital, too. However, it is 
possible that not all components of the SUF-system are strictly required for the 
generation of [Fe-S] clusters, but rather fulfill auxiliary roles, at least in parts of the 
Plasmodium life cycle. To address these possibilities, systematic generation of loss-




Figure 3.21: Targeted gene deletion of SUF genes and NFU. 
(A) Replacement strategy to delete nuclear-encoded PbSUF genes. The respective 




(dark gray bars) flanking the open reading frames (light gray arrow), a high 
expressing GFP cassette (green), and the hDHFR-yFcu drug-selectable cassette 
(blue). Integration- and WT-specific primer combinations (see section 2.XXX) and 
expected fragments are indicated. (B) Overview of all transfection experiments. For 
each target gene, a diagnostic PCR of the WT locus, the outcome of three 
independent transfection experiments (green circle; successful gene deletion; red 
circle; unsuccessful gene deletion), and diagnostic PCR of the drug-selected 
parasites are shown. (C) Southern blot analysis of the clonal nfu–parasite line used 
in all phenotypic assays. gDNAs were restriction-digested with NdeI. The 3ʼ 
homologous sequence used for targeted integration was used as the probe. (D) 
PCR-based genotyping of clonal nfu–parasites to verify successful deletion of 
NFUapi. Absence of WT signals confirms the purity of the clonal population. 
 
Upon successful double cross-over recombination events, recombinant parasites are 
predicted to contain high-expressing GFP- and drug-selectable cassettes in place of 
the respective genes. 
For targeted gene deletion of the P. berghei SUF genes, fragments of the 5ʼUTR and 
of the 3ʼUTR were amplified from gDNA. PCR fragments were cloned into the 
pBART-SIL6 transfection vector (Kooij et al., 2012), which contains the human 
dihydrofolatereductase (hDHFR) gene that confers resistance to pyrimethamine and 
the antifolate W99210. The resulting plasmids were linearized and P. berghei WT 
ANKA parasites were transfected (Fig. 3.21 A). Each KO was attempted in three 
independent transfection experiments. In none of the transfections integration of the 
targeting plasmid into the parasite genome could be achieved, as tested by 
diagnostic PCR (Fig. 3.21 B). 
This finding lends genetic evidence for the importance of the five [Fe-S] cluster 
assembly proteins in the apicoplast. 
 
 
3.4.2 Generation of P. berghei nfu— parasites 
 
For targeted gene deletion of P. berghei NFUapi, a plasmid was generated, following 
the same principles as the SUF targeting plasmids (Fig. 3.21 A).  
Integration-specific PCR amplification of the NFU locus to confirm the predicted 
deletion of NFU was done using the following primers: 5ʼHSP70rev and GT-5ʼNFU-F 
(5ʼ integration, 958 bp), and GT-3ʼNFU-R and 5ʼDHFRrev (3ʼ integration,1,210 bp) 
(Fig. 3.21 B). After successful integration a clonal nfu— parasite line was generated 




specific PCR products using primers GT-5ʼNFU-F and GT-5ʼNFU-R (5ʼ WT ANKA 
control, 960 bp), and GT-3ʼNFU-F and GT-3ʼNFU-R (3ʼ WT ANKA control, 702 bp) 
confirmed the purity of the clonal nfu– parasite line (Fig. 3.21 D). The genotype of the 
clonal nfu– parasite line was also confirmed by Southern blot analysis. For 
amplification of the hybridization probe, primers TV-3ʼNFU-F and TV-3ʼNFU-R were 
used. The hybridization probe was annealed to NdeI digested gDNA resulting in 
bands of 2.2kb (WT) and 7.0kb (nfu–) (Fig. 3.21 C). 
 
 
3.4.3 NFU is dispensable for life cycle progression 
 
In marked contrast to the SUF genes, NFUapi was readily replaced (Fig. 3.21 B)). 
Successful generation of a clonal nfu– parasite line permitted detailed in vivo 
phenotyping of parasite fitness during life cycle progression.  
First, transmission to the Anopheles vector and sporogony was tested. Mosquito 
infectivity, numbers of mosquito midgut- and salivary gland-associated sporozoites of 




Figure 3.22: NFUapi assists onset of Plasmodium blood stage infection in vivo. 
(A) Infectivity and mean sporozoite numbers (± S.D.) in midgut-associated oocysts 
(day 14 after infection) and salivary glands (day 17-21 after infection) of WT and nfu–-




cultured hepatoma cells. Shown are mean numbers (± S.D.) 24, 48, and 72 hours 
after infection from four independent experiments (n=3 each). Data for nfu::tag 
parasites are from a single experiment (n=3). (C) Merosome formation at 72 hours 
after inoculation of cultured hepatoma cells with 10,000 sporozoites. Shown are 
mean values (± S.D.). Data are from two (nfu::tag) or four (WT and nfu–) independent 
experiments. Merosome formation of nfu– liver stage parasites was significantly 
reduced compared to WT and nfu::tag parasites (Kruskal-Wallis test followed by 
Dunnʼs multiple comparison test. ***, p < 0.001). (D) Kaplan-Meier analysis of time to 
malaria blood stage infection. C57BL/6 mice were infected with WT (gray) or nfu– 
(black) parasites by natural bite by 5-7 infected mosquitoes (single experiment; WT, 
n=3; nfu–, n=7) or by intravenous injection of 10,000 (three independent experiments; 
WT, n=8; nfu–, n=16) or 100 (two independent experiments; WT, n=8; nfu–, n=10) 
isolated sporozoites. Animals were monitored daily for presence of parasites in 
Giemsa stained thin blood smears. (E) Asexual blood stage development following 
intravenous injection of 1,000 infected erythrocytes. Parasitemia of recipient mice 
(n=10, from three independent experiments) was monitored daily by examination of 
Giemsa-stained thin blood smears. Shown are mean values (± S.D.). Except for 
merosome formation, differences observed between WT and nfu– parasite 
development were non-significant. 
 
Next, cultured hepatoma cells were infected with isolated sporozoites (Fig. 3.22 B). 
Numbers of nfu– liver stage parasites were similar to those of WT and nfu::tag 
parasites. However, when merosome development was quantified, a significant 
(~60%) reduction as compared to WT parasites (Fig. 3.22 C) was apparent. The in 
vivo development of nfu– parasites in mice was followed. Consistent with the 
observed reduction of nfu– merosome formation (Fig. 3.22 C), a trend towards a 
delay in prepatency following intravenous injection of 100 sporozoites was observed. 
Two mice injected with 100 nfu– sporozoites stayed malaria-free (Fig. 3.22D). 
However, these differences were non-significant and when mice were infected by bite 
of 5-7 infected mosquitoes the prepatent period was identical in nfu– and WT-infected 
animals (Fig. 3.22 C). Finally, naive NMRI mice were infected by transfusion of 1,000 
infected erythrocytes. In good agreement with the data from sporozoite-induced 
infections, mice infected with nfu– parasites displayed a small but non-significant 
delay in blood stage expansion (Fig. 3.22 D). After 8 days this difference was 
completely abrogated and nfu–-infected animals displayed high parasitemia.  
Together, this phenotyping establishes an auxiliary role of NFU for the onset of the 
blood stage infection, particularly for the release of liver stage merozoites into the 






3.4.4 Generation of P. berghei nfu::tag parasites 
 
To verify the predicted apicoplast targeting of NFUapi, a transgenic parasite line that 
expresses NFUapi with a combined fluorescent protein-epitope tag was generated 
(Fig. 3.23 A).  
 
 
Figure 3.23: Apicoplast localization of NFU. 
(A) Replacement strategy to generate stable parasite lines that express the 
endogenous NFUapi fused to the mCherry-3xMyc tag (red). In addition, recombinant 
parasites contain the high-expressing GFP cassette (green) and the drug-selectable 
hDHFR yFcu cassette (blue). Integration-specific (5ʼINT and 3ʼINT) and wild type-
specific (5ʼWT and 3ʼWT) primer combinations (Tab. 2.1) are indicated by arrows and 
expected fragments as dotted lines. (B) PCR-based genotyping of nfu::tag parasites 
to verify successful fusion of NFUapi with the mCherry-3xMyc tag. Absence of WT 
signals confirms the purity of the isogenic parasite line. (C) Co-staining of fixed, 
nfu::tag parasite-infected hepatoma cells 48 hours after sporozoite infection using 
anti-myc and anti-ACP antibodies. Note substantial overlap between NFUapi and the 
signature apicoplast protein. Bar, 10 μm. (D) Drug treatment of nfu::tag-infected 
hepatoma cells to corroborate apicoplast localization of NFUapi. During liver stage 
development nfu::tag-infected cells were left untreated (control), treated with 100 μM 
fosmidomycin, or 1μM azithromycin. Liver stages were stained with anti-myc 
antibodies and anti-sera against upregulated in infective sporozoite protein 4 (UIS4), 
a signature protein of the parasitophorous vacuolar membrane. Bars, 10 μm. (E) 
Quantification of the percentage of control (n=70), fosmidomycin- (n=100), or 






For this purpose the C-terminal part and the 3ʼUTR of NFU were amplified by PCR 
and cloned into the pBART-SIL6 vector (Kooij et al., 2012), which contains the 
mCherry coding region fused to a triple c-myc tag sequence and the human 
dihydrofolatereductase (hDHFR) gene for positive selection (Fig. 3.23 A). 
Plasmodium berghei WT ANKA parasites were transfected with the linearized 
plasmid and correct integration by double homologous recombination of the 
replacement construct was confirmed by integration-specific PCR using primers GT-
C-NFU-F and A70 (5ʼ integration, 758 bp), and GT-3ʼNFU-R and 5ʼDHFRrev (3ʼ 
integration, 1,210 bp). After successful integration, flow cytometric isolation of green 
fluorescent parasites resulted in an isogenic parasite line (Kenthirapalan et al., 
2012). Absence of WT-specific PCR products using primers GT-C-NFU-F and TV-
3ʼNFU-R (5ʼ WT ANKA control, 1,106 bp), and GT-3ʼNFU-F and GT-3ʼNFU-R (3ʼ WT 




3.4.5 Localization of NFU 
 
Live nfu::tag parasites only produced faint undefined signals in developing midgut-
associated oocysts and cultured liver stage parasites. To enhance the NFU::tag 
signal, fixed liver stage parasites at 48 hours after infection were stained with 
antibodies against the myc epitope tag. The extended branched structure was 
reminiscent of the apicoplast. This was further supported by co-localization with a 
signature apicoplast protein, acyl carrier protein (ACP (Friesen et al., 2010)) (Fig. 
3.23 C). 
To further corroborate these findings, nfu::tag liver stage parasites were treated with 
azithromycin, which led to apicoplast disintegration and a complete loss of NFUapi 
signal (Fig. 3.23 D and E). When parasites were treated with fosmidomycin, the 
NFUapi signal showed a healthy looking branched apicoplast at levels comparable to 












4.1 PALM - a novel Plasmodium apicoplast protein important for liver 
merozoite formation 
 
In this study, a previously uncharacterized hypothetical gene, later named 
Plasmodium-specific Apicoplast protein important for Liver Merozoite formation 
(PALM), was analyzed. In silico analysis revealed that PALM is conserved in 
Plasmodium species, and no orthologs in any other organism were identified (Fig. 
3.1). Further, the presence of a signal peptide and an apicoplast-targeting signal was 
revealed, strongly suggesting apicoplast localization of PALM. No functional domain 
could be identified that might hint at the function of PALM. However, a highly 
conserved region with a pair of conserved cysteine residues was apparent. It is 
tempting to speculate that these cysteine residues might play a functional role, but it 
is also conceivable that they have structural or other functions. Partial gene deletions 
of the conserved region and mutation of the conserved cysteins might reveal, if this 
sequence is essential for PALM function. 
The predicted apicoplast localization of PALM was confirmed by generation of 
parasites that express fluorescently tagged PALM (Fig. 3.2). PALM-mCherry-myc 
parasites behaved undistinguishable from wildtype (WT) parasites, suggesting that 
function of PALM was not impeded by the protein tag. It was previously published 
that PALM expression is especially high in late liver-stage parasites (Tarun et al., 
2008). Liver-stage expression and apicoplast localization could be confirmed. As a 
clearer and more reliable visualization of the apicoplast was obtained by α-myc 
antibodies in combination with PALM-mCherry-myc parasites than by α-ACP 
antibodies, PALM-mCherry-myc parasites provide a good opportunity to test 
apicoplast localization of other proteins via co-localization with α-myc antibodies. In 
addition, PALM-mCherry-myc parasites might also be used as a tool to test the effect 
of further drugs on the apicoplast.  
Generation of palm— parasite lines by targeted gene deletion offered the possibility to 
study the role of PALM during the whole life cycle. Blood- and mosquito-stage 
development of palm— parasites was indistinguishable from WT parasites. In 
contrast, transition from liver- to blood-stage infection was severely impaired in 
palm— parasites. A large proportion of mice infected with palm— sporozoites did not 
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develop any blood-stage infection. When breakthrough infections occurred, blood-
stage patency was delayed by at least four days, which can either be a sign of 
delayed liver-stage development or release of less merozoites. However, blood 
transfers from mice that were infected with palm— sporozoites showed that, at least in 
some mice, palm— parasites were already present in the blood at day 3 after per bite 
infection. It is possible that this is not the case for all animals because some mice 
only became blood-stage positive later. It is also possible that the amount of blood 
that was transfused was too small to harbor the few infected erythrocytes. Together, 
the results indicate that the delay in patency seen with in vivo infections with palm—
parasites is probably primarily due to a lower number of merozoites released from 
hepatocytes and not to a general delay in development. 
Assuming that breakthroughs of palm— parasites that establish a blood stage 
infection are due to a threshold that is passed, for example in terms of nutrient 
availability, or maybe even mechanical release of merozoites, it would be expected 
that injections with increasing doses of palm— sporozoites would also lead to 
increasing amounts of breakthrough infections. Surprisingly, injections of 1,000, 
10,000 and 100,000 palm— sporozoites lead to comparable numbers of blood-stage 
positive mice, which currently cannot be explained (Fig. 3.11). There does not seem 
to be a limiting factor, e.g. nutrient availability, or a mechanical restriction. In these 
scenarios, a linear relationship between inoculum size and pre-patency would be 
expected. 
Furthermore, it is interesting to note that passage of palm— parasites through more 
than one life cycle did not result in an increase of breakthrough infections in mice 
(data not shown). Thus, palm— parasites do not seem to adapt rapidly to the loss of 
PALM, for instance by gene mutations or upregulation of other genes. 
Mice that became blood-stage positive after infection with palm— sporozoites only 
rarely showed symptoms of experimental cerebral malaria (ECM) and breaching of 
the blood-brain barrier and in this case a dose-dependent increase was observed. 
However, when infection occurred through injection of blood-stage palm— parasites, 
bypassing the liver phase, all mice showed symptoms of ECM and blue staining of 
the brain after Evans Blue injection. Instead of a direct role of PALM, it seems rather 
likely that a liver-stage infection resulting in a particularly slow onset of blood-stage 
infection influences the host defense and provides an advantage that prevents the 
development of ECM symptoms. A similar effect was also observed for other 
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knockout parasites that led to a delay in blood-stage patency, such as sera4— 
parasites (Putrianti et al., unpublished data). 
A second, independent method to evaluate ECM development confirmed that palm— 
sporozoites lead to a reduced incidence of ECM (Fig. 3.13). Mice were infected with 
WT or palm— sporozoites and when WT infected mice started showing ECM 
symptoms, the mice were injected with Evans Blue, a dye that stains the brain, if the 
blood-brain barrier is breached. One hour later, WT-infected mice showed a blue 
brain, whereas only with a higher dose of injected sporozoites a single palm—-
infected mouse showed blue staining of the brain. 
In vitro infection of hepatoma cells with palm— sporozoites revealed that 24 and 48 
hours after infection the parasite numbers were in the WT range, suggesting that 
host cell invasion and early liver-stage development of palm— are not impeded. 
Strikingly, at 72 hours after infection significantly more palm— than WT parasites 
could still be detected inside host hepatocytes, suggesting that they are not able to 
efficiently leave the host cells. This was independently corroborated by lower 
numbers of in vitro merosome formation of palm— parasites when compared to WT. 
When total numbers of merosomes were injected intravenously into mice, all mice 
injected with palm— merosomes became blood-stage positive. These results 
revealed that once merozoites and merosomes can be formed by palm— parasites, 
they are infectious and capable of establishing a blood-stage infection. 
The time point of developmental arrest was further characterized by 
immunofluorescence assays with α-MSP1 and α-UIS4 antibodies of liver-stage 
parasites (Fig. 3.9). Palm— parasites were able to form schizonts, as was seen by the 
nuclear division visualized by the DNA stain with DRAQ5. Quantification of different 
staining patterns of the merozoite signature protein MSP1 revealed that palm— 
parasites express MSP1, but are almost completely incapable of forming merozoites, 
which in WT parasites are clearly surrounded by MSP1. Furthermore, prolonged in 
vitro cultivation of palm— parasites for 94 hours did not result in more merozoites. 
This finding suggests, that merozoite formation is not simply delayed in palm—, but 
instead a rare event. Strikingly, at 72 hours, and even more so at 94 hours, after 
infection a large proportion of palm— parasites showed aberrant MSP1 outside of the 
parasitophorous membrane. This might hint at leakage of the parasitophorous 
membrane and might be a sign of parasite death. Expression of MSP1 in palm— 
parasites is also different from mutants of the FASII pathway, which mostly lack 
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expression of this merozoite signature protein and therefore seem to be attenuated at 
an earlier developmental stage (Vaughan et al., 2009; Yu et al., 2008). 
Staining of developing liver-stage palm— parasites with antibodies against a 
signature apicoplast-targeted protein (ACP) demonstrated that apicoplast growth, 
branching and protein import of ACP are unaffected in the absence of PALM (Fig. 
3.10). Therefore, a structural role for apicoplast maintenance, branching and growth 
can be excluded. 
 
It was shown that PALM is expressed throughout the parasite life cycle in the same 
structured pattern that was previously observed for other apicoplast proteins 
(Stanway et al., 2009) (Fig. 3.3). A puzzling question is why PALM is not equally 
important for other replicative Plasmodium life cycle stages, in particular blood-stage 
trophozoites and during mosquito midgut sporozoite formation, where the presence 
of the myc-tagged PALM protein was clearly demonstrated. Apparently, specific 
requirements for the development of malaria parasites are clearly needed in 
hepatocytes. This has previously been suggested by the generation of FASII 
pathway mutants that progress normally through the life cycle and only lead to 
growth arrests in late liver-stage development (Vaughan et al., 2009; Yu et al., 2008). 
Based on the distinct later time point of arrested development in comparison with 
FASII pathway mutants, a metabolic role in the biogenesis of fatty acids seems 
unlikely. 
Remarkably, no PALM ortholog was found in Plasmodium gallinaceum. This raises 
the intriguing possibility that PALM emerged in response to specific requirements for 
the development of malaria parasites in hepatocytes, as exo-erythrocytic 
development of avian malaria species, such as P. gallinaceum, mainly occurs in 
leukocytes and endothelial cells of the brain (Frevert et al., 2008a; James, 1938; 
Macchi Bde et al., 2010). The enormous number of merozoites that are produced 
during liver-stage schizogeny may require a yet unidentified synthetic pathway in the 
apicoplast that is dispensable for other life cycle stages and related apicomplexan 
parasites. As the sequencing of the complete genome of P. gallinaceum is still 
ongoing, cloning and sequencing of the orthologous region of P. gallinaceum needs 
to be awaited to reveal whether P. gallinaceum harbours a PALM gene or not.  
Application of a recently developed extended similarity group method (Chitale et al., 
2009) revealed protein binding and metal ion binding among the top hits of probable 
molecular function of both PfPALM and PbPALM. Although these predictions are 
rather vague, it is tempting to speculate that PALM might be involved in iron 
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metabolism and maybe even in [Fe-S] cluster biogenesis. Preliminary tests using 
different media for injection of palm— sporozoites suggest that the medium used for 
dissection and injection of parasites might influence the amount of breakthrough 
infections (data not shown). Interestingly, the medium with higher iron content 
seemed to increase the amount of breakthrough infections.  
Altogether, this study demonstrates a distinct and important role of PALM in full 
maturation of liver merozoites. In the absence of PALM, efficient formation of liver 
merozoites is the limiting step in Plasmodium life cycle progression. 
 
 
4.2 Palm— parasites as whole-organism vaccine 
 
Despite the efforts undertaken in the past decades to develop a safe and efficient 
vaccine against malaria, no vaccine has been licensed, yet. Clinical trials with the 
RTS,S/AS01 vaccine only show partial, short-lived protection (Agnandji et al., 2011) 
and demonstrate that there is still a long way to go until a vaccine that induces robust 
and lasting protection against Plasmodium infection vaccine will be commercially 
available. Various alternative approaches have been developed, including a vaccine 
using radiation-attenuated sporozoites (RAS) (Nussenzweig et al., 1967), genetically 
attenuated parasites (GAPs) (Mueller et al., 2005b; van Schaijk et al., 2008) and non-
attenuated sporozoites under prophylactic drug cover (Belnoue et al., 2004). Each of 
these approaches bears advantages and disadvantages concerning safety, costs, 
efficacy, mode of application and storage. 
In this thesis palm— parasites were generated, which, to date, are the latest liver-
stage arrested GAPs. In contrast to several genetically arrested parasites deficient in 
apicoplast-targeted proteins of the FASII pathway (Pei et al., 2010; Vaughan et al., 
2009; Yu et al., 2008), palm— parasites develop to a later time point, as indicated by 
the expression of the merozoite signature protein MSP1 (Fig. 3.9). At late time points 
in liver-stage development in vitro, MSP1 staining was frequently observed outside of 
palm— parasites. It would be interesting to see, if this holds true for in vivo infections 
and if the protection efficacy might benefit from broader antigen presentation. 
Important improvements could be achieved by the generation of palm— parasites. 
Complete sterilizing immunity by only two doses of genetically arrested P. berghei 
parasites is unprecedented thus far. Two studies have reported protection in a 
fraction of mice by two consecutive immunizations (Mueller et al., 2005b; van Dijk et 
al., 2005). In addition to incomplete protection, in both cases challenges were 
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performed already after 7 (Mueller et al., 2005b) or 10 days (van Dijk et al., 2005) 
following the final boost, and in one case the immunization doses were also 
substantially higher (van Dijk et al., 2005). 
A recent study using the P. yoelii/ Balb/c model showed that late arrested fabb/f— 
parasites mount superior antimalarial immunity compared to early arrested and non-
efficient sap1— parasites, suggesting enhanced protection of late liver-stage arrested 
GAPs, probably due to a broader set of presented antigens (Butler et al., 2011). 
These results indicate that advanced liver-stage development may correlate with 
more potent immune responses.  This notion is further supported in experimental 
human trials by the potent long-term protection against re-infection induced by 
delivery of low-dose sporozoite inocula under chloroquine cover (Roestenberg et al., 
2009; Roestenberg et al., 2011).  
Immunizations with palm— parasites corroborate the superior protection of late liver-
stage arrested parasites (Tab. 3.2). Even after a period of more than 100 days, six of 
seven mice were completely protected from challenge of 10,000 intravenously 
injected WT sporozoites by only two immunizations with palm— sporozoites. The 
single mouse that developed a blood-stage malaria infection showed a substantial 
delay in patency of 5 days, suggestive of the presence of strong pre-erythrocytic 
immunity, and did not develop any ECM-associated symptoms.  
It is interesting to note that, although palm— parasites express the merozoite surface 
marker MSP1, and might also express other blood-stage antigens, immunization with 
palm— parasites did not lead to a protection against challenge with blood-stage 
parasites. The only report that a GAP also induced protection against blood-stage 
challenge was achieved in the P. yoelii/ BALB/c model using fabb/f— parasites (Butler 
et al., 2011). Again, the reason for this difference might be that the P. berghei/ 
C57BL/6 model is the rodent malaria model most difficult to protect against (Doolan 
and Hoffman, 2000; Ngonseu et al., 1998).  
The longevity of protection with whole-organism vaccines against Plasmodium re-
challenge was previously analyzed for up to 1 year (Douradinha et al., 2011; 
Douradinha et al., 2007; Jobe et al., 2007; Nganou-Makamdop et al., 2012). So far, 
one study describes long-term protection of 118 days using the P. berghei-C57BL/6 
model with genetically arrested Pbuis3 —/uis4 — parasites (Jobe et al., 2007). The 
protocol employed three subsequent immunization rounds and it is unclear, but 
unlikely in the light of incomplete short-term protection acquired using uis4 - parasites, 
that a single booster would suffice. In another study, long-term protection of up to 9 
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months following P. berghei immunization of C57BL/6 mice with RAS or infection with 
sporozoites under chloroquine cover was assessed (Nganou-Makamdop et al., 
2012).  Challenges 9 months after the last immunization showed superior protective 
efficacy of RAS, as 100% of RAS immunized mice were still protected against re-
infection whereas only 50% of mice immunized with sporozoites under chloroquine 
chemoprophylaxis were sterilely protected. Douradinha and colleagues analyzed 
protection of RAS and p52— parasites for up to one year (Douradinha et al., 2007). 
However, in this study 6 immunizations were applied before final challenge after 365 
days. Only 2 out of 4 p52— immunized mice were protected (Douradinha et al., 2007).  
Challenge of more than 13 months after the last boost revealed sterile protection in 
25% of palm— immunized animals, after a 3 to 4 dose immunization protocol, and a 
mean delay of blood-stage patency of 2.3 days compared to naive control mice in the 
rest of the palm— immunized animals. Such long-term protection is unprecedented 
with malaria whole-organism vaccines in the rodent model and encourages further 
optimization attempts. 
Development of immunization protocols with lower and fewer doses is particularly 
important in the context of integrating a safe, affordable and accessible malaria 
vaccine into the expanded program of immunization for infants. Although still elusive, 
such a vaccine should ideally have the capacity to induce potent immune responses 
after as few postnatal care visits as possible. 
Livers of palm— immunized animals showed a significantly lower relative liver 
infection load, even when challenged one year after the last boost, indicating that 
protection against WT challenge also is reflected in lower liver loads (Fig. 3.15). The 
liver loads of immunized mice ranged over three orders of magnitude, which is 
consistent with the variance that was also seen in the initiation of blood-stage 
development after sporozoite challenge (Fig. 3.14). It seems likely that animals with 
very low liver loads correspond to those protected against WT challenge, whereas 
animals with increasing liver loads reflect the shift towards shorter pre-patent periods. 
A small, but significant increase of antigen-experienced CD11ahi CD8+ T and CD4+ T 
cells was observed in the livers of palm–-immunized mice (Fig. 3.16). However, 
overall levels of CD11ahi T cells were very high, rendering this activation marker 
inappropriate. This is probably due to the old age of the mice and might, for instance, 
be caused by unwanted exposure of mice to other pathogens over the long time of 
the experiment.  
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The findings of long-term protection experiments showed that antigen-specific 
effector T cells persist in the target organ even in aging mice. The results also 
corroborate previous findings that CD8+ lymphocytes and IFNγ production, but not 
TNF and IL-2 (Fig. 3.19), play a major role in pre-erythrocytic immunity (Jobe et al., 
2007; Mueller et al., 2007). More IFNγ-producing lymphocytes were found in the liver, 
the site of the first stages of Plasmodium infection, than the spleen. Antigen-specific 
stimulations with the three epitopes revealed that even one year after the last 
immunization, palm—-immunized mice showed higher levels of CD8+ and CD4+ IFNγ-
producing liver lymphocytes, emphasizing the long-lasting protection achieved by 
immunization with palm— sporozoites. However, total numbers of IFNγ-producing 
lymphocytes stimulated with the applied peptide stimulations were overall very low. 
This might be explained by vanishing pathogen-specific lymphocytes over this long 
period or generally small Plasmodium-specific IFNγ-producing lymphocyte 
populations activated by immunization with liver-attenuated, metabolically active 
parasites. 
 
Due to substantial breakthrough infections, direct translation of palm— parasites as 
genetically arrested parasites for human vaccine trials is currently not possible. 
However, palm— parasites illustrate the advantages of tailor-made mutant parasites 
that arrest at a very last moment in liver development, before merozoite release from 
hepatocytes. This likely results in the broadest possible presentation of parasite 
antigens from sporozoite injection until liver merozoite formation. Complete 
attenuation of palm— parasites might be achieved by additional deletions of genes 
that are important for late liver-stage development. Deletion of several genes 
involved in different pathways might have a synergistic effect, preventing merozoite 
release from hepatocytes in multiple ways and thus making GAPs safer. Ideal 
additional gene deletion candidates would also arrest at a very late time point in liver-
stage development and also show expression of late liver-stage and merozoite 
signature proteins. One such candidate might be the cysteine-type protease sera 
repeat antigen 4 (SERA4). Pbsera4— parasites display a two-day delay in 
establishing blood-stage patency and show expression of MSP1 of in vitro cultured 
liver stages (Putrianti et al., unpublished results). Another hypothetical candidate 
gene (PBANKA_110500) that encodes a protein, which is predicted to localize to the 
apicoplast, and was reported to have increased expression in late liver stages (Tarun 
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et al., 2008) was refractory to gene deletion. Therefore, it could not be considered for 
generation of a double knockout (data not shown).  
A tight attenuation would also be important for follow-up immunization studies, 
because no mice would have to be discarded due to breakthrough infections. Once 
late liver-stage arrested parasites have been generated that do not show any 
breakthrough infections in the P. berghei/ C57BL/6 model, side-by-side studies could 
be performed with early arrested GAPs, where immunization doses, boosts, and 
duration of protection could be directly compared. This would then also offer the 
possibility of analyzing the underlying molecular and immunological mechanisms of 
protection, to evaluate if some protective mechanisms are shared between early and 
late arrested GAPs, as it was shown for early arrested GAPs and radiation-
attenuated sporozoites (Kumar et al., 2009). 
However, in addition, safety, production, route of delivery, and storage of genetically 
arrested parasites still need to be optimized before they can realistically be 
considered as malaria vaccines.  
Altogether, I could show that immunizations with palm— parasites induce 
unprecedented potent, long-lasting protection against re-infection in the P. berghei/ 
C57/BL/6 model. These findings suggest that generation of a safe, MSP1-positive, 
genetically arrested parasite line may be an important improvement over first 
generations, which are arrested during onset of liver-stage development.  
 
 
4.3 [Fe-S] cluster biogenesis in the apicoplast of P. berghei 
 
[Fe-S] cluster biogenesis has been well studied in bacteria and yeast, and to a lesser 
extent in other eukaryotes (Balk and Pilon, 2011; Johnson et al., 2005a; Lill and 
Muhlenhoff, 2006; Seeber, 2002; Xu and Moller, 2011). However, very little functional 
data are yet available for apicomplexan parasites.  
In this study I applied in silico analysis to identify nuclear-encoded components of the 
SUF system in various Apicomplexa and analyzed their predicted localization with a 
recently published program (Cilingir et al., 2012a). I then targeted the components of 
the P. berghei SUF system systematically by double-homologous recombination to 
test whether they are essential or not during blood infection in vivo. In T. gondii, 
NFUapi and a complete set of SUF genes, with the exception of SufA, were identified 
(Tab. 3.4). B. bovis and T. annulata only possess  a reduced set of Fe-S cluster 
biosynthesis genes in the apicoplast, namely SufS and, SufS and NFUapi, 
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respectively. However, through the search for Pfam domain PF02657-containing 
genes with OrthoMCL, I could identify two previously unrecognized SufE orthologs, 
namely BBOV_III005960 and TA12620, which were also briefly mentioned in a 
recent review (Seeber and Soldati-Favre, 2010).  
Of note, none of the annotated Toxoplasma gondii SUF proteins contain an 
apicoplast-targeting sequence. For one of the components, TgNFUapi, apicoplast 
localization has been shown experimentally (Sheiner et al., 2011). Assuming that 
gene and protein annotation in the T. gondii genome database is correct, this might 
suggest that the other components of the SUF pathway [Fe-S] cluster biogenesis 
also localize to the apicoplast, despite the uniform absence of a signal peptide and 
apicoplast-targeting sequence. It remains elusive how this alternative targeting to the 
apicoplast might have evolved and if there are specific reasons why all of the SUF 
components in T. gondii are targeted through this alternative pathway. Clearly, other 
apicomplexan parasites target these components through a classical signal peptide 
and apicoplast-targeting sequence-dependent import pathway. 
In Plasmodium spp. a complete set of SUF genes and NFU is present (Seeber and 
Soldati-Favre, 2010). Interestingly, the avian malaria parasite P. gallinaceum appears 
to lack a gene encoding NFUapi, while all SUF elements were readily identified (data 
not shown). As for PALM, this might be easily explained by incomplete sequence 
data available for this Plasmodium species, nevertheless it is striking that another 
gene encoding a Plasmodium apicoplast protein is also missing from its genome. 
Moreover, searching published [Fe-S] cluster-containing proteins in A. thaliana for 
orthologs in Plasmodium spp., new potential [Fe-S] cluster-containing proteins were 
identified (Tab. 3.6). These candidates can now be considered for biochemical 
analysis and evaluation of the possible impact on [Fe-S] cluster biogenesis or 
unrelated metabolic pathways. 
Three independent transfection experiments using the most recent and efficient 
techniques available for experimental genetics in P. berghei showed that the SUF 
genes were refractory to gene deletions. Positive selection of pyrimethamine-
resistant parasites in vivo only yielded WT parasites. This finding suggested that the 
malarial SUF system is critical for survival during blood stage growth (Fig. 3.21). 
However, definitive proof would require additional experimentation, including gene 
complementation and conditional gene ablation strategies, which are unfortunately 
not established in the P. berghei system. Cross-species complementation could 
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prove, that the gene locus can be targeted and might also provide information on 
functional conservation of these proteins in other species.  
Presence of [Fe-S] clusters in the penultimate and ultimate enzymes of the DOXP 
pathway of isoprenoid biosynthesis, ISPG and ISPH, respectively, make it plausible 
that the components of the SUF assembly machinery are refractory to targeted gene 
deletion. In a recent publication it was shown that apicoplast destruction by 
antibiotics treatment in cultured P. falciparum parasites could be compensated for by 
supplementation with IPP, one of the endproducts of the DOXP pathway of 
isoprenoid biosynthesis (Yeh and DeRisi, 2011). However, it remains unclear what 
happens to nuclear-encoded apicoplast proteins upon azithromycin treatment. Are 
these proteins still present in the cytoplasm and can partially fulfill their biological 
functions? In such a scenario apicoplast proteins might fulfill other essential functions 
in blood-stage parasites that are simply not affected by azithromycin treatment. This 
also raises the question if [Fe-S] cluster biosynthesis is essential because of the 
presence of [Fe-S] clusters in enzymes of the DOXP pathway of isoprenoid 
biosynthesis. This hypothesis can be tested in P. falciparum where gene deletions of 
SUF pathway components might be feasible under IPP supplementation. This would 
show whether the DOXP pathway of isoprenoid biosynthesis is the sole reason for 
the essentiality of [Fe-S] cluster biogenesis in the apicoplast in Plasmodium blood 
stages or not. P. berghei parasites cannot be kept in in vitro culture for multiple 
rounds of replication and, hence, this experiment cannot be performed in this model. 
Since transfections are currently not possible in other life cycle stages IPP 
complementation cannot be tested directly.  
The assembly of results presented in this thesis and previously published data on 
apicoplast gene deletion experiments can provide a basis for the evaluation of the 
significance of specific apicoplast pathways and interdependences of these 
pathways, as for the [Fe-S] cluster biosynthesis pathway and [Fe-S] cluster-
containing proteins of other pathways (Fig. 4.1). It is evident that the various 
pathways do not have equal importance for different life cycle stages, as some 
components are refractory to gene deletion in blood stages, such as the SUF genes, 
whereas others can be deleted, but reveal significance for liver stages, as observed 
with PALM and genes involved in fatty acid biosynthesis (Vaughan et al., 2009; Yu et 
al., 2008), or seem to have redundant or non-essential functions, as LipB (Gunther et 
al., 2007), for instance.  
 




Figure 4.1: Updated overview of Plasmodium apicoplast genes targeted for 
gene deletion. 
Shown is an updated overview of apicoplast localized biosynthesis pathways that 
have been targeted for gene deletions in Plasmodium. Apicoplast enzymes 
successfully targeted by transfection plasmids and enzymes refractory to gene 
deletion are depicted in green and red, respectively. Apicoplast proteins that contain 
a [Fe-S] cluster are depicted as brown circles. For references see text in sections 
1.4.2, 1.5 and 1.6. (PPT= phospho-enolpyruvate transporter, PEP= phospho-
enolpyruvate, PDH= pyruvate dehydrogenase, CoA= coenzyme A, FabD= malonyl-
CoA:ACP transacylase, ACP= acyl carrier protein, FabH= b-ketoacyl-ACP synthase 
III, FabG= β-ketoacyl-ACP reductase, FabZ= β-hydroxyacyl-ACP dehydratase, FabI= 
trans-2-enoyl-ACP reductase, FabB/F= β-ketoacyl-acyl-carrier-protein synthase  , 
LipB= lipoate protein ligase, LipA= lipoate synthase, Suf= sulfur utiliuzation factor, 
NFU= nitrogen fixation factor U, TPT= triose phosphate transporter, TrioseP= triose-
phosphate, DXS= DOXP synthase, DXR= DOXP reductosiomerase, IspG= GcpE; 4-
hydroxy-3-methyl-but-2-enyl-diphosphate (HMBPP)-synthase, IspH= LytB; HMBPP-
reductase, DMAPP= dimethylallyl pyrophosphate, IPP= isopentenyl pyrophosphate, 
MiaB= (Dimethylallyl)adenosine-tRNA-methylthiotransferase), DOXP= 1-deoxy-D-
xylulose-5-phosphate) 
 
In contrast, to the SUF genes a PbNFUapi loss-of-function mutant was readily 
obtained (Fig. 3.21). Through the generation of nfu::tag parasites it was possible to 
verify the localization of NFUapi to the apicoplast (Fig. 3.23). During in vitro liver-
stage development nfu::tag parasites were treated with azithromycin to exclude 
mitochondrial targeting, similar to the experiments with PALM-mCherry-myc 
parasites. In this experiment fosmidomycin was also tested. High doses (100µM) of 
fosmidomycin did not abolish apicoplast structures. This finding is in perfect 
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agreement with a recent publication by Baumeister and colleagues, where it was 
shown that up to 100µM of the fosmidomycin derivate FR900098 does not inhibit 
growth of P. berghei liver stages in vitro at 48 hours after infection (Baumeister et al., 
2011). FR900098 activity was also tested in vivo by infection of C57BL/6 mice with 
10,000 P. berghei sporozoites and subsequent treatment with four high doses of 250 
mg/kg FR900098 at 12 hours intervals. Again, no significant difference in parasite 
load could be observed 42 hours after infection. However, others reported that 
fosmidomycin can kill Plasmodium liver-stages (Nair et al., 2011). This apparent 
discrepancy is difficult to reconcile and argues for follow-up experimentation, 
including heterologous expression of a transporter in hepatoma cells and synthesis of 
membrane-permeable derivates of fosmidomycin. 
The only available functional data for NifU-like domain containing proteins in 
apicomplexan parasites to date, is the confirmation of the apicoplast subcellular 
localization of T. gondii NFUapi (TGME49_021920) (Sheiner et al., 2011). 
Furthermore, Sheiner et al. were apparently able to delete TgNFUapi by experimental 
genetics, as the authors listed the gene as non-essential. Yet, no phenotypical data 
on Tgnfuapi— were provided. 
As the P. berghei malaria model allows in depth analysis of the entire life cycle, life 
cycle progression of nfu— parasites was carefully observed (Fig. 3.22). Despite not 
being critical, PbNFUapi seems to fulfill an auxiliary function. Presence of NFUapi 
results in a more efficient release of merosomes and thus a slightly faster onset of 
blood stage infection following sporozoite inoculation. In other organisms NifU-like 
proteins have been shown to act as [Fe-S] cluster scaffolds (Touraine et al., 2004; 
Yabe et al., 2004) and NFUapi might present an alternative scaffold to SufA. The 
plant-type ferredoxin, a [Fe-S] cluster-containing protein in the apicoplast of 
Plasmodium (Vollmer et al., 2001), was proposed to function as a reductant in a light-
independent manner, for example in the desaturation of fatty acids (Schmidt and 
Heinz, 1990; Wada et al., 1993). If deletion of NFUapi would influence ferredoxin 
activity, this hypothesis might explain the observed defect in merosome formation 
where high amounts of fatty acids are required for the membranes of tens of 
thousands of invasive merozoites.  Interestingly, it was shown that the [2Fe-2S] 
cluster-containing NifU of cyanobacterium Synechocystis PCC6803 possesses the 
ability to deliver its [2Fe-2S] cluster to apoferredoxin (Nishio and Nakai, 2000) and 
thus provides a rationale for further investigations on the role of Plasmodium NFUapi 
on the maturation of the plant-type ferredoxin.          
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It should also be considered that all analyses of nfu— parasites were performed in 
vivo or under optimal culture conditions. In Escherichia coli deficiencies in the SUF 
pathway do not result in phenotypes under normal growth conditions. However, when 
cultured in low iron (Outten et al., 2004) or increased oxidative stress conditions 
(Nachin et al., 2003; Zheng et al., 2001), bacteria demonstrate marked growth 
problems. Another NifU-like protein in E. coli, NfuA, was also shown to be required 
for maturing of [Fe-S] cluster proteins under oxidative stress and iron starvation 
conditions (Angelini et al., 2008). Therefore it would be interesting to test nfu— 
parasites under stress conditions. One possibility would be to study in vitro liver 
stage development in the presence of iron chelators or in medium with decreased 
iron content. It is tempting to speculate that under such suboptimal conditions nfu— 
parasites might reveal a stronger deficiency in development.  
In conclusion, the results of this study and the absence of a plastid-like SUF system 
in humans, provide the first genetic evidence for the importance of the Plasmodium 






In the presented study I could characterize a previously unrecognized Plasmodium-
specific apicoplast protein, termed PALM. The distinct and important role of PALM for 
full development of liver-stage merozoites and establishment of blood-stage infection 
in the vertebrate host are important findings. However, the biochemical function of 
PALM remains to be determined.  
Recombinant expression and purification of PALM in E. coli would be required to 
initiate biochemical studies. Crystallization and successful x-ray structure 
determination might reveal possible functions, assuming that it displays structural 
similarity to previously described proteins. Purified PALM protein might also indicate 
if PALM binds iron, as other iron-binding proteins display a distinct brown color upon 
purification (Raux-Deery et al., 2005). 
The search for proteins that interact with PALM might provide information on the 
biological function(s) and involvement in metabolic pathways. To find interaction 
partners, complementary methods can be applied including co-immunoprecipitation 
of Plasmodium liver-stage lysates with PALM-mCherry-myc parasites or 
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recombinantly expressed PALM and a yeast-2-hybrid screen with PALM as bait 
against a Plasmodium liver-stage library. However, biochemical studies with 
Plasmodium liver stages are not trivial as the parasite material is very limited and 
development of biochemical assays and metabolome profiling has not been 
established yet. Microarray analysis in palm— parasites could give additional 
indications if genes are upregulated to compensate for the loss of PALM. 
As an alternative approach, PALM could be transgenically expressed in T. gondii 
were no PALM ortholog is present. This could reveal if its presence alters parasite 
growth or egress. Similarly, PALM could also be overexpressed in P. berghei by 
placing it under a strong liver-stage promoter. Possible scenarios might be larger 
liver-stage parasites, growth deficiencies because of toxic effects, and/or premature 
merozoite formation. 
Altogether, the characterization of PALM knockout mutants provides an exciting 
opportunity to discover missing pieces in the puzzle of Plasmodium liver-stage 
development. Identification of PALM functions might reveal new apicoplast pathways 
that are tailor-made for efficient pre-erythrocytic development in the liver. 
 
Immunizations with palm— sporozoites as whole-organism vaccine yielded promising 
improvements over previous studies, including fewer immunization doses and long-
term protection. These results encourage the development of late liver-stage 
genetically arrested parasites that express blood-stage antigens. To achieve safe 
attenuation without breakthrough infections, multiple genes should be deleted. 
Differential gene expression with upregulation in late liver stages might be a helpful 
tool to identify additional candidates for genetic targeting. However, it should be kept 
in mind that it would only be a first indication as another candidate with a similar 
expression profile to PALM was refractory to gene deletion in blood stages 
(PBANKA_110500). Moreover, one candidate (NFUapi) could be deleted, but did not 
show an essential function during liver-stage development. In addition, late liver-
stage arrested parasites in the rodent malaria model are needed to be rigorously 
tested in pre-clinical research before advancing to clinical trials. 
 
My experimental findings argue for the essential role of [Fe-S] cluster biogenesis in 
the apicoplast of Plasmodium. Expression analysis of [Fe-S] cluster biogenesis 
genes in different parasite life cycle stages can provide additional indications, 
whether [Fe-S] cluster biogenesis and all proteins involved are equally important in 
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all life cycle stages. Higher or reduced expression levels would suggest critical and 
less important roles. Generation of conditional knockout mutants in T.gondii could 
provide additional proof for the proposed central role of [Fe-S] cluster biogenesis in 
parasite survival. Follow-up analysis of [Fe-S] cluster biogenesis could also include 
cross-species complementation with bacterial, plant or other apicomplexan orthologs 
to analyze if protein function is conserved among these species. 
A recent study provided the first biochemical analysis of SUF proteins (Kumar et al., 
2011). Certainly further analyses will help to unravel specific functions of the proteins 
involved in [Fe-S] cluster biogenesis in Plasmodium. This may or may not confirm 
functions that have been already described for orthologs in other species.  
The proposed auxiliary function of NFUapi might be connected to the desaturation of 
fatty acids through the [Fe-S] cluster-containing plant-type ferredoxin. In another 
organism, the cyanobacterium Synechocystis, NFU was shown to transfer the [Fe-S] 
cluster to apoferredoxin (Nishio and Nakai, 2000). This provides an exciting 
hypothesis for the role of PbNFUapi in the formation of liver-stage merozoites where 
high amounts of fatty acids are required for the membranes of the merozoites. Future 
investigations on the functions of PbNFUapi should consider this possibility. As a first 
step, a possible direct interaction of PbNFUapi and plan-type ferredoxin could be 
tested. 
The biogenesis of [Fe-S] clusters in the mitochondrion and the cytoplasm remains to 
be investigated. It will be interesting to see if they are equally important as in the 
apicoplast and if assembly in the cytosol is dependent on one of the organellar [Fe-S] 
clusters biosynthesis pathways. 
Many mysteries, such as the source of iron for [Fe-S] clusters and the exact functions 
of all components, are yet to be unraveled and the presented results on [Fe-S] cluster 
biogenesis may serve as a starting point to kick off future studies on this exciting, yet 
for so long mostly disregarded, pathway. 
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A   adenosine 
ACP    acyl carrier protein 
A. stephensi Anopheles stephensi 
A. thaliana   Arabidopsis thaliana 
ATP   adenosine trisphosphate 
ATS   apicoplast targeting signal 
B. bovis   Babesia bovis 
bp    base pairs 
BS   blood stages 
C   cytosine 
°C   degrees celcius 
cat.   catalogue 
CD   cluster of differentiation 
cDNA  complementary DNA 
CIA   cytosolic iron-sulfur protein assembly 
C. parvum   Cryptosporidium parvum 
CSP   circumsporozoite protein 
C-terminal   carboxy terminal 
d   days 
DHFR/TS  dihydrofolate reductase-thymidilate synthetase 
DMEM  Dulbeccoʼs Modified Eagle Medium 
DMSO  dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
ECM   experimental cerebral malaria 
E. coli   Escherichia coli 
EDTA  ethylendiamine-tetraacetate 
dNTP  deoxynucleoside triphosphate 
DOXP  1-deoxy-D-xylulose 5-phosphate 
EEF    exo-erythrocytic form 
ER    endoplasmatic reticulum 
FACS  fluorescence activated cell sorter 
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FAS II   fatty acid synthesis type II 
FCS    fetal calf serum 
g   gram 
G   guanosine 
GAP    genetically attenuated parasite 
GAPDH   glyceraldeyde-3-phosphate dehydrogenase 
GFP    green fluorescent protein 
h   hours 
hpi   hours post infection 
HSP70   heat shock protein 70 
ID   identification 
IFA   immunofluorescence assay 
IFN   interferon 
IL   interleukin 
IPP   isopentenyl diphosphate 
ISC   iron-sulfur cluster 
i.v.   intravenous 
kb   kilo bases 
KO    knockout 
l    liter 
LB medium  Luria-Broth medium 
LS    liver stage 
m    milli  
M   molar 
min    minutes 
mRNA   messenger ribonucleic acid 
MSP1   merozoite surface protein 1 
NIF   nitrogen fixation  
nm    nanometer 
NMRI   Naval Medical Research Institute 
N-terminal   amino terminal 
No.   number 
ORF   open reading frame 
P.    Plasmodium 
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PALM Plasmodium apicoplast protein important for liver merozoite 
formation 
pBART  Plasmodium berghei adaptable recyclable transfection plasmid 
PBS    phosphate buffered saline 
PCR   polymerase chain reaction 
PDH    pyruvate dehydrogenase 
pH    potentia hydrogenii 
PV   parasitophorous vacuole 
PVM   parasitophorous vacuole membrane 
RAS    radiation attenuated sporozoites 
RNA    ribonucleic acid 
qPCR  quantitative real-time PCR 
rpm    rotations per minute 
RT   room temperature 
RT-PCR  reverse transcription polymerase chain reaction 
s   seconds 
SD    standard deviation 
sg    salivary gland 
SP    signal peptide 
spp.    species 
spz    sporozoite 
SUF    sulfur utilization factor 
T   thymidine   
Taq    Thermus aquaticus 
T. gondii   Toxoplasma gondii 
TNF   tumor necrosis factor 
TP    transit peptide 
UIS   upregulated in infective sporozoites 
UTR    untranslated region 
V    volt 
WT    wildtype 
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